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Abstract 
The ultimate aim of periodontal treatment is to regenerate the tissue lost during 
the  disease  process,  thereby  restoring  the  aesthetics  and  function  of  the 
periodontium.  Guided  tissue  regeneration  (GTR)  is  one  technique  that  is  used 
clinically to promote tissue regeneration.  The technique employs a membrane to 
create space in the appropriate surgical site to produce periodontal regeneration.  
However  there  may  be  considerable  potential  to  improve  the  outcomes  of  this 
technique by development of novel membrane materials.  
The aim of the studies described in this thesis was to investigate the potential of 
polylactic acid calcium phosphate (PLA Ca P) composite materials to be developed 
into  a  GTR  membrane  with  increased  potential  for  producing  periodontal 
regeneration.    Ca  P  materials  included  nano hydroxyapatite  (n HA)  and  ß  tri 
calcium  phosphate  (ß TCP).    PLA Ca  P  composite  films  were  produced  by  the 
solvent casting method. The Ca P powders and the PLA Ca P composite films were 
characterized.  The degradation of PLA Ca P composites was analysed in phosphate 
buffer saline (PBS).  The bioactive potential of the composite films was determined 
in  simulated  body  fluid  (SBF).    The  growth  and  differentiation  of  PDL  cells  and 
osteoblasts were assessed on PLA nHA composite films and the ability of these films 
to carry platelet derived growth factor (PDGF) and its effect on osteoblast growth 
was  investigated.    Further,  fibre  reinforced  PLA HA  composite  membranes  were 
fabricated and their mechanical strength and kinetics of protein interactions were 
investigated. Finally mandibular alveolar bone profiles were analyzed to define the 
possible shapes required for manufacture of GTR membranes.  
Results showed that Ca P decreased the degradation and increased the bioactivity 
of  the  PLA Ca  P  composite  films.    The  cell  proliferation  on  composite  films 
containing  10  wt  %  nHA  was  high  when  compared  to  PLA  films.  However,  cell 
proliferation decreased with increase in nHA concentration. The highest alkaline 
phosphate activity (ALP) was shown by cells on composite films containing 70 wt % 
nHA.  The  PDGF  added  to  the  PLA nHA  composite  films  retained  its  activity  and 
increased the proliferation of osteoblasts. The flexural strength was high for the  
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fibre reinforced PLA HA composite membranes, containing maximum number of PLA 
fibres laid at 0°. The fibre reinforced membranes containing HA showed gradual 
and sustained protein release compared to fibre reinforced membranes without HA. 
The  analysis  of  alveolar  bone  profiles  of  different  patients  showed  marked 
similarities between each other, suggesting that only a few membrane shapes may 
be required to fit most patients in clinical use.     
These  studies  demonstrate  the  potential  of  fibre  reinforced  PLA HA  composite 
material  to  be  used  for  the  production  of  preshaped  GTR  membranes  with 
favourable properties to increase periodontal regeneration. Acknowledgements 
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CHAPTER 1: LITERATURE REVIEW 
   
1.1 INTRODUCTION 
Periodontal  diseases  are  common  and  in  their  advanced  stages  can  lead  to 
severe periodontal tissue loss, ultimately resulting in tooth loss. Different modes 
of treatments ranging from scaling the teeth to the use of advanced techniques 
such as bone grafts and guided tissue regeneration (GTR) have been employed 
for treatment of periodontal diseases depending on the severity of disease and 
amount of tissue loss. In the last two decades GTR has evolved as an effective 
mode of treatment for regeneration of periodontal tissues lost during the disease 
process.  GTR  has  helped  to  overcome  the  limitations  and  disadvantages 
associated with other regeneration techniques. However there is still a need for 
research to optimise and improve the results possible with the use of GTR. GTR 
works on the principle of blocking the invasion of competing non osteogenic soft 
tissue cells into the wound defect area by placement of a membrane over the 
bone  defect.  The  membrane  maintains  a  space  between  the  defect  and  soft 
tissue and allows periodontal ligament and bone cells to repopulate the space.  
Both  resorbable  and  nonresorbable  membranes  have  been  used  for  GTR 
procedures, however the membranes used have limitations and the results with 
these  membranes  have  been  modest.  Thus  there  is  a  need  to  develop  a 
membrane with better mechanical properties with the ability to deliver growth 
factors and to facilitate tissue regeneration.  
This  study  aims  towards  making  a  composite  membrane  for  GTR  procedures, 
with better mechanical and physical properties, and with the ability to release 
bioactive  proteins  at  the  defect  site  to  facilitate  and  accelerate  the 
regeneration process. 
 
 Chapter 1 
  25 
1.2 PERIODONTIUM  
The periodontium consists of tissues that surround and anchor the tooth in the 
alveolar  processes  of  maxilla  and  mandible.  The  periodontium  includes:  (a) 
Gingiva, (b) Periodontal ligament, (c) Cementum and (d) Alveolar bone (Figure 
1.1).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Schematic presentation of periodontium [adapted from Suchanek et al., 2002]. 
 
The  characteristics  of  a  healthy  periodontium  are  shown  in  Figure  1.2.The 
functions of the periodontium include: 
  a) To provide a tissue seal at the cervical portion of the tooth.  
  b) To provide support to the teeth during mastication 
  c) To hold the tooth in the socket 
  d) To protect the dentine Chapter 1 
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   e) Mechanoresponsive regulation of mastication  
 
Figure 1.2 Schematic drawing of a healthy periodontium [from Rose, 2004]. 
 
1.2.1 Gingiva    
Gingival tissue covers the alveolar processes of the jaws and cervical portions of 
the teeth and provides a seal around the cervical portions of the teeth. It is 
composed of an outer layer of epithelium and an inner core of connective tissue 
called the lamina propria. The healthy gingiva is pale pink, however, the colour 
may  vary  depending  on  epithelial  thickness,  keratinisation,  vascularity  and 
pigmentation. The gingiva consists of free and attached gingiva (Figure 1.3). 
The free gingiva is also called the marginal or unattached gingiva. It surrounds 
the tooth at the region of the cemento enamel junction (CEJ). It consists of the 
gingival tissue from the gingival margin to the free gingival groove. The space Chapter 1 
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Free gingiva 
 
Attached gingiva 
between the free gingiva and tooth surface is called the gingival sulcus. It meets 
the tooth in a thin rounded margin called the gingival margin.   
The  attached  gingiva  is  located  between  the  free  gingiva  and  the  alveolar 
mucosa and is tightly attached to the cementum of the cervical third of the 
tooth and to the periosteum of the alveolar bone. Healthy attached gingiva is 
pink and has stippling which is caused by the presence of connective fibres that 
attach  the  gingival  tissue  to  the  cementum  and  the  bone.  Attached  gingiva 
provides  support  to  the  gingival  tissue  during  mastication,  talking  and  tooth 
brushing [Rose, 2004].  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Schematic presentation of free and attached gingiva [dapted from Eley and 
Manson, 2004]  
 
The epithelium of gingiva, which is a keratinized stratified squamous epithelium, 
is divided into four cell layers depending on the degree of keratin producing cell 
differentiation. These layers are the basal cell layer, prickle cell layer, granular 
cell layer and keratinized cell layer. Keratin producing cells comprise 90% of the 
total  cell  population  of  the  oral  epithelium;  other  cells  present  in  the  oral 
epithelium are melanocytes, Langerhan’s cells, Merkel’s cells and inflammatory 
cells.      
The connective tissue of gingiva consists of collagen fibres (60%), vessels and 
nerves (35%), fibroblasts and other cells (5%).  The collagen fibres of gingival 
connective  tissue  are  produced  by  fibroblasts,  which  are  the  main  cells  of Chapter 1 
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connective tissue and comprise 65% of total cell population. Other cells present 
are  mast  cells,  macrophages  and  inflammatory  cells.  The  cells,  nerves  and 
vessels are embedded in a matrix which is mainly produced by fibroblasts [Nanci 
and Ten Cate, 2003].  
1.2.2 Periodontal Ligament   
The  periodontal  ligament  (PDL)  is  a  soft  connective  tissue  which  is  highly 
vascular and cellular. It covers the tooth root and attaches it to the bone of the 
tooth socket. The periodontal ligament is composed of fibre bundles which are 
attached to the cementum on one side and to the alveolar bone of the tooth 
socket on the other side. The length of periodontal ligament fibres is in the 
range of 0.2   0.4mm depending on their position around the tooth root.  
PDL  contains  osteoblasts,  osteoclasts,  cementoblasts,  fibroblasts  and 
undifferentiated  mesenchymal  cells.  Undifferentiated  mesenchymal  cells 
present  in  the  PDL  can  differentiate  into  osteoblasts,  cementoblasts  and 
fibroblasts when a suitable trigger is applied. PDL cells can play an important 
role  during  alveolar  bone  regeneration  and  during  normal  alveolar  bone 
formation  [Hosoya  et  al.,  2008;  Zhou  et  al.,  2008].  Studies  have  shown  that 
regeneration of periodontal tissue can be achieved when epithelial and gingival 
connective  tissue  cells  are  blocked  and  cells  from  periodontal  ligament  are 
allowed to repopulate the healing area [Gottlow et al., 1984]. Progenitor PDL 
cells  differentiate  into  cementoblasts  on  direct  contact  with  root  dentin 
[Hasegawa et al., 2005]. It is still not clear whether a single progenitor cell gives 
rise  to  daughter  cells  which  then  differentiate  into  different  cell  types,  or 
whether separate progenitor cells are present for each cell type [Nanci and Ten 
Cate, 2003].  
The fibres of periodontal ligament are divided into five groups depending on 
their location (Figure 1.4): 
Alveolar crest:  Extend from the cervical cementum to the alveolar crest. They 
resist lateral forces and retain the tooth in the alveolus.  Chapter 1 
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Horizontal: Present just below the alveolar crest fibres and their orientation is 
perpendicular to the long axis of the tooth. 
Oblique: Extend from the cementum and run diagonally towards the crown of 
the  tooth  inserting  in  the  alveolus.  These  fibres  provide  resistance  against 
axially directed forces. 
Interradicular:  Present between the roots of multi rooted teeth, they prevent 
tipping and extrusion of the teeth. 
Apical:  Present at the apex of the root. They prevent the extrusion of teeth 
and provide protection to the blood vessels and nerve supply of teeth.  
 
 
 
 
 
 
 
Figure 1.4: Schematic presentation of PDL fibres [adapted from Nanci and Ten Cate, 2003] 
 
The PDL has the following functions: 
Supportive  function:  PDL  attaches  and  maintains  the  teeth  in  the  alveolar 
sockets.  PDL  allows  the  transfer  of  forces  generated  during  mastication  and 
tooth contact to be transferred to and absorbed by the alveolar bone.  
Nutritive function: It provides nutrition to the bone and the cementum. Chapter 1 
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Sensory function: Sensory feelings such as pain and pressure are provided to the 
tooth by the PDL. 
Formative function: It builds up and maintains cementum and alveolar bone of 
the tooth socket.  
Resorptive  function:  In  response  to  the  pressure  the  PDL  can  remodel  the 
alveolar bone, as occur during orthodontic procedures.  
1.2.3 Alveolar Bone 
Alveolar  bone  surrounds  and  supports  the  tooth  root.  The  development  of 
alveolar bone is dependent on the presence of teeth. Alveolar bone resorbs after 
the extraction of teeth and does not develop if teeth do not erupt. Alveolar 
bone constantly undergoes remodelling depending on its functional stimuli. The 
outer surfaces of alveolar processes consist of compact bone which overlies a 
trabecular bone structure. There are numerous small canals in the alveolar walls 
through  which  vessels  and  nerves  enter  the  periodontal  ligament  space.  The 
layer of the bone into which the fibres are inserted is sometimes referred to as 
“bundle bone” and it has many features similar to root cementum in respect of 
function and structure. The compact bone on the superficial/outer aspects of 
the alveolar processes varies in thickness. In the  maxilla, the buccal cortical 
bone  in  the  incisor,  canine  and  premolar  regions  is  thin,  but  thicker  at  the 
buccal and palatal aspect of the molars. In the mandible the cortical bone is 
thinner on the buccal aspect of the incisors and premolar, whereas in the molar 
region it is thinner on the lingual aspect than on the buccal aspect. Alveolar 
bone like other bones consists of bone matrix and bone cells [Rose, 2004].  
1.2.3.1  Bone Matrix 
Bone matrix consists of organic collagen fibres, ground substance and inorganic 
bone minerals (Table 1.1). Toughness and stiffness of bone is provided by its 
mineral  content  whereas  collagen  provides  bone  with  tensile  strength  and 
flexibility [Murugan and Ramakrishna, 2005]. The organic matter consists of type 
I  collagen  and  amorphous  ground  substance  containing  proteoglycans, 
glycoproteins, glycosaminoglycans, lipids and peptides [Triffitt and Owen, 1973]. Chapter 1 
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The  organic  matter  of  bone  is  produced  by  osteogenic  cells  which  are  then 
surrounded by this organic matter. 90% of the organic matrix is collagenous and 
these collagen fibres in association with hydroxyapatite gives bone its stiffness 
and strength. Noncollagenous protein and ground substance act as a cementing 
agent for collagen fibres and crystals. They also play a role in mineralisation of 
the bone.     
The inorganic matter makes up 50% of the dry weight of bone matrix and mainly 
consists  of  calcium  and  phosphorus  in  addition  to  bicarbonate,  citrate, 
magnesium, potassium and sodium ions [Damien and Parsons, 1991]. Calcium and 
phosphorus form substituted hydroxyapatite crystals having the composition Ca10 
(PO4)6(OH) 2 with the substances also including CO3, Si and Fl. 
Table 1.1: Composition of bone matrix [adapted from  Murugan and Ramakrishna, 2005] 
Inorganic components  Organic components 
                                                Wt% 
Hydroxyapatite                           60 
Carbonate                                   4 
Citrate                                        0.9 
Sodium                                        0.7 
Magnesium                                  0.5 
Others:  Cl
 ,  F
 ,  K
+,  Sr
2+,  Pb
2+,  Zn
2+, 
Cu
2+, Fe
2+ 
                                                   Wt% 
Collagen                  20 
Water                   9 
Non collagenous proteins               3 
                                                          
 
Others:  Polysaccharides,  lipids, 
cytokines                                       
 
1.2.3.2  Bone Cells 
The three main cells of bone are osteoblasts, osteocytes and osteoclasts. These 
cells are responsible for the production, maintenance and resorption of bone 
respectively. In addition to these cells, bone also contains mesenchymal stem 
cells which are present in the bone marrow and which act as a cell reservoir 
[Weiss, 1988]. These stem cells can differentiate into different cell types which 
include osteoblasts, chondrocytes, myocytes and adipocytes (Figure 1.5) [Aubin, 
1998; Spagnoli et al., 2009].  
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Figure  1.5:  Schematic  presentation  of  bone  mesenchymal  stem  cells  differentiation  into 
different cells types showing the three major cell lines they can form [adapted from Aubin, 
1998]. 
 
Osteoblasts:  Osteoblasts are the bone producing cells which are derived from 
multipotent mesenchymal stem cells, and are present at the surface of the bone 
tissue.  They  synthesize  and  secrete  the  organic  component  of  bone  matrix 
including type I collagen, proteoglycans and glycoproteins between the cell and 
the mineralized matrix [Gorski, 1998]. During active production of bone matrix 
osteoblasts have cuboidal or columnar shape (Figure 1.6) and have high alkaline 
phosphatase activity, however as their activity declines they become flattened 
[Barrere et al., 2006]. Active osteoblasts produce a new layers of uncalcified 
matrix  (osteoid),  calcium  salts  are  subsequently  deposited  into  this  newly 
formed matrix thus completing the process of bone apposition. When entrapped 
in  newly  formed  matrix  osteoblasts  become  osteocytes.  As  matrix  is  formed 
around  the  cell  and  cytoplasmic  process,  lacunae  and  canaliculi  appear 
[Junqueira and Carneiro, 2005].   Chapter 1 
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Figure 1.6: Bone forming osteoblasts depositing new bone [adapted from Junqueira and 
Carneiro, 2005]. 
 
Osteoblasts also play a part in the calcification of the bone by regulating the 
flow  of  calcium  and  phosphate  through  bone.  It  is  believed  that  in  bone 
remodelling the growth factors released during the bone matrix resorption by 
osteoclasts  causes  the  preosteoblast  cells  to  differentiate  into  osteoblasts 
[Martin, 2009]. Plasma membranes of active osteoblasts contain high amounts of 
alkaline phosphatase which is a marker for the osteoinductive nature of the cell. 
Alkaline  phosphatase  from  osteoblasts  tends  to  cause  cleavage  of  organically 
bound  phosphatase  which  in  turn  contributes  to  the  initiation  and  growth  of 
mineral crystal of bone. Osteoblasts also produce certain cytokines and growth 
factors in addition to matrix protein. These growth factors, which include bone 
morphogenic proteins 2 (BMP 2) and 7 (BMP 7), insulin like growth factors (IGF), 
fibroblast  growth  factors  (FGF)  and  platelet  derived  growth  factors  (PDGF) 
increase the process of bone formation and repair. Parathyroid hormone (PTH), 
which is the most important hormone affecting bone (high concentration=>bone 
resorption,  low  concentration=  >bone  formation),  works  by  controlling  the 
secretion of growth factors and cytokines. When bone is not being formed the 
inactive osteoblasts become flat and extend along the bone surface, these cells 
are termed as bone lining cells. These cells control the mineral homeostasis by 
forming the gap junctions with osteocytes [Weiss, 1988; Nanci and Ten Cate, 
2003].     
 
 
Osteoblasts 
 
Newly formed 
bone matrix 
Osteocyte Chapter 1 
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Osteocytes:    During  the  process  of  bone  deposition  some  of  the  osteoblasts 
become trapped inside the matrix. These osteoblasts are then called osteocytes. 
The  number  of  osteoblasts  being  surrounded  by  matrix  and  converted  into 
osteocytes  is  directly  proportional  to  the  speed  of  bone  formation.  Initially 
osteocytes resemble osteoblasts, however with time their size reduces and they 
become flat, almond shaped with reduced Golgi complex and rough endoplasmic 
reticulum.  The  spaces  occupied  by  osteocytes  inside  the  matrix  are  called 
lacunae. Lacunae for younger osteocytes are round, however as the osteocytes 
mature  and  their  size  reduces,  the  lacunae  also  become  oval  or  lenticular. 
Lacunae have narrow extensions called canaliculi which house the cytoplasmic 
processes of osteocytes and are formed by deposition of matrix around these 
processes (Figure 1.7). The cells make contact and exchange of molecules takes 
place with the adjacent osteocytes and with the bone lining cells through these 
processes. Osteocytes are responsible for the maintenance of bone matrix and 
the matrix is resorbed following the death of these cells [Weiss, 1988; Nanci and 
Ten Cate, 2003].  
Osteocytes play an important role in maintaining the integrity and vitality of the 
bone, especially in repairing micro fractures. Osteocytes detect the biochemical 
and mechanical changes and transmitting the signal through their processes to 
osteoblasts and osteoclasts or to bone lining cells [Lanyon, 1987].  
 
 
 
 
 
 
Figure 1.7: Schematic drawing of osteocytes present in lacunae arranged between lamellae 
[adapted from Junqueira and Carneiro, 2005].  
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Osteoclasts:  Osteoclasts  are  bone  resorbing  cells  and  are  of  hematopoietic 
origin. They are large cells ranging from 20  m to more than 100  m in diameter 
and  are  multinucleated,  containing  from  5  to  50  nuclei.  Osteoclasts  contain 
abundant mitochondria which are scattered throughout the cytoplasm and Golgi 
complexes  which  are  present  around  multiple  nuclei.  Osteoclasts  can  be 
cytochemically distinguished from the multinucleated giant cells by the presence 
of tartrate resistant acid phosphatase in their cytoplasmic vesicles and vacuoles. 
Acid, collagenase and other proteolytic enzymes secreted by osteoclasts attack 
the  bone  matrix  thus  liberating  the  calcified  ground  substance  and  also 
eliminate the debris produced during bone resorption.  In the areas where active 
bone resorption is taking place they sit in enzymatically etched depressions in 
the matrix which are known as Howship’s lacunae. When osteoclasts are active 
their bone facing surface is folded into irregular, subdivided projections, which 
are known as the ruffled borders. The importance of this ruffled border is seen 
in  osteopetrosis,  a  genetic  disease  in  which  osteoclasts  lack  ruffled  border 
formation, which renders them incapable of bone resorption. A cytoplasmic zone 
which is devoid of organelles and rich in actin, vinculin and talin surrounds the 
ruffled border. This zone creates a microenvironment between the cell and the 
bone matrix and provides cell adhesion to the site. Lysosomal enzymes which are 
synthesized  in  the  rough  endoplasmic  reticulum  are  transported  to  Golgi 
complex from where these enzymes are transported to  the ruffled border. A 
proton  pump,  which  is  associated  with  the  ruffled  border  creates  an  acidic 
microenvironment and causes demineralisation of the bone thus exposing the 
organic matrix (Figure 1.8). The exposed organic matrix is then degraded by the 
released enzymes [Barrere et al., 2006].  
The  activity  of osteoclasts  is  regulated  by  cytokines  which are  local  proteins 
mediators and calcitonin which is a thyroid hormone. Although osteoclasts do 
not have receptors for parathyroid hormone, when osteoblasts are activated by 
parathyroid hormone they produce cytokines which in turn activate osteoclasts 
[Junqueira  and  Carneiro,  2005].    Osteoblasts  play  an  important  role  in  the 
regulation  of  osteoclasts  as  they  produce  M CSF  and  RANKL  which  affect  the 
proliferation and differentiation of osteoclast precursor cells. M CSF stimulate 
the  proliferation  of  osteoclast  precursors  cells  by  binding  to  c Fms  which  is 
present on the cells surface.  Whereas RANKL produced by osteoblasts triggers Chapter 1 
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osteoclast  precursors  differentiation  into  mature  osteoclasts  [Hughes  et  al., 
2006].   
 
 
 
 
 
 
 
 
Figure 1.8: Schematic presentation of bone resorption process by an osteoclast [adapted 
from Junqueira and Carneiro, 2005].   
 
In  bone  remodelling,  osteoclasts  resorb  a  certain  amount  of  bone  and  die, 
leaving  the  space  to  be  filled  by  mesenchymal  cells  that  differentiate  into 
osteoblasts and form bone [Martin, 2009].  
1.2.4 Cementum 
Cementum is a thin layer of hard and mineralized tissue which covers the root of 
the tooth, it is yellow in colour and covers the dentine. The matrix of cementum 
consists of calcified collagenous fibrils, mucopolysaccharides and glycoproteins, 
the mineral content is apatite. The main collagen fibres of cementum are of 
type I, however it also contains <5% of type III collagen fibres [Christner et al., 
1977]. There are two main types of cementum, acellular which covers the upper 
portion  of  the  root  and  cellular  which covers  the  lower  portion  of  the  root. 
Cellular cementum plays an adaptive role in response to tooth movement and 
wear. Cementum is produced by cells called cementoblasts which do not have a 
regular  shape  and  are  differentiated  from  PDL  fibroblasts  by  their  close 
proximity to cementum. Cementoblasts, like osteoblasts, have receptors for PTH 
[Zhang  et  al.,  1992].  The  origin  of  cementoblasts  is  considered  to  be  from Chapter 1 
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Hertwig’s
 epithelial root sheath (HERS) [Hammarstrom et al., 1996; Bosshardt, 
2005]. Recent studies have shown that enamel matrix proteins (EMPs) can cause 
porcine  bone  marrow derived  stromal  cells  (BMSCs)  to  differentiate  into 
cementoblasts  [Song  et  al., 2007].  Cementum  is  more  resistant  to  resorption 
than bone which makes it possible for teeth to be moved by orthodontic forces 
as they cause the resorption of alveolar bone for tooth movement without the 
resorption  of  the  root.  It  is  suggested  that  cementoblasts  are  generally 
nonresponsive to mechanical stimulation. Cementum does not resorb or remodel 
extensively. However it is deposited throughout life. Cementum lacks its own 
blood or nutrient supply and receives its nutrients from the PDL [Nanci and Ten 
Cate, 2003].  
Cementum  plays  an  important  part  of  holding  the  tooth  in  the  socket  by 
providing anchorage to the ends of the PDL.  PDL fibres are present between 
cementoblasts  and  are  inserted  into  the  cementum  produced  by  these. 
Cementum  protects  the  dentine  and  provides  a  seal  for  the  open  dentinal 
tubules. Toothwear at the occlusal or incisal surface of the teeth is compensated 
by the formation of cementum at the apical area of the tooth [Weiss, 1988].   
1.3 DISEASES OF THE PERIODONTIUM 
The  primary  aetiological  factor  associated  with  periodontal  disease  is  the 
accumulation  of  dental  plaque  around  the  gingival  margin  and  interdental 
gingiva on the tooth. The accumulation of plaque changes the microbial flora to 
pathogenic leading to mild to moderate gingivitis or severe periodontitis. 
1.3.1 Gingivitis 
Gingivitis is inflammation of the gingiva. It is characterised by changes in the 
color, contour and consistency of the gingival tissue (Figure 1.9). Gingivitis can 
be divided into plaque induced and nonplaque induced gingival inflammation. 
Plaque induced gingivitis can be further subdivided into plaque induced gingivitis 
with  and  without  other  local  or  systemic  aggravating  factors.  These  factors 
include pregnancy, diabetes mellitus and certain medications [Seymour et al., 
2000].  In  pregnancy  the  fluctuation  of  hormones  causes  enhanced  growth  of Chapter 1 
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certain plaque flora, whereas some drugs such as phenytoin and cyclosporin can 
cause the enlargement of gingiva in plaque induced gingivitis [de Oliveira Costa 
et  al.,  2006].  In  diabetes  mellitus  the  gingival  inflammatory  condition  is 
aggravated as antibacterial host response is compromised. Nonplaque induced 
gingivitis can be caused by fungal, bacterial and viral infections [Scully et al., 
1998].  Hypersensitivity  to  certain  restorative  materials  and  other  oral  care 
products  can  also  produce  gingival  inflammation  resembling  plaque  induced 
gingivitis [Holmstrup, 1999].   
 
Figure 1.9: Schematic drawing of gingivitis [from Rose, 2004]. 
 
Gingivitis is a reversible condition with no permanent tissue damage and resolves 
when  its  aetiology  is  removed  [Mariotti,  1999].  Blood  flow  to  the  gingiva 
increases,  which  gives  the  gingiva  a  red  appearance.  The  gingiva  becomes 
swollen as a result of the leaking of leukocytes and plasma proteins from the 
capillaries into the connective tissue. Gingival pockets are formed in gingivitis Chapter 1 
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due to gingival enlargement caused by swelling or fibrosis. At this stage there is 
no damage to PDL and alveolar bone. In most cases the body’s immune system is 
adequate to counter bacterial infection and with patient self care and treatment 
gingivitis is resolved and the tissue returns to a healthy state.  
In many untreated cases gingivitis may persist for years without ever progressing 
to the next stage of the disease. However in some cases (10 15% of population) 
it may aggravate to periodontitis.  
1.3.2 Periodontitis  
Initiation and sustainability of periodontitis is related to the accumulation of 
dental plaque. However the destruction of periodontal tissues depends on the 
host response to the plaque bacteria and the characteristics of the disease may 
also be affected by the individual’s immune system [Kinane, 1999; Rose, 2004; 
Honda et al., 2006].  Periodontitis can be divided into chronic and aggressive 
periodontitis.    Both  forms  of  periodontitis  can  be  further  subdivided  into 
localised  and  generalized  periodontitis.  However,  in  chronic  periodontitis  the 
two forms have the same aetiology and pathogenesis [Armitage, 2004], whereas 
in aggressive periodontitis the two forms may have differences in aetiology and 
pathogenesis [Lang et al., 1999]. In chronic periodontitis the tissue destruction 
process is not continuous. Short periods of tissue destruction are followed by 
extended periods of disease inactivity and the rate of tissue destruction may 
vary throughout the mouth [Socransky et al., 1984].   
The  severity  of  periodontal  disease  is  judged  by  the  amount  of  clinical 
attachment  loss.  1 2mm  attachment  loss  is  described  as  slight,  3 4mm 
attachment loss is referred to as moderate and more than 5mm attachment loss 
is  considered  to  be  severe  periodontal  disease  [Armitage,  1999].  Clinical 
attachment  loss  is  measured  by  measuring  the  distance  from  cementoenamel 
junction to the base of the probable crevice. Periodontitis causes irreversible 
damage  to  the  tissues  and  affects  all  parts  of  the  peridontium  including  the 
gingiva, PDL, cementum and alveolar bone (Figure 1.10). Clinical characteristics 
of chronic and aggressive periodontitis are shown in Figure 1.11 and are listed in 
Table 1.2. Chapter 1 
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Figure 1.10: Schematic drawing of a periodontally involved tooth [from www.drfudge.com 
;Rose, 2004]. 
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Table 1.2:  Clinical characteristics of chronic and aggresive periodontitis [from Lang et al., 
1999; Lindhe et al., 1999; Armitage, 2004] 
 
Chronic periodontitis 
Mostly in adults, however can also occur in children and adolescents 
Subgingival calculus 
Apical migration of junctional epithelium and pocketing 
Connective tissue attachment loss 
Alveolar bone loss 
Tooth mobility   
Slow to moderate progression rate with periods of rapid progression 
Can be associated and aggravated with systemic diseases 
Local predisposing factors can be associated 
Smoking and emotional stress can effect the disease characteristics 
Aggressive periodontitis 
Except for periodontitis the patient is healthy 
Attachment loss and bone destruction is rapid 
                                           Localized                 Generalized 
Onset:                                Circumpubertal          Usually under 30 years 
Subgingival calculus:          Usually absent           May or may not be present 
Serum antibody response     
to infecting agents:            Robust                      Poor 
 
Involvement: First molar/incisor presentation   Interproximal loss is generalized 
                     Interproximal attachment loss      affecting at least three  
                    on two permanent teeth one of     permanent teeth other than 
                    which is first molar.                     first molar and incisor. 
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Figure 1.11 (a) Chronic periodontitis, gingival recession and bone loss is visible. (b) 
Localized periodontitis, bone loss of mandibular anterior teeth. (c) Generalized 
periodontitis, bone loss involving all teeth [from Armitage, 2004]. 
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1.4 TREATMENT OF PERIODONTAL DISEASES 
Treatment  of  periodontitis  involves  two  components,  elimination  of  bacterial 
plaque and correction of anatomical deformities produced by the periodontitis. 
There  are  two  approaches  to  correct  the  anatomical  defects:  resective  and 
regenerative.  In  resective  treatment  periodontal  defects  are  eliminated  by 
removal  of  gingival  and  bony  walls;  this  includes  gingivectomy,  apically 
positioned  flaps  and  apically  positioned  flaps  with  osseous  resection. 
Regenerative  treatment  involves  elimination  of  periodontal  defects  by  the 
production of new bone and periodontal ligament and coronal displacement of 
gingival attachment. 
1.4.1 Plaque removal and root planing 
Elimination  of  bacterial  plaque  is  essential  for  the  treatment  of  periodontal 
diseases.  Removal  of  supragingival  and  subgingival  plaque  and  calculus  using 
conventional methods of scaling and root planing with or without flap surgery is 
useful. With scaling a reduction in the probing depth can be gained and it can be 
effective in treating periodontal disease [Becker et al., 2001]. However studies 
have shown that nonsurgical subgingival root planing does not always produce 
good results in terms of complete removal of calculus deposits as produced with 
surgical subgingival root planing [Eaton et al., 1985; Sherman et al., 1990]. In 
root planing the cementum is removed along with calculus deposits and the root 
surface is made smooth and hard. These procedures improve gingival conditions 
and reduce gingivitis and bleeding.  
1.4.2  Resective surgical procedures 
Resective surgical procedures are done to eliminate the disease and to correct 
anatomical deformities. These procedures create the conditions which stop the 
recurrence of the disease and eliminate or reduce gingival pockets:  
1.4.2.1  Gingivectomy  
Gingivectomy involves removal of the soft tissue wall of pathological periodontal 
pocket. The development of flap techniques has limited the use of gingivectomy Chapter 1 
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to removal of enlarged gingiva and minor reshaping.  Gingivectomy is indicated 
in cases where there is a need to eliminate the persistent gingival pockets after 
completion of scaling or root planing or to eliminate gingival enlargements due 
to any medication or genetic factors (Figure 1.12). Studies have shown that the 
regenerated gingiva following gingivectomy contains smaller lesions with lower 
densities of immunocompetent cells when compared to gingiva following non 
resective  open flap  debridement  [Zitzmann  et  al.,  2005].    For  drug  induced 
gingival  overgrowth,  gingivectomy  remains  the  treatment  of  choice 
[Mavrogiannis et al., 2006]. However gingivectomy is contraindicated in cases of 
acutely  inflamed  gingiva  and  where  there  are  infrabony  defects  and  large 
exostoses [Rose, 2004].  
 
 
 
 
 
 
 
 
Figure 1.12(a) Gingival enlargement, a candidate for gingivectomy. (b) Gingival incision at 
the pocket depth(c) A sharp pointed periodontal knife to relieve interproximal area. (d) A 
normal gingiva after treatment [from Rose, 2004].  
 
1.4.2.2  Apically repositioned flaps 
This procedure eliminates the periodontal pocketing and increases the zone of 
attached gingiva by moving the flap in an apical direction [Carnio and Miller, 
1999]. Carnio et al. [2007] described a modification of the apically repositioned 
flap  which  produced  better  results  than  the  conventional  method.  After 
(d
(a)  (b) 
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repositioning the flap the alveolar crest is covered thus eliminating the pocket. 
A mucoperiosteal attached gingival zone is created on merging of connective 
tissue on the inner surface of the flap with the bone.  
1.4.2.3  Apically positioned flap with osseous resection 
This procedure is also used to reduce or eliminate periodontal pockets.  This 
procedure involves (a) periodontal flap elevation, (b) granulation tissue removal 
(c)  tooth  root  treatment  and  (d)  bone  contour  correction.  This  results  in 
positioning of the flap more apically than its original position. This procedure 
gives  a  stable  dentogingival  junction  and  is  ideal  for  reducing  periodontal 
pockets in patients with moderate periodontitis. However the main disadvantage 
associated with this technique is the root surface exposure which can result in 
hypersensivity and aesthetic problems [Rose, 2004].   
1.4.3 Regenerative procedures 
The resective procedures described above only arrest the disease process, but 
do not reverse or replace the tissue lost during the disease [Needleman et al., 
2002]. Procedures such as bone grafting and guided tissue regeneration (GTR) 
are used to produce regeneration of tissues destroyed by periodontal disease. 
Architecture and function of the lost tissue can be restored by regeneration to a 
limited extent. 
1.4.3.1  Bone grafts  
Tissue loss in severe periodontal disease has been treated with bone grafts for 
many years. Bone grafts can play a part in the correction of the osseous aspects 
of  periodontal  defects  either  by  the  process  of  osteoinduction  or 
osteoconduction  [McAllister  and  Haghighat,  2007].  An  osteoinductive  material 
can induce bone formation by recruiting undifferentiated mesenchymal cells and 
causing  them  to  differentiate  into  osteoblastic  cells,  whereas  an 
osteoconductive material acts as a scaffolding material for new bone formation 
from existing bone. 
 Chapter 1 
  46 
Graft materials can be divided into following four general types; 
Autograft:  Autografts  are  obtained  from  the  same  individual.  The  bone  is 
harvested from the patient’s own jaw (intraoral) or from any other part of the 
patient’s body (extraoral). Figure 1.13 shows a block autograft obtained from 
the  patient’s  own  ramus.  Autograft  bone  eliminates  the  possibility  of  graft 
rejection and transfer of disease. In one study iliac autografts were shown to 
successfully fill 87% of Class II furcation defects and a bone fill from 2.6mm to 
4.16mm was achieved [Schallhorn et al., 1970]. In another study where intraoral 
bone autografts were used, a bone gain of 2.88 to 3.44mm was achieved [Hiatt 
and Schallhorn, 1973]. However there are some studies in which autografts is 
shown not to produce good results [Carraro et al., 1976]. The factors on which 
the outcome of the treatment can depend include the morphology of the defect 
and the type of the bone used. In addition the availability of bone is limited and 
the patient has to undergo surgical procedures at two sites, which can increase 
pain and the potential for complications.  
 
 
Figure 1.13 A block autograft fixed with screws [from McAllister and Haghighat, 2007].  
 
Allograft:  Allograft  is the bone from another donor of the same species  and 
provides a substitute for autograft (Figure 1.14). Allografts have the advantages 
of high availability as these are obtained from cadavers and eliminate need of a 
second  surgical  procedure  on  the  patients.  Iliac  allografts  were  shown  to 
produce bone gain of up to 3.6mm in periodontal defects [Hiatt et al., 1978]. 
Allografts used in periodontal regeneration are available in two forms: freeze Chapter 1 
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dried  bone  allografts  (FDBA)  and  demineralised  freeze dried  bone  allografts 
(DFDBA)  [Rose,  2004].  FDBA  and  DFDBA  both  can  be  effective  in  correcting 
periodontal bone defects [Mellonig, 1992]. The osteogenic potential of DFDBA 
may depend on the age of the bone donor and recipient. Rat studies have shown 
that DFDBA obtained from middle age animals had more bone forming potential 
than younger animals and bone formation is better in younger recipients than 
older recipients [Jergesen et al., 1991]. Disease transfer, including HIV/AIDs and 
hepatitis, is one of the drawbacks of allografts.    
 
 
Figure 1.14 A block allograft fixed with screws [from McAllister and Haghighat, 2007]. 
 
Xenograft:  Xenograft is bone obtained from different species. These bones are 
obtained from bovine or porcine sources and are thought to be osteoconductive 
and  resorbed  to  be  replaced  by  the  host  bone  over  time  [McAllister  and 
Haghighat, 2007]. A xenograft grafted at the defect site is shown in Figure 1.15. 
Bovine  bone  is  treated  with ethylene diamine  which  removes  its  organic  and 
antigenic fractions, but retains its inorganic structure.  In comparative studies 
anorganic bone showed better restoration of bone defects than bioactive glass 
ceramics [Schmitt et al., 1997], whereas there was no significant difference in 
the results produced by DFDBA and bovine derived xenograft [Richardson et al., 
1999].    However  risk  of  bovine  or  porcine  virus  or  other  infective  agent 
transmission is associated with these grafts [Sogal and Tofe, 1999]. 
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Figure 1.15 A bovine xenograft placed at the defect site [from Richardson et al., 1999]. 
 
 
Grafts  of  bone  substitutes  and  synthetic  materials  (Alloplast):  Alloplasts 
eliminate the problem of limited supply of autograft bone and risk of disease 
transmission from allograft or xenografts. However these materials only act as 
biocompatible space fillers. The following types of alloplastic synthetic grafts 
are available: 
a) Porous hydroxyapatite 
b) Non-porous hydroxyapatite 
c) Beta tricalcium phosphate 
d) HTR polymer 
e) Bioactive glasses and ceramics 
Bioactive glass produced similar clinical results and gain in attachment levels in 
comparison with expanded polytetrafluoroethylene (ePTFE) membranes for the 
treatment of mandibular Class II furcation [Yukna et al., 2001].    
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1.5 GUIDED TISSUE REGENERATION (GTR) 
In modern periodontal disease treatment the aim is not only to stop the disease 
but also to regenerate lost periodontal and supporting bone tissues [Needleman 
et al., 2002]. Guided tissue regeneration (GTR) technique uses a membrane to 
cover the periodontal defect which isolates the defective area from overlying 
soft tissue, thus blocking fast growing soft tissue cells from invading the area 
and allowing mesenchymal cells from PDL or bone to repopulate the area.   
It was proposed by Melcher [1976] that the nature of periodontal tissue healing 
depends on the type of cells which repopulate the root surface. Regeneration at 
the  periodontal  defect  occurs  if  the  root  surface  is  populated  by  the 
undifferentiated mesenchymal cells from PDL or perivascular region of the bone 
which  then  differentiate  into  specific  tissue  forming  cells,  whereas  if  the 
surrounding  tissues  replace  the  lost  periodontal  tissues  the  healing  of  the 
periodontal defect occurs by repair.  In repair, if the root surface is populated 
by the cells from gingival epithelium it results in formation of a long junctional 
epithelium and a connective tissue attachment is formed when the root surface 
is populated by the cells from gingival connective tissue which can also cause 
root resorption. If the cells from surrounding bone repopulate the root surface, 
then they will cause root resorption and ankylosis, which is fusion of the tooth to 
the bone.   
The predictability of regenerating bone destroyed by periodontal diseases has 
been increased by use of guided tissue regeneration (GTR) techniques. For more 
than a decade GTR has been considered an effective method to regenerate the 
lost periodontal tissue [Caffesse et al., 1997]. Superiority of GTR over traditional 
techniques  has  been  reported  in  a  number  of  clinical  studies  [Nyman  et  al., 
1982; Murphy and Gunsolley, 2003].  
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1.5.1 Principles of GTR 
GTR is based on the three principles of wound healing.  
First principle is that if the fast growing gingival epithelium and connective 
tissue are blocked from invading the periodontal wound, periodontal tissue can 
regenerate from multipotent cells of PDL and bone. Studies have shown that the 
gingival epithelium cells migrate more rapidly to the periodontal defect than the 
cells from PDL or bone [Caton et al., 1980]. GTR membranes are used to block 
the  invasion of  competing  non osteogenic  soft  tissue  cells  to  the  periodontal 
defect [Bunyaratavej and Wang, 2001; Ueyama et al., 2002]. 
Second principle is that if a GTR membrane maintains a space between the 
mucoperiosteal  flap  and  the  periodontal  defect,  which  allows  migrating  and 
proliferating cells to reconstruct the defect. 
Third principle is that GTR membranes stabilize and mechanically protect the 
newly formed clot in the wound [Koyama et al., 2003]. Protection of blood clot 
is  important  for  the  successful  outcome.  This  clot  acts  as  a  scaffold  for  the 
regenerating  osteogenic  cells  which  regenerate  bone  [Koyama  et  al.,  2003; 
McAllister and Haghighat, 2007].   
1.5.2 Ideal requirements of GTR membranes 
A GTR membrane should have the following properties to obtain the best results: 
•  Biocompatibility  
•  Mechanical stability    
•  Biodegradability 
•  Resorbability 
•  Adaptability 
•  Ability to release bioactive proteins  
•  Clinical manageability  Chapter 1 
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1.5.3 Types of GTR membranes  
GTR membranes can be divided into two types, resorbable and nonresorbable 
membranes. Nonresorbable membranes require a second surgical procedure for 
their removal. Resorbable membranes have the advantage over nonresorbable 
membranes as they do not require removal and are eliminated from the body by 
metabolic processes [Zellin et al., 1995; Mayfield et al., 1997].  
1.5.3.1  Nonresorbable membranes 
These membranes require a second surgical procedure for their removal which 
not only increase the cost and discomfort for the patient but the removal can 
also damage the newly formed tissue.   
Expanded Polytetrafluoroethylene (ePTFE): These were the first commercially 
available  membranes  used  for  GTR.  These  membranes  are  removed 
approximately  1  to  3  months  after  placement  [Pontoriero  et  al.,  1988].  This 
membrane has two parts, a collar portion which has open pores which prevent 
migration  of  epithelium  and  allow  ingrowth  of  connective  tissue,  and  an 
occlusive portion which prevents the contact of flap tissue to the root surface 
[Scantlebury, 1993]. For larger defects ePTFE membranes are used with titanium 
reinforcement to improve space maintenance ability of the membrane (Figure 
1.16). 
 
Figure 1.16 A titanium reinforced ePTFE membrane fixed with screws [from McAllister and 
Haghighat, 2007]. 
  
Although the use of ePTFE membranes in treatment of periodontal defects like 
class II furcation have shown improved clinical results, the regenerated tissue 
did not completely fill the defects [Pontoriero et al., 1988]. A comparative study Chapter 1 
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showed no significant difference between the results obtained from the defects 
treated by ePTFE and DFDBA [Guillemin et al., 1993]. Imbronito et al. [2002] 
have shown that the membranes made of ePTFE showed similar amounts of bone 
regeneration as compared to polylactic acid (PLA) membranes. In addition these 
membranes have the problem of exposure due to tissue dehiscence which may 
lead to their bacterial contamination which can negatively affect the outcome of 
GTR procedures [Tempro and Nalbandian, 1993; Nowzari et al., 1996; Machtei, 
2001].  In  a  study  carried  out  by  Zitzmann  et  al.  [1997],  44%  of  the  ePTFE 
membranes had to be removed prematurely due to exposure. The use of ePTFE 
has  now  mostly  been  replaced  by  resorbable  membranes  [Dupoirieux  et  al., 
2001].    
1.5.3.2  Resorbable membranes 
Due to the limitations associated with nonresorbable membranes, their use is 
mostly  replaced  by  resorbable  membranes  which  eliminate  some  of  the 
drawbacks of nonresorbable membranes [McAllister and Haghighat, 2007]. These 
materials are resorbed and by products are eliminated by the body so do not 
require a second surgical removal procedure. Resorbable materials (Figure 1.17) 
have the advantage of less patient discomfort, cost and less chances of damage 
to  newly  formed  tissues  [Scantlebury,  1993;  Caffesse  et  al.,  1997].  The 
mechanical properties of resorbable membranes are generally not as good as 
those  of  nonresorbable  membranes,  however  they  can  be  equally 
osteopromotive and improve GTR if they can be designed to maintain the space 
for an adequate time [Zellin et al., 1995].  
 
Figure 1.17: A PLA/PGA composite resorbable membrane placed over a periodontal defect 
[from Cortellini and Tonetti, 2000].  
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Resorbable  membranes  are  divided  into  two  groups:  synthetic  and  natural 
[McAllister  and  Haghighat,  2007].  Synthetic  and  natural  membranes  have 
different  degradation  mechanisms.  A  study  in  which  a  synthetic  membrane 
consisting of PLA/PGA copolymer and a natural type I collagen membrane was 
used  showed  equal  clinical  improvements  from  the  use  of  either  membrane 
[Jepsen et al., 2000].  
Synthetic polymers: These polymers are eliminated out of the body through 
metabolic  processes.  Degradable  polymers  used  for  the  production  of  GTR 
membranes include: (a) Polylactic acid (b) Co-polymers of polylactic (PLA) and 
polyglycolic acid (PGA) (c) Polyurethane. 
Commercially  available  membranes  made  up  of  synthetic  polymers  includes 
Resolute
®, Atrisorb
®, Vicryl Periodontal Mesh
®, Epi Guide
® and Mempol
®.  
Resolute
®, which is a composite of PLA and PGA retains its structure for four 
weeks and then completely resorbs within 5 to 6 months [Hurzeler et al., 1997]. 
PLA and PGA copolymer membranes can promote regeneration when used for the 
treatment  of  intrabony  defects  and  were  easier  to  suture  than  collagen 
membranes, which tended to tear when tension is applied at the suture [Mattson 
et al., 1999]. Mayfield et al. [1997] used Resolute
® in their clinical study and 
showed bone regeneration and complete bone coverage of implant threads in 14 
cases out of 17 and partial coverage in 3 cases. Zellin et al. [1995] showed that 
polylactic/polyglycolic copolymer membranes produced a very low inflammatory 
response in the surrounding tissue and most of it was degraded after 6 weeks of 
healing.  Resolute
®  produced  equally  good  clinical  improvements  in  a 
comparative study with ePTFE [Caffesse et al., 1997].  
Atrisorb
® consists of polylactic acid and is prepared at the chair side, is reported 
to be completely resorbed in six to twelve months after implantation [Bogle et 
al., 1997]. A study carried out by Stoller et al. [2001] showed regeneration of 
cementum, alveolar bone and periodontal ligament when they used polylactic 
acid membranes for the treatment of class II furcation defects.   
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Natural biomaterials:  Natural biomaterials used for GTR include: 
1).  Collagen:  These membranes  are  of porcine  or  bovine  origin  consisting  of 
either type I or a combination of type I and type III collagen. A commercially 
available collagen membrane, Bio Gide
®, is produced from collagen of porcine 
origin.  Studies  have  shown  the  ability  of  collagen  membranes  to  promote 
regeneration  in  periodontal  defects.  Collagen  membranes  have  been  used  in 
combination  with  other  materials  which  include  bone  grafting  material, 
fibronectin and heparan sulfate to enhance their regeneration potential [Mattson 
et  al.,  1999;  Bunyaratavej  and  Wang,  2001].  When  using  these  collagen 
membranes a space filling bone substitute should be used to avoid the collapse 
of these membranes into the defect and to improve GTR results [Strietzel et al., 
2006]. Collagen membranes have a fast degradation rate which can affect their 
ability  to  act  as  a  barrier,  however  studies  have  shown  the  ability  of  these 
membranes to inhibit apical migration of epithelium during early wound healing 
when epithelium actively migrates apically. It is reported that regenerative cells 
from bone and PDL reach the wound area in 3 to 4 weeks [Bunyaratavej and 
Wang, 2001]. On the whole, collagen membranes have limited potential to be 
used as GTR membranes because of their lack of ability to maintain space over 
the wound area [Tatakis et al., 1999a]. 
2). Dura mater: These are obtained from cadavers and consist of an irregular 
network of collagen fibres.  They are processed and sterilized, but still pose a 
risk of transferring Creutzfeldt Jakob disease to the patient and the operator as 
well [Martinez Lage et al., 1994]. Their use as GTR membranes is limited [Yukna, 
1992].   
1.5.4 Limitations of GTR  
The limitation with the currently used GTR membranes is that the nonresorbable 
materials  need  to  be  removed  via  a  second  surgical  procedure  which  can 
adversely affect the newly formed periodontal tissues but they generally have 
suitable mechanical properties. Resorbable membranes on the other hand do not 
require removal but currently have too low mechanical properties. Resorbable 
membranes have shown variable results in term of their ability to produce GTR Chapter 1 
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mainly depending on their ability to maintain space and resist collapse. These 
membranes are prone to collapse because of their low mechanical properties. 
Furthermore  although  GTR  techniques  have  been  shown  to  increase  the 
regeneration of periodontal tissues, the increase has been modest [Needleman 
et al., 2002]. To improve the effectiveness of GTR, new research is focused on 
using the combination of different materials which can compliment each other 
to produce increased regeneration. One such combination can be the use of a 
bioactive composite membrane with the ability to deliver growth factors.      
1.5.5 Growth factors and tissue regeneration 
There  is  considerable  interest  in  the  potential  therapeutic  application  of 
bioactive molecules such as growth factors to enhance healing outcomes, and 
GTR membrane materials might also be suitable as carriers for the sustained 
delivery of bioactive molecules [King, 2001; Hughes et al., 2006]. 
Different  studies  have  shown  the  potential  of  growth  factors  to  induce  the 
regeneration of periodontal tissues [Cho et al., 1995; Park et al., 1995]. Growth 
factors  are  proteins  or  polypeptides  which  have  the  ability  to  initiate  the 
proliferation  or  activity  of  cells.  High  concentrations  of  growth  factors  are 
present in bone and cementum which are released following an injury which 
effect  the  repair  and  regeneration  of  periodontal  tissue  [Giannobile,  1996]. 
Growth factors bind to specific receptors on target cells, generating a cascade of 
intracellular molecular signals, thus causing cells to proliferate and differentiate 
[Davidson et al., 1985; Giannobile, 1996; Rose, 2004].  Growth factors found in 
bone,  cementum  and  other  healing  tissues  include  Platelet  Derived  Growth 
Factors (PDGF), Bone Morphogenic Proteins (BMPs), Enamel Matrix Derivatives 
(EMDs), Fibroblast Growth Factors (FGFs) and Insulin like Growth Factors (IGFs) 
[Giannobile, 1996].  These growth factors have the ability to induce and promote 
periodontal regeneration [King and Cochrant, 2002].  
1.5.5.1  Platelet derived growth factors (PDGF) 
PDGF  is  a  heparin binding  polypeptide  having  a  molecular  weight  of  approx 
30,000 Da [Antoniades, 1981]. Human platelet derived PDGF is a heterodimer of Chapter 1 
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A and B chains [Ross et al., 1986]. In addition to these chains, C and D chains 
have been recently discovered (AA, BB, AB, CC, DD). The principal source of 
PDGF  is  α granules  of  platelets,  however  macrophages  and  fibroblasts  when 
activated  also  produce  PDGF.  PDGF  binds  to  the  α  and  ß  receptors  on  the 
surfaces of the cells. Both A and B chains bind to α receptors on the cell surface, 
however only the B chain of PDGF binds to the ß receptors of cells [Chong et al., 
2006].  Each  PDGF  receptor  contains  five  immunoglobulin like
  domains 
extracellulary,  and  there  is  a  tyrosine  kinase  domain
  intracellulrly. 
Autophosphorylation  of  PDGF  receptors  produce  two  affects;  first, 
phosphorylation
  of  tyrosine  residue  inside  the  kinase  domains  results  in  an 
increase
 in the catalytic efficiencies of the kinases. Secondly, phosphorylation of 
tyrosine residues located outside
 the kinase domain produce docking sites for  
SH2
  domain  protein  such  as  phosphatidylinositol  3' kinase
  (PI  3 kinase), 
phospholipase C (PLC)  . PI 3 kinase binds to and is activated by tyrosine kinase 
receptors,  it  plays  a  central  role  in  the  transduction  of  intracellular  signals, 
many  different  cellular  responses  are  mediated  by  it  which  includes,  actin
 
reorganization, chemotaxis and cell growth. PLC   acts on the same substrate as 
PI 3 kinase.  On binding to PDGF
 receptor it phosphorylate on specific tyrosine 
residues  and  its  catalytic activity  increases.  PLC    stimulates cell  growth
 and 
motility in certain cell types [Heldin and Westermark, 1999]. 
PDGF  is  considered  to  play  an  important  role  in  defining  the  activity  of 
mesenchymal cells and an in vitro study showed that the proliferation of PDL 
was enhanced on addition of PDGF [Mumford et al., 2001]. Interestingly, Hsieh 
and Graves [1998] showed that although PDGF increases the proliferation and 
differentiation of bone forming cells, prolonged exposure of differentiated bone 
cells to PDGF inhibits their bone forming function. PDGF has been reported to 
have  mitogenic  and  chemotactic  effects  on  osteoblasts  and  it  enhances  the 
production of type I collagen by osteoblasts [Bolander, 1992]. 
During fracture healing PDGF is produced at the fracture site and PDGF receptors 
on the surfaces of cells also increase which suggests that it has a role during 
bone repair [Andrew et al., 1995; Fujii et al., 1999]. In a human clinical study 
enhanced  periodontal  regeneration  was  achieved  when  PDGF  was  used  in 
combination with bone allografts for the treatment  of Class II furcations and 
interproximal intrabony defects [Nevins et al., 2003]. In another clinical study Chapter 1 
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PDGF  was  shown  to  stimulate  the  cells  involved  in  periodontal  regeneration 
resulting in enhanced periodontal bone regeneration [Cooke et al., 2006]. An 
increased number of cell receptors for growth factors are found in regenerated 
tissues compared to normal gingival and periodontal ligament tissues [Parkar et 
al., 2001]. In a rat study PDGF loaded chitosan sponge produced enhanced bone 
regeneration in calvarial defects [Lee et al., 2000; Park et al., 2000b]. Sant'Ana 
et al. [2007a] showed increased proliferation of PDL cells in response to PDGF in 
an  in  vitro  study.  Howell  et  al.  [1997]  reported  increased  alveolar  bone 
formation in human osseous defects with the use of PDGF as compared to bone 
formed by conventional flap surgery.  PDGF absorbed to ß TCP alloplast material 
produced increased proliferation of osteoblastic cells in vitro [Bateman et al., 
2005].  
1.5.5.2  Bone morphogenic proteins (BMPs) 
Bone morphogenic proteins (BMPs) belong to the transforming growth factor ß 
(TGF ß) family and their activity was first identified by Urist in 1965 when he 
showed that demineralised bone extracts contains substances which can induce 
bone formation at ectopic sites in rodents [Urist, 1965; Sigurdsson et al., 1997; 
Massague, 1998]. Later these substances were recognized as BMPs and BMP 1,2, 
3 and 4 were successfully purified and cloned [Wozney et al., 1988]. BMPs can be 
isolated  and  purified  from  dentine,  bone  and  osteosarcoma  tissues,  however 
demineralized bone matrix still is used extensively as their source [Urist et al., 
1984; Granjeiro et al., 2005].  
Since then more than 20 different types of BMPs have been identified with each 
having  a  different  biological  activity.  BMPs  play  important  roles  both  during 
embryonic growth and later throughout life in repair [Boden, 2005]. BMPs act by 
binding to transmembrane serine threonine kinase receptors which are present 
on the cell membranes. BMPs form a complex by binding to type II receptors on 
the  cell  surface  and  then  recruiting  a  type  I  receptor.  The  receptors 
phosphorylate after the formation of the BMP receptor II receptor I complex and 
then  phosphorylate  SMAD  proteins.  These  phosphorylated  SMAD  proteins  then 
enter the nucleus of the cell and cause the transcription regulation of target 
genes [Massague, 1996; Sakou, 1998]. A schematic description of the possible 
mechanism of action of BMPs on a cell is shown in Figure 1.18.   Chapter 1 
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BMPs regulate the processes of cell proliferation, differentiation and apoptosis 
and  can  induce  different  tissue  formation  [Granjeiro  et  al.,  2005].  BMPs 
stimulate the differentiation of mesenchymal stem cells into osteoblasts and can 
induce the production of new bone, among BMPs differentiation of osteoblasts is 
specially  regulated  by  BMP 2,  BMP 4  and  BMP 7  [Hughes  et  al.,  2006]  [Rose, 
2004].  
 
Figure 1.18: A schematic description of BMP action on cell. BMPs bind to the receptors in 
the cell and signals are transduced through Smad 1/4/5 to the cell nuclei [Adapted from 
Yamaguchi et al., 2000].  
 
Interestingly, it was found in vitro that when mesenchymal cells were exposed 
to low concentrations of BMPs they differentiate into adipocytes, however, on 
exposure  to  high  concentrations  these  mesenchymal  cells  differentiate  into 
osteoblasts. This finding lays emphasis on the importance of specifying the dose 
for their clinical use [Granjeiro et al., 2005]. In different animal studies BMP 2 
has been shown to induce bone formation [Murakami et al., 2002]. An animal 
study has shown that BMP 2 can also be used for the treatment of osteoporosis 
as it increases the activity of mesenchymal cells and can reverse the age related 
bone loss when administered systemically [Gadi et al., 2002].  Although BMPs 
can induce regeneration even without a carrier, a delivery system is needed to 
get  a  better  and  more  localized  effect.  BMPs  play  a  considerable  role  in Chapter 1 
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periodontal  healing  and  have  osteoinductive  activity.  Application  of  rhBMPs 
enclosed  in  collagen  membrane  sponges  in  Wistar  rats  has  been  shown  to 
stimulate early cell proliferation and migration towards the periodontal wound 
area and subsequent differentiation occurs more rapidly than in a normal wound 
[Boyne et al., 1997; King et al., 1998; King and Hughes, 2001]. 
In a human clinical study recombinant human (rh) BMP 2 was used for maxillary 
floor  sinus  augmentation  incorporated  in  an  absorbable  collagen  sponge,  the 
results showed significant increased bone growth with a mean gain of 8.51 mm. 
No serious adverse effects were observed in the patients, however facial edema, 
oral erythema and rhinitis were reported [Boyne et al., 1997].  In another human 
clinical trial, Howell et al. [1997] also used rhBMP 2 in a resorbable collagen 
sponge for the treatment of localised osseous defects and prevention of alveolar 
ridge after tooth extraction.  They also found out that the rhBMP 2 was effective 
in regenerating bone after tooth extraction and rhBMP 2 was well tolerated by 
the patients with no serious side effects.  
1.5.5.3  Enamel matrix derivatives (EMD) 
Enamel matrix derivatives consist of proteins which are derived from Hertwig’s 
root  sheath  of  porcine  origin.  EMD  contains  different  low  molecular  weight 
proteins which include amelogenins (90%), ameloblastins and enamelin. EMD can 
induce  acellular  cementum  regeneration  which  is  an  important  part  of 
periodontal  regeneration,  based  on  the  theory  that  a  protein  preparation 
present in the EMD resembles the matrix proteins which induce cementogenesis 
[Hammarstrom, 1997; Rose, 2004].  
In vitro studies have shown that EMD enhances the proliferation, proteins and 
collagen production, differentiation and osteoprotegerin production of PDL cells 
and  when  myoblast  cells  were  exposed  to  EDM  they  differentiated  into 
osteoblasts  or  chondroblasts.  EMD  did  not  show  a  significant  effect  on  the 
proliferation of epithelial cells in vitro [Gestrelius et al., 1997; Ohyama et al., 
2002;  Lossdorfer  et  al.,  2007].    In  another  study,  Lyngstadaas  et  al.  [2001] 
showed that when PDL cells were exposed to EMD the attachment rate, growth 
rate  and  metabolism  of  these  cells  was  increased  and  they  subsequently 
produced more growth factors.  Chapter 1 
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In  a  monkey  study,  buccal  alveolar  bone,  periodontal  ligament  and 
corresponding cementum were removed and the defects were then treated with 
porcine enamel matrix with and without a carrier system, the results obtained 
showed that application of EMD produced complete regeneration of cementum 
and collagenous  fibres  which  were  embedded  in  newly  formed  alveolar  bone 
[Hammarström, 1997].  
In a clinical trial intrabony defects were treated with the application of EMD. 
The  treatment  with  EMD  produces  regeneration  of  periodontium  which  was 
comparable with the regeneration produced using a GTR membrane. In addition 
no systemic adverse effects with the application of EMD were observed [Sculean 
et al., 1999].  In another human study EDM was used with xenografts for the 
treatment of osseous periodontal defects with favourable results [Scheyer et al., 
2002].       
1.5.5.4  Fibroblast growth factor (FGFs) 
FGFs  belong  to  heparin  binding  growth  factor  family.  Basic  FGF  is  found  in 
gingiva, periodontal ligament and bone.  
In an in vitro study FGF was shown to have a mitogenic effect on PDL cells, when 
used  with  allografts  as  carrier,  which  can  be  beneficial  for  periodontal 
regeneration [Dereka et al., 2006]. In an animal study FGF in a gelatin carrier 
was topically applied to the created class II bone defects. The application of FGF 
produced more periodontal ligament formation and cementum along with new 
bone formation as compared to controls, without producing any ankylosis or root 
resorption. FGF inhibits the differentiation of PDL cells and inhibit their ability 
to produce calcified nodules, however, it enhances the proliferation of PDL cells 
in the early stages of healing. These undifferentiated cells in the later stages of 
healing  differentiate  into  osteoblasts  and  cementoblasts  which  increase 
periodontal  regeneration  [Murakami  et  al.,  2003].  A  schematic  description  of 
FGF effect on PDL cells is shown in Figure 1.19.  
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Figure 1.19:  A schematic description of FGF effect on PDL cells. FGF has the positive effect  
on  the  mitosis  of  multipotent  immature  cells,  whereas  it  downregulates  the  collagen 
synthesis and formation of calcified nodules by PDL cells [adapted from Takayama et al., 
1997] 
 
The proliferation effect of FGF on PDL proliferation is dose dependent and it 
decreases if the dose increases above an optimal level [Takayama et al., 1997].   
1.5.5.5  Insulin like growth factors (IGFs) 
IGFs are nonglycosylated polypeptides with a molecular weight of approx 7,500 
Da. Their synthesis takes place in liver, smooth muscle, placenta and osteoblasts 
[Caffesse and Quinones, 1993].  
In vivo studies have shown that application of IGF enclosed in dextran–co gelatin 
hydrogel  microspheres  to  denuded  root  surface  in  beagle  dogs  enhanced  the 
regeneration of bone and cementum [Chen et al., 2006]. IGF application showed 
increased  osteoblastic  collagen  synthesis  and  bone matrix  apposition  and 
increased the regeneration of bone in an in vitro study [Hock et al., 1988]. In an 
animal study 100  g IGF was delivered entrapped in biodegradable poly (lactide 
co glycolide) microspheres at 8 10mm defects in ovine long bones. The results 
showed  that  IGF  application  not  only  induced  new  bone  formation  but  also 
reduced bone resorption and inflammation at the bone injury site [Meinel et al., 
2003]. IGFs have also shown to increase the adhesion and proliferation of PDL 
cells in an in vitro study [Sant'Ana et al., 2007b] Chapter 1 
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1.6 BIODEGRADABLE POLYMERS AND CERAMICS  
Biodegradable polymers are suitable for use in situations where an implant is 
only required to stay in the body for a limited period of time. They are currently 
used in sutures, drug delivery systems, fracture fixation devices and as scaffolds. 
Poly ε caprolactone (PCL), polyglycolic acid (PGA) and polylactic acid (PLA) are 
synthetic  biodegradable  polymers  and  belong  to  the  family  of  aliphatic 
polyesters.  
PCL is a semicrystalline polymer with a melting temperature between 59 to 64°C 
and glass transition temperature of  60°C. It has a slow degradation rate which 
makes it suitable for use in the long term drug delivery system. Many studies 
have reported use of PCL as a drug delivery system  including antibiotics and 
antihypertensive drugs. Its degradation rate and mechanical properties can be 
tailored by copolymerizing it with PLA or PGA or blending it with ceramics. It has 
also been investigated as a scaffold material for bone [Marra et al., 1999; Wan 
Ju et al., 2003; Sinha et al., 2004].  
PGA  is  synthesised  by  ring  opening  polymerisation  of  cyclic  dimer  of  glycolic 
acid. PGA has a melting point between 224 and 228°C and a glass transition 
temperature of 36°C. In the body PGA is degraded by a hydrolytic process and 
the  degradation  products  are  metabolized  by  the  citric  acid  cycle  which  are 
subsequently  eliminated  out  of  the  body  in  the  form  of  carbon  dioxide  and 
water. It is mainly used as a suture material, however its is being expanded by 
using it as a copolymer with PLA [Athanasiou et al., 1996a; Liu et al., 2005].  
PLA is synthesised by ring opening polymerisation of a cyclic dimer of lactic acid 
and is considered to be one of the most promising biodegradable polymers due 
to its processibility and ability to have tailored physical and biological properties 
and has been used in many biomedical applications [Rokkanen et al., 2000a; Lu 
et al., 2002; Georgiou et al., 2007; Gupta et al., 2007]. PLA is discussed in detail 
in section 1.6.1.   
Drawbacks  associated  with  biodegradable  polymers  such  as  low  mechanical 
properties,  low  bioactivity  and  unpredictable  degradation  pattern  can  be 
improved  by  combining  them  with  calcium  phosphates  and  using  them  as  a Chapter 1 
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composite material [Huang et al., 2008]. In bone contacting applications calcium 
phosphate are commonly used as coatings and composite fillers and are mainly 
hydroxyapatite (Ca10(PO4)6(OH)2) and tricalcium phosphate (Ca3(PO4)2). Calcium 
phosphates are discussed in detail in section 1.6.2.  
PLA  is  being  used  as  sutures,  scaffolds,  fracture  fixation  devices,  bone 
regeneration and in drug delivery systems due to its favourable properties. In 
the  following  section  PLA  is  discussed  in  detail  as  it  was  selected  for  the 
production of polymer  Ca P composites due to its manipulable properties. 
1.6.1 Polylactic acid (PLA) 
Polylactic  acid  (PLA)  is  a  degradable  polymer  which  has  been  used  in  many 
biomedical applications and is still a subject of extensive research to expand its 
use due to its favourable properties. It belongs to the aliphatic polyesters family 
and is prepared by ring opening polymerisation of the cyclic dimer of lactic acid 
(HOCHCH3COOH) [Conn et al., 1995]. The chemical structure of PLA is shown in 
Figure 1.20. 
 
 
Figure 1.20: Chemical structure of PLA, where (n) denotes the central repeat unit [modified 
from Conn et al., 1995; Garlotta, 2001]. 
 
Lactic  acid  is  converted  into  high  molecular  weight  PLA  by  two  methods.  A 
solvent free route in which condensation of lactic acid produces a low molecular 
weight PLA, this is followed by controlled depolymerisation of this low molecular 
weight PLA which produces a cyclic dimer known as lactide. Lactide is purified 
by  distillation.  High  molecular  weight  PLA  is  then  produced  by  catalytic  ring 
opening  polymerisation.  The  second  route  is  a  solvent  based  azeotropic 
condensation in which lactic acid undergoes reduced pressure distillation for 2 to 
3 hours at 130°C which removes most of the condensation water. Catalyst and 
diphenyl ether are then added and after passing through a molecular sieves the 
solvent is again kept at 130 °C for further 30 to 40 hours. This process also 
produces high molecular weight PLA Lunt, 1998; Garlotta, 2001]. A schematic 
description of these two processes is shown in Figure 1.21.  
 HO       CH3         (O       CH3)n      O        CH3            OH 
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Figure 1.21: Schematic description of PLA synthesis [ modified from Garlotta, 2001] 
 
Lactic acid is a chiral molecule and exists in two stereoisomeric forms, L and D 
enantiomers (Figure 1.22) [Garlotta, 2001]. Mechanical properties, crystallinity 
and degradation of PLA depend and can be controlled by the ratio and type of 
the  enantiomers  used.  L  enantiomer  provides  PLA  with  higher  mechanical 
strength and adding D enantiomers to PLLA reduces its melting temperature and 
crystallinity [Gupta et al., 2007].     
 
 
 
 
Figure 1.22:  Structure of L and D enantiomers of PLA [adapted from Gupta et al., 2007] 
 
A more amorphous material is generally obtained when the D content is above 20 
%,  whereas  a  highly  crystalline  material  can  be  produced  by  keeping  the  D 
content below 2 % [Gupta et al., 2007].  Depending on the ratio of L to D a 
polymer with a molecular weight of thousands to millions can be produced. The Chapter 1 
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ratio  and  distribution  of  enantiomers  play  an  important  role  in  defining  the 
thermal, mechanical and biological properties of PLA [Mehta et al., 2005].   
Four different morphological types of polymers with different properties can be 
prepared depending on the enantiomers; 
•  PDLA:  Semicrystalline  and  has  good  mechanical  strength  compared  to 
PDLLA.  
•  PLLA:  It  is  semicrystalline  and  has  high  mechanical  strength,  used  for 
applications  needing  mechanical  strength  like  sutures  and  fracture 
fixation. It has a melting point temperature of 170  180 °C and a glass 
transition temperature of 57 67 °C.  
•  PDLLA: It is amorphous and racemix, used for applications such as drug 
delivery. Its properties depend on its L: D ratio. It is more susceptible to 
hydrolysis than to PLLA.   
•  meso-PLA: Obtained from L and D lactides, this type of PLA is rarely used. 
A comparison of mechanical properties of PLAs containing different enantiomers 
is shown in Table 1.3. 
Table 1.3:  Effect of different enantiomers on the mechanical properties of poly lactic acid 
[modified from Garlotta, 2001]. 
PLLA                              PDLLA 
Tensile strength (MPa)                                       59                                   44 
Elongation at break (%)                                      7.0                                  5.4 
Modulus of elasticity (MPa)                                3750                                3900 
Yield strength (MPa)                                          70                                   53 
Flexural strength (MPa)                                     106                                  88 
Unnotched Izod impact (J/m)                            195                                 150 
Notched Izod impact (J/m)                                26                                   18 
Rockwell hardness                                             88                                   76 
Heat deflection temperature (°C)                      55                                   50 
Vicat penetration (°C)                                       59                                   52                  Chapter 1 
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Degradation of PLA occurs by hydrolysis in which PLA is converted into lactic 
acid which is a metabolite present in the body. The degradation products are 
then eliminated out of the body after being converted into carbon dioxide and 
water.  The  mechanism  of  degradation  involves  hydrolytic  cleavage  of  ester 
bonds on penetration of water inside the polymer, a new carboxyl end group is 
formed from the cleavage of each ester bond which in turn starts the process of 
autocatalysation [Zhang et al., 2005]. This autocatalysis speeds up the process of 
hydrolysis of the remaining ester bonds. In the beginning the degradation of PLA 
is a bulk degradation process and is homogeneous, however as oligomers are 
produced later in the process the pattern of degradation changes. The oligomers 
and carboxyl end groups produced inside the matrix cause an increase in acidity 
which in turn speeds up the degradation of the internal matrix, whereas the 
oligomers and carboxyl groups present close to the surface escape and become 
neutralised. Thus the outer surface does not degrade at the same rate as the 
internal  matrix  [Li,  1999].  PLA  becomes  more  hydrophilic  as  the  degradation 
proceeds  which enhances  water  uptake  and further accelerating  degradation. 
Degradation  of  PLA  depends  on  a  number  of  factors  such  as  its  chemical 
composition,  molecular  weight,  molecular  weight  distribution,  processing 
condition, shape and implantation site and ranges from six months to two years. 
Degradation  processes  include  reduction  in  the  mass,  molecular  weight, 
configuration changes and reduction in the mechanical properties of an implant 
[Vert et al., 1992; Athanasiou et al., 1996b]. The ratio of L and D enantiomers 
plays an important role in determining the rate of degradation, the degradation 
rate  of  polymer  is  proportional  to  the  D  content.  The  degradation  of  high 
molecular  weight  polymers  will  be  slower  than  that  of  polymers  with  low 
molecular  weight  [Li,  1999].  Glass  transitional  temperature  (Tg)  and  melting 
temperature  (Tm)  both  are  directly  proportional  to  the  molecular  weight, 
materials with high molecular weight have high Tg and Tm [Gupta et al., 2007]. 
The crystallinity and Tg of PLA also affect the degradation rate. PLA with high 
crystallinity has tightly packed and ordered polymer chains which make it more 
resistant to degradation and a polymer with a high Tg is more resistant to the 
penetration  of  water  molecules  which  also  makes  it  more  resistant  to 
degradation. In addition local pH, device morphology and size also affect the 
rate of PLA degradation [Place et al., 2009]. Factors which can play a role in the 
degradation of the biodegradable polymers are summarized in Table 1.4. Chapter 1 
  67 
Table 1.4:  Factors affecting the degradation of biodegradable polymers [from Vert et al., 
1992].   
•  Structure of polymer 
•  Composition of polymer 
•  Ionic group presence 
•  Configurational structure 
•  Molecular weight and its distribution  
•  Presence of low molecular weight compounds like monomer, 
     oligomers, solvents, initiators, drugs, etc 
•  Processing conditions 
•  Shape 
•  Sterilizing process 
•  Amorphous or semicrystalline 
•  Storage history 
•  Implantation site 
•  Adsorbed and absorbed compounds (water, lipids, ions, etc.) 
•  Shape and size 
•  Hydrolysis mechanism (enzymatic or hydrolytic) 
 
1.6.1.1  Bone contacting applications of PLA 
PLA is used in number of biomedical applications, however there are two major 
clinical  areas  where  it  comes  in  contact  with  bone.  These  two  areas  are 
orthopaedics and dentistry where PLA is used as fracture fixation devices and as 
membranes for GTR respectively. 
The use of biodegradable PLA internal fixations devices such as pins, screws, 
plates  etc  (Figure  1.23)  instead  of  metallic  osteofixation  devices  not  only 
eliminates the need of second removal surgery, but can also avoid the long term 
complications associated with metallic implants such as irritation and damage of 
soft tissue and disturbance of joint movement [Waris et al., 2004]. The use of 
biodegradable polymers in orthopaedics is also favourable as it eliminates the 
problems of stress shielding associated with metal implants. Studies have shown 
that the stress shielding effect associated with metallic implants results in a Chapter 1 
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weak, thin bone and an increase risk of fracture in mandible. Bone resorption is 
also reported in the cases of condylar fractures treated with metallic implants 
[Kennady et al., 1989; Iizuka et al., 1991]. 
 
Figure 1.23: Pins, rods , screws and plates made of SR PLLA [from Waris et al., 2004]. 
 
In the early 1970s, Kulkarni et al. [1971] successfully used polylactic acid pins 
for the treatment of mandibular fractures in dogs and 2mm thick polylactic acid 
films for the treatment of orbital floor fractures in monkeys. The results showed 
that  the  pins  were  completely  degraded  by  8  months  and  the  healing  was 
comparable to the controls where stainless steel pins were used. In an in vivo 
study  PLLA  pins  implanted  in  the  femur  of  the  rats  were  shown  to  have 
osteostimulatory effect around their borders and did not produce a noticeable 
inflammatory response [Nordstrom et al., 1998].  
In a clinical study self reinforced poly L lactide (SR PLLA) screws were used for 
the  fixation  of  subtalar  extraarticular  arthrodesis  in  children  and  the  results 
showed that the cases treated with SR PLLA screws had good fusion without any 
adverse response and that the screws maintained their strength for an adequate 
period  [Partio  et  al.,  1992].  Pihlajamaki  et  al.  [1997]  treated  patients  with 
displaced malleolar fractures by internal fixation using absorbable PLLA plugs 
and used magnetic resonance imaging (MRI) for postoperative assessment. The 
study showed that PLLA implants were visible in MRI and the implants did not 
produce any adverse response.  Chapter 1 
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The use of biodegradable devices in craniofacial surgery was of great interest in 
the 1990s and extensive research is still being done to optimise the properties of 
such devices and maximise their use in order to avoid the risks and problems 
associated with metallic implants, especially in paediatric craniofacial surgery 
[Ashammakhi et al., 2001].  Moe  et al.  [2001]  reported  a  study  in  which PLA 
implants  were  used  for  facial  cosmetic  and  head  and  neck  reconstructive 
surgery. PLA implants produced comparable results to metal implants with the 
advantages  of  ease  of  contouring  the  implants,  less  operative  time  and  soft 
tissue reaction. In a clinical study a copolymer made of 82% L lactide acid and 
18%  glycolic  acid  was  used  for  the  treatment  of  zygomatic  fracture  in  65 
patients. The results showed good results for fracture fixation and there were no 
long term side effects associated with the degradation process of the polymers 
[Enislidis et al., 2005]. In another clinical study 80 patients with maxillary and 
mandibular fracture and reconstruction cases were treated with poly (L lactide 
co glycolide) (PLGA) copolymer or poly (L lactide  co DL lactide) implants. Only 
6  %  of  the  patients  showed  foreign  body  reactions,  which  was  successfully 
controlled by conservative treatment and local curettage. All the devices were 
degraded within 24 months of implantation [Landes et al., 2006]. 
Another clinical area where, although poly L lactic acid (PLLA) does not come in 
direct contact with the bone, is its use for the treatment of facial asymmetry. 
When implanted in soft tissue PLA causes a foreign body reaction which results 
in  fibrosis  and  collagen  formation.  This  effect  of  PLLA  is  utilized  for  the 
treatment of facial asymmetry. In different studies the treatment has produced 
long  lasting  changes  in  dermal  thickness  which  resulted  in  improved  facial 
symmetry and appearance in patients. The treatment was well tolerated and the 
only  adverse  effect  reported  were  non bothersome  subcutaneous  papules 
[Barton et al., 2006; Burgess, 2008].   
PLA  or  copolymers  of  PLA  and  PGA  have  been  used  and  are  commercially 
available as periodontal tissue regeneration membranes with varying success. In 
a clinical study 11 patients were treated with PLA membranes (Atrisorb
® Free 
Flow
TM) in combination with bovine bone mineral (BBM) for intrabony defects. 
The results showed that the use of PLA BBM produced a reduction of probing 
depth  of  4.72  mm  and  a  gain  clinical  attachment  level  of  3.71  mm  in  the 
patients which was better than in the patients which were treated with access Chapter 1 
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flap procedures which showed a reduction of 2.50 mm in the probing depth and 
a clinical attachment level gain of 2.43 mm [Ioannis et al., 2004].   
In another clinical study, patients with Class II furcation defects in lower molars 
were treated with a polylactic acid membrane (Atrisorb). The results at the end 
of  six  weeks  did  not  show  significant  difference  in  relative  vertical  clinical 
attachment  level  and  relative  horizontal clinical  attachment  level  among the 
patients  treated  with  Atrisorb  or  open  flap  debridement  (control).  However 
significant difference was found among the patients in probing depth reduction 
[Bremm et al., 2004].  
Park et al. [1997] produced PLA membranes for guided tissue regeneration with 
the ability of controlled drug delivery and tested it in vitro. Lee et al. [2001b] 
reported the fabrication of PDGF loaded PLA TCP membrane for GTR and have 
shown that these PLA TCP membranes loaded with PDGF produced more bone 
formation when tested in rabbits.   
With the advantages of PLA there are also some drawbacks which are associated 
with PLA, the most important being mechanical weakness and aseptic swellings 
due  to  accumulation of  their acidic  degradation products.  However, this  was 
mainly seen with the early implants where the method of manufacture leads to a 
high molecular weight outer layer which degraded more slowly than the core. 
After about two years the outer layer degraded enough to release the acidic 
central core degradation products producing a sudden release and consequently 
“sterile sinus” or inflammatory response. Other potential hazards, although not 
very common, associated with the use of biodegradable implants are toxicity, 
mutagenicity and infection [Bostman and Pihlajamaki, 2000].  
The formation of sterile sinuses is more likely with crystalline poly (L lactide) 
than  amorphous  poly  (D lactide)  due  to  the  formation  of  highly  crystalline 
debris, however fast degradation rate of amorphous (D lactide) can also be a 
cause  of  swelling  as  the  low  pH  produced  can  cause  inflammatory  tissue 
reactions. Clinical use of amorphous polylactides can be more favourable than 
crystalline  polylactides  where  mechanical  strength  is  not  a  requirement 
[Tegnander et al., 1994; Ignatius et al., 2001; Ishii et al., 2003; Maquet et al., 
2003]. In a clinical study by Bergsma et al. [1995], zygomatic bone fractures Chapter 1 
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were treated with high molecular weight poly lactic acid (PLLA) bone plates and 
screws.  After  three  years  of  implantation  swelling  was  reported  at  the 
implantation site which may be due to accumulation of degradation product and 
increase in osmotic pressure due to the degradation fragments. In vitro studies 
showed  that  amorphous  PDLLA  does  not  produce  crystalline  remnants  on 
degradation [Heidemann et al., 2001].  
A survey showed that only 1 out of 491 patients (0.2 %) treated with polylactic 
acid implants showed foreign body reaction and in other studies the reaction to 
poly lactic acid implants was also found to be lower than to polyglycolic acid 
implants [Bostman and Pihlajamaki, 2000]. No adverse response was observed in 
many clinical studies where polylactic acid implants were used [Partio et al., 
1992; Pihlajamaki et al., 1997].   
Optimised combinations of mechanical properties and degradation rates can be 
achieved by using appropriate ratios of D and L enantiomer, implant size, use of 
polymer  as  composite  with  ceramics  or  self  reinforcement.  The  addition  of 
ceramics such as HA and TCP can enhance the bioactivity and can improve the 
biological properties and mechanical properties of PLA [Rokkanen et al., 2000b; 
Kim et al., 2006; Jeong et al., 2008]. 
1.6.2 Bioactive calcium phosphate ceramics 
Calcium  phosphates  (Ca  P)  have  been  used  extensively  in  the  field  of 
biomaterials. Calcium phosphates of various kinds having different Ca/P ratio 
ranging from 0.5 to 2.0 can be synthesized by mixing calcium and phosphate 
solutions. However, the two calcium phosphates of major interest and which are 
widely used in biomaterials are HA and TCP. HA has a Ca/P ratio of 1.67 and its 
chemical  formula  is  Ca10(PO4)6(OH)2.  The  Ca/P  ratio  of  TCP  is  1.50  and  its 
chemical formula is Ca3(PO4)2.  
HA is a major component of bones and teeth and is one of the most important 
and  widely  used  ceramic  in  biomaterials  and  tissue  engineering  due  to  its 
chemical and physical similarity to natural bone [Rossa, 1991; Kurashina et al., 
1995]. In bones HA is present in the form of nanocrystals having dimensions of 
the order of 4 Χ 20 Χ 50 nm. Synthetic and natural HA are not identical but have Chapter 1 
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chemical and crystallographical similarities [Damien and Parsons, 1991]. Ca/P 
ratio of natural HA is less than the 1.67 Ca/P ratio of synthetic HA. HA present in 
the bones is not stoichiometric whereas synthetic HA is mostly stoichiometric 
[LeGeros  et  al.,  1988;  Murugan  and  Ramakrishna,  2005].  HA  and  TCP  are 
considered bioactive, osteoconductive and non immunogenic which makes them 
a  material  of  choice  for  biomaterial  applications  [Frame,  1987;  Damien  and 
Parsons,  1991;  Murugan  and  Ramakrishna,  2005].  General  physiochemical, 
biological and mechanical properties of synthetic HA and TCP are listed in Table 
1.5. 
Table 1.5: General properties of HA [from Kitsugi et al., 1987; LeGeros, 1993; Larry, 1998; 
Murugan and Ramakrishna, 2005] 
                                                            HA                                TCP 
Chemical composition                           Ca10(PO4)6(OH)2            Ca3(PO4)2 
Ca/P molar ratio                                   1.67                            1.50 
Crystal system                                       Hexagonal 
Young_s modulus (GPa)                          80–110 
Compressive strength (MPa)                   400–900 
Bending strength (MPa)                          115–200 
Density (Mgm
 3)                                      3.16                           3.07  
Fracture toughness (MPa m
1/2)                0.7–1.2 
Hardness (HV)                                        600 
Decomposition temperature (°C)            >1000 
Melting point (°C)                                  1614 
Thermal conductivity (Wcm
 1 K
 1)            0.013 
Biocompatibility                                     High                           
Bioactivity                                              High                          High 
Biodegradation                                       Low                           High 
Cellular compatibility                             High                           
Osteoinduction                                       Nil                             Nil 
Osteoconduction                                     High                          High 
 
Ceramics like HA and TCP degrade to varying degrees, the degradation tendency 
of  HA  and  TCP  depends  on  various  factors  which  include  synthesis  method, 
crystallographic structure, particle size and site of implantation [Frame, 1987].  
Biodegradation  or  bioresorbtion  of  ceramics  is  characterized  by  mechanical Chapter 1 
  73 
strength loss, porosity changes, dissolution, formation of other CaP phases and 
transformation of these phases on the surface of the ceramic [LeGeros et al., 
1988]. It is assumed that there are two mechanisms of ceramic bioresorption: 
the first mechanism involves dissolution of the ceramic implant by physiological 
solutions  and  second  mechanism  involves  cell  mediated  processes  such  as 
phagocytosis, which result in the reduction of pH which increases the dissolution 
of the ceramic. In addition to these two mechanism physical abrasion, fracture 
and  disintegration  also  contribute  to  the  ceramic  resorbtion  [Jarcho,  1981; 
LeGeros  et  al.,  1988].  Resorption  of  HA  and  TCP  is  affected  by  the  site  of 
implantation. The close proximity of implants to the cell systems, particularly 
osteoblasts and osteoclasts, plays an important role in the degradation of the 
implant. Studies have shown that the HA implanted in bone resorbs faster than 
implants implanted subcutaneously [Dubok, 2000]. Porosity of HA also play an 
important  role  in  the  degradation,  more  porous  implants  have  higher 
degradation rate [Klein et al., 1983]. Factors which affect the biodegradation of 
HA and TCP are [LeGeros et al., 1988]: 
•  Porosity 
•  Crystal size 
•  Crystal imperfections 
•  Grain size 
•  pH level at the implantation site 
•  Implantation site 
•  Degree of bone contact      
 
 
The size and shape of bioceramic particles is important for their application. 
Small particles and more uniform shape adjust better in a defect area than the 
particles  with  irregular  shapes  which  also  create  large  voids.  HA  with  small 
particles have higher strength and lower porosity, as they have more contact 
points than larger particles [Ginebra et al., 2004]. Particles with nanosize and 
nanostructure  provide  a  large  surface  area  for  adhesion  which  increases  the 
interaction of particles with the surrounding environment [Ginebra et al., 2004].  
Compared  to  micro  HA,  nano HA  promotes  increased  osteoblast  adhesion, 
enhanced cell differentiation, proliferation and deposition of calcium containing Chapter 1 
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minerals by osteoblasts which can result in increased formation of new bone 
tissue [Webster et al., 2000]. 
1.6.2.1  Synthesis of Hydroxyapatite (HA) 
HA powders having different morphology, stoichiometry and level of crystallinity 
can  be  produced  by  using  different  preparation  techniques  [Suchanek  et  al., 
2002]. It is important to produce HA with controlled stoichiometry, crystal size, 
shape and agglomeration characteristics. All these factors play an important role 
in determining dissolution, bioactivity and mechanical properties of HA [Mostafa, 
2005]. The different methods employed for the preparation of HA include a dry 
method, a wet chemical method, a mechano chemical hydrothermal method, a 
mechano chemical method, spray pyrolysis, emulsion processing and microwave 
assisted synthesis [Feng et al., 2005; Murugan and Ramakrishna, 2005].  Some of 
the commonly used methods are described below: 
•  Wet-Chemical Method 
o  Precipitation 
Precipitation is the common method for the synthesis of HA. It involves a wet 
chemical reaction between calcium and phosphate precursors under controlled 
pH and temperature. Nano size crystals having shapes of plates, needles and 
rods  can  be  prepared,  crystallinity  and  Ca/P  of  the  particles  depend  on  the 
preparation  conditions  and  are  mostly  lower  than  from  well crystallised 
stoichiometric  HA  [Suchanek  et  al.,  2002].  This  process  involves  a  reaction 
between ammonium phosphate and calcium nitrate at 60°C and pH is maintained 
between 9 and 10 [Bezzi et al., 2003]. The precipitate after aging and drying is 
calcined at 400 °C to 600 °C and then sintered between 1000 °C and 1200 °C. 
This process however has some disadvantages such as it is important to maintain 
the pH value above 9, as reduction in the pH below 9 leads to formation of Ca 
deficient HA and the subsequent formation of tricalcium phosphate due to the 
decomposition  of  hydroxyapatite  as  a  result  of  sintering  at  high  temperature 
[Jillavenkatesa and Condrate, 1998].   
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o  Sol-gel 
Highly pure HA powder can be produced by sol gel method as it provides strict 
control on the process parameters. This process does not require maintenance of 
high  pH  values  and  high  sintering  temperatures  unlike  the  precipitation 
technique [Feng et al., 2005]. Improved chemical homogeneity can be achieved 
by molecular mixing of calcium and phosphorous. High reactivity of the sol gel 
powder results in the reduction of the processing temperature and degradation 
during sintering [Bezzi et al., 2003]. However possible hydrolysis of phosphates 
and expensive raw materials are two of drawbacks of this technique [Livage et 
al., 1992].   A variant of the sol gel method was developed by Deptula et al. 
[1992] in which repetitive emulsification of calcium acetate and phosphoric acid 
mixture followed by solidification by water extraction produces hydroxyapatite 
spheres. Calcination of these spheres produces HA particles. 
Jillavenkatesa and Condrate [1998] also synthesized HA by the sol gel method 
using  relatively  inexpensive  calcium  acetate  and  triethyl  phosphate  as 
precursors. This process also overcomes the difficulties associated with the slow 
hydrolysis of phosphate as the gel formed during the process is colloidal. 
Feng  et  al.  [2005]  reported  a  simple  sol  gel  method  which  eliminates  the 
requirements  of  controlling  pH  value,  vigorous  stirring  and  long  time  for 
phosphate hydrolysis associated with conventional sol gel method. In the process 
the  sintering  temperature  and  aging  time  determine  the  crystallinity  and 
morphology of the resulting HA powder.  A flow chart of their process which 
produced 10 15 nm diameters HA powder is shown in Figure 1.24.  
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Figure 1.24: Synthesis of HA by a sol gel method reported by Feng et al. [2005] 
 
o  Hydrothermal 
Highly crystalline and pure HA can be obtained from this process. This process 
involves application of high temperatures to aqueous solutions which facilitate 
the precipitation of crystals of larger dimensions than obtained from ordinary 
wet methods. Crystals size in the range of nanometers to millimeters can be 
obtained [Narasaraju and Phebe, 1996].  
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o  Hydrolysis 
Micron size HA particles of needle or blade shape can be obtained by hydrolysis 
of tricalcium phosphate, monetite, brushite and octacalcium phosphate at low 
temperature. However the calcium phosphate produced by this process is mostly 
nonstoichiometric HA [Suchanek et al., 2002]. 
•  Mechanochemical Method 
Mechanochemical  synthesis  describes  a  solid  state  method  in  which 
thermodynamic  and  kinetic  reaction  between  solids  is  enhanced  by  pressure 
applied  perturbation  of  surface  bonded  species  [Suchanek  et  al.,  2002].  This 
method of ceramic powder synthesis can be used in the industrial production of 
HA due to its simplicity and low cost.  The mechanochemical method is different 
from  mechanochemical  hydrothermal  method  as  it  only  involves  solid state 
reaction  whereas  the  latter  process  also  involves  an  aqueous  phase.  Simple 
equipment such as ball mills and vibratory mills are used for mechanochemical 
synthesis. In mechanochemical synthesis the overall temperature stays close to 
room temperature whereas local zones of high pressures and temperatures (up 
to 450 700°C) are produced due to friction of slurries and adiabatic heating of 
gas bubbles [Suchanek et al., 2002].   
 
•  Mechanochemical Hydrothermal Method 
The  mechanochemical  hydrothermal  method  is  at  the  intersection  of 
hydrothermal and mechanochemical processes. It incorporates an aqueous phase 
which accelerates the kinetic processes. The water participates actively in the 
processes by dissolving the reactant powders and serving as a reaction medium 
which produces highly crystalline and stoichiometric powder [Shuk et al., 2001]. 
Like  the  mechanochemical  method  this  process  can  also  be  used  to  produce 
large quantities of HA as it requires simple equipment and is processed at room 
temperature, unlike hydrothermal method which requires high temperature. HA 
produced by mechanochemical hydrothermal method has better densification, 
uniform microstructure and mechanical properties as compared to HA produced 
by wet chemical precipitation method [Mostafa, 2005].  Chapter 1 
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•  Solid-state reaction 
Stoichiometric and well crystallized HA can be produced by solid state reactions, 
however these reactions involve high temperatures and long duration of heat 
treatment [Lin et al., 2007].  
•  Emulsion Processing 
Well  crystallized  and  pure  nano  HA  can  be  synthesized  by  this  process,  the 
morphology  and  size  of  the  particles  strongly  depends  on  the  reaction 
temperature [Furuzono et al., 2001].  Water in oil emulsion method can be used 
to prevent the flocculation of HA particles during the synthesis as small micro or 
nano  sized  water  spheres  act  like  miniature  reactors  which  prevent  particle 
flocculation and limit particles growth [Phillips et al., 2003].  
•  Microwave Irradiation 
Microwave irradiation has been developed to eliminate the long sintering, time 
consuming  and  tedious  processes  associated  with  synthesis  of  HA.  It  involves 
performing the precipitation method of producing HA but microwave energy is 
applied to accelerate the synthesis. This process has been shown to enhance the 
production  of  seed  crystals  of  hydroxyapatite  [Lerner  et  al.,  1991].  Using 
microwave technique it is possible to obtain HA much faster than conventional 
methods [Teoreanu et al., 2008; Arami et al., 2009]. Siddharthan et al. [2004] 
successfully synthesized nanosized calcium deficient HA rapidly by microwave 
irradiation  whilst  reacting  calcium  nitrate  hydrate  and  phosphoric  acid.  In 
another study HA nano rods having a diameter from 60 to 80 nm and lengths of 
about  400 nm  were  prepared  by  a  one step  microwave assisted  solid state 
reaction at room temperature in much less time than using conventional heating 
[Cao et al., 2005].  
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1.6.2.2  Biomedical applications of HA 
Owing to its biocompatibility, osteoconductivity and bioactivity HA is used in a 
wide of range of biomedical applications [Dubok, 2000]. Biomedical applications 
of  HA  include  repair  of  alveolar  bones  through  to  long  bones  defects  and 
fractures, middle ear prostheses, eye implants, spinal fusion, vertebral fusions, 
cranioplasty,  craniofacial  repairs,  in  dental  restorative  materials,  drug  and 
growth  factor  delivery  [Damien  and  Parsons,  1991;  Paul  and  Sharma,  2003; 
Murugan and Ramakrishna, 2005]. Particle size plays a key role in modifying the 
properties of HA. It is a useful parameter in order to adjust the behavior of the 
material to the specific clinical applications. The bioactivity of nanosize HA is 
higher  than  coarser  crystals  and  it  provides  a  formulation  with  improved 
osseointegration for use in orthopedic and dental implants [Han et al., 2004]. 
The first use of synthetic HA for treatment of bone defects was reported by Ray 
and Ward [1951] when they successfully synthesed and implanted HA in the short 
bones of cats and monkeys and long bones in dogs with positive outcomes. HA 
does not have the capacity to induce bone, however it is osteoconductive and 
provides  a  physical  matrix  which  is  suitable  for  deposition  of  new  bone  and 
allows bone growth. It is believed that the new bone formed bonds directly onto 
the  implanted  HA  without  any  intermediate  fibrous  layer,  this  property  is 
particularly important when used as bone graft substitute [Frame, 1987; Damien 
and  Parsons,  1991].  Implantation  of  HA  in  the  body  is  followed  by  an 
inflammatory process in which macrophages invade the implantation site and 
attack the surface of the HA in addition to clearing the area of dead cells and 
debris. This results in formation of a chemical apatite layer on the rough HA 
surfaces which is similar to biological apatite. Migrated osteoblasts then produce 
an osteoid layer in the surface of HA which is followed by mineralisation [Kitsugi 
et al., 1987]. 
Due to its high biocompatibility, sufficient mechanical strength and ease of use, 
HA is considered to be an ideal material for the augmentation of alveolar ridges 
[Dubok, 2000]. Treatment of alveolar bone defects such as defects created by 
periodontal  diseases  and  surgical  bone  defects  can  be  achieved  by  packing 
porous or dense hydroxyapatite granules in the defect area. For more than two 
decades HA has been successfully used for periodontal defect restoration and Chapter 1 
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correction  of  alveolar  ridge  defects.  Figure  1.25  shows  HA  blocks  and  HA 
particles  deposited  by  a  syringe used  for ridge augmentation. The  use  of  HA 
eliminates the drawbacks associated with use of autologus and autogenous bone 
grafts  for  the  treatment  of  these  defects  as  discussed  in  section  1.4.3.1 
[Rothstein et al., 1984].  
 
 
 
 
 
Figure  1.25:  Hydroxyapatite blocks  and  particles  deposited  by  syringe for alveolar  ridge 
augmentation [adapted from Frame, 1987]  
 
Kent et al. [1986] used HA and HA /autogenous bone grafts for alveolar ridge 
augmentations in more than 200 patients and followed the cases for five years. 
They found that all the cases either treated with HA alone or in combination 
with  autogenous  bone  showed  good  alveolar  ridge  regeneration.    In  another 
study 110 patients with deficient alveolar ridges were treated with HA implants 
and followed for 33 months, all the cases showed improvement in the height, 
bulk, contour of the ridges without any major complications associated with the 
implants [Rothstein et al., 1984].  
1.6.2.3  Use of hydroxyapatite for drug release 
HA is considered to have the ability to act as a drug carrier and attempts have 
been made to exploit HA constructs for the delivery of growth factors and drugs 
[Paul  and  Sharma,  2003].  In  an  in  vitro  study  enhanced  proliferation  and 
differentiation of human osteoblasts was observed when these were exposed to 
growth  factors  delivered  by  HA  [Zambonin  et  al.,  2000;  Matsumoto  et  al., 
2004b]. Ono et al. [1998] loaded porous HA rods (5 mm diameter, 10 mm length) 
with 1 g or 5 g rhBMP 2 and implanted them into the cranial bones of rabbits. 
They found that adding rhBMP 2 to the HA rods increased the bone formation. Chapter 1 
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The bone formation was higher with the higher dose of rhBMP 2. Adding rBMP 2 
to  HA  rods  also  increased  the  strength  of  the  rods  in  the  initial  stages  of 
implantation. Porous blocks of HA have also been tested for sustained release of 
anticancer drugs in a rat model. The results showed a slow release profile of the 
drug  sustained  for  3  months  which  was  more  effective  in  inhibiting  tumour 
growth  than  when  administered  intraperitoneally  [Uchida  et  al.,  1992].  
Sustained and slow release of antibiotics from porous blocks of HA was evaluated 
by Shinto et al. [1992]. Gentamicin sulphate was placed in cylindrical cavity of 
HA blocks and implanted in rats. The release of gentamicin sulphate into the 
bone of rats was slow after maximum release within first week and sustained 
even at 12 weeks after implantation. In addition the antibacterial activity of the 
drug was not affected by the addition to HA.   
1.6.3 Hydroxyapatite-polylactic acid composite 
Drawbacks  associated  with  degradable  polymers  such  as  low  mechanical 
properties and unpredictable degradation pattern can be improved by combining 
them with other biomaterials and using them as a composite material [Huang et 
al., 2008]. The addition of stiff filler will increase the stiffness and may increase 
the strength of a polymer. In bone contacting applications calcium phosphates 
are commonly used. ß tricalcium phosphate added to PLA was shown to slow the 
degradation rate of the polymer [Nazhat et al., 2001; Niemelä, 2005]. 
The  use  of  ceramics  such  as  HA  in  PLA,  may  confer  a  number  of  potential 
therapeutic advantages, including increasing mechanical properties, promoting 
cell attachment and osteoconduction, and the potential for use as a vehicle for 
slow delivery of bioactive proteins such as growth factors. HA may also provide 
mechanical reinforcement for the PLA, improving its stiffness and strength [Sui 
et  al.,  2007]  which  can  enable  it  to  maintain  its  shape  during  functional 
pressures  in  situ.  Bleach  et  al.  [2001]  showed  that  adding  HA  increases  the 
flexural  modulus  and  yield  strength  of  polymer  composites.  HA  has  regularly 
been  proposed  as  a  potential  synthetic  graft  material  with  osteoconductive 
properties  [Bonfield  et  al.,  1981;  Wang  et  al.,  2003;  Liao  et  al.,  2005].  HA 
containing composite membrane materials may increase osteoconductivity over 
PLA or other resorbable membrane materials as cell attachment to the mineral Chapter 1 
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will be dependent on protein absorption to the surface of the material. HA–PLA 
composite materials have been shown to be biocompatible, resorbable with good 
mechanical properties [Shikinami and Okuno, 1999].  HA PLA composites have 
been  proposed  as  a  substitute  for  autologus  bone  powder  [Ignjatovic  et  al., 
2001].  
In  addition  to  other  properties,  HA  also  has  the  ability  to  both  adsorb  and 
release protein; protein adsorption increases with the increase in the surface 
area of HA [Matsumoto et al., 2004a; Nakamura et al., 2006].   A number of 
mineral based carriers have been used experimentally for controlled release of 
growth  factors  in  tissue  regeneration  experiments;  for  example  collagen 
hydroxyapatite microspheres have been successfully used as a carrier of bone 
morphogenic proteins (BMPs)
 for bone regeneration [Wang et al., 2003]. 
1.7 SUMMARY AND AIMS OF THESIS 
Although GTR  procedures  are  widely  used  for  periodontal  regeneration,  their 
outcomes remain clinically modest on many occasions. There is thus the need to 
develop new ways of improving clinical outcomes. Currently used membranes for 
GTR are often limited by their relatively poor mechanical properties resulting in 
poor  space  maintenance  during  healing.    In  addition  there  is  considerable 
research into the possible application of growth factors to wounds to improve 
the outcome of existing regenerative procedures.   
One possible approach to address these issues is to consider using a resorbable 
composite material made from a PLA HA composite. This material may be able 
to address issues of mechanical properties, whilst improving osteoconductivity 
and the possibility of using as an adjunctive delivery system for growth factors 
to promote regeneration further. 
Thus the aims of these studies are to develop a degradable composite membrane 
for guided tissue regeneration and to investigate the physical, mechanical and 
biological properties of these membranes. Specific objective includes:   
1). To develop a membrane with good mechanical properties which can maintain 
a space for periodontal regeneration without collapsing under occlusal pressure. Chapter 1 
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2).  To  investigate  the  possibility  of  incorporating  growth  factors  in  the 
membrane  for  their  controlled  release  at  the  wound  site  to  enhance  tissue 
regeneration. 
3). And to determine a membrane shape and size which can be can be used in 
most  clinical  situations/sites  by  analysing  different  bone  resorption  patterns.     
CHAPTER  2:  CHARACTERISATION  OF  CALCIUM 
PHOSPHATE  POWDERS,  POLYLACTIC  ACID  AND 
POLYLACTIC ACID CALCIUM PHOSPHATE FILMS 
   
2.1  INTRODUCTION 
Calcium phosphates (Ca P) such as hydroxyapatite (HA) and tricalcium phosphate 
(TCP) have been extensively used as bone substitutes and in dental applications 
as their chemical composition closely resembles the mineral phase of bone and 
teeth [Soriano, 2000]. The drawbacks associated with Ca P such as brittleness, 
low impact resistance and low tensile strength limit their scope however these 
can  be  overcome  by  combining  them  with  polymers  such  as  PLA.  The 
combination  of  Ca  P  and  PLA  enables  easy  fabrication  of  devices  with  good 
mechanical and biological properties [Sui et al., 2007; Jeong et al., 2008].   
Polylactic  acid  (PLA)  is  a  degradable  polymer  which  has  been  used  in  many 
biomedical applications and is still a subject of extensive research to expand its 
use due to its biodegradability. With the advantages of PLA there are also some 
drawbacks, the most important being variable degradation rate in early devices 
and  aseptic  swellings  due  to  accumulation  and  burst  release  of  acidic 
degradation products.  
The  use  of  Ca  P  within  PLA  may  confer  a  number  of  potential  therapeutic 
advantages  on  this  material,  including  increased  mechanical  properties, 
promotion of cell attachment and osteoconduction, and the potential for use as 
a vehicle for slow delivery of bioactive proteins such as growth factors. HA may 
also provide mechanical reinforcement for the PLA, thus improving its stiffness 
and strength.  [Sui et al., 2007; Jeong et al., 2008]  
In  this  study  the  fabrication  of  PLA Ca  P  composite  films  and  their 
characterisation is reported.    Chapter 2 
  85 
2.2  MATERIALS 
2.2.1 Polylactic acid (PLA) 
PLA with an L: DL ratio of 70/30 and an IV of ~ 3.0 dl/gr (MW 500,000 600,000) 
was obtained from PURAC Biochem, The Netherlands. It was supplied in the form 
of granules.  
2.2.2 Nano-hydroxyapatite (nHA) 
nHA with mean particle size less than 200nm was purchased from Sigma Aldrich, 
UK. 
2.2.3 Micro-hydroxyapatite 
Two different types of micron size hydroxyapatite (HA) powders were used in 
the study. First, was spray dried HA (rHA) and the second was sintered HA (sHA), 
both having average particle size of 3.80 and 4.46  m respectively, but with a 
factor of over 13 difference in the specific surface areas. Both the powders were 
purchased  from  Plasma  Biotal  Limited,  UK.  These  two  powders  have  been 
characterized  previously  by  Zhang  and  Tanner  [2008]  and  the  particle  size 
distribution and specific surface area are given in table 2.1.  
Table 2.1: Physical properties of rHA and sHA [from Zhang and Tanner, 2008] 
 
 
 
Powder 
 
 
Particle size ( m)            Specific surface 
d0.1      d0.5     d0.9             Area (m
2 g
 1)  
  
rHA 
 
sHA 
0.99    3.80    6.23              13.54 
 
0.76    4.46   11.12              0.97 
 
    
2.2.4 Beta tricalcium phosphate (ßTCP) 
ßTCP was purchased from Plasma Biotal Limited, UK. The average particle size 
was 4 m.   Chapter 2 
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2.3  METHODS  
2.3.1 PLA and PLA-Ca P composite film fabrication 
PLA and PLA Ca P composite films were produced by a solvent casting method. 
To produce the PLA films 25 ml of chloroform was poured into spherical flasks 
and 0.5 g of PLA was added while stirring. The solution was then left on the 
stirrer for 24 hrs at room temperature. After 24 hrs of stirring the solution was 
spread in glass Petri dishes and then left overnight to allow slow evaporation of 
the chloroform. The same size of Petri dishes was used for all the films to get 
films of the same thickness.  
For the production of PLA Ca P composite films Ca P powders were added to the 
PLA  solution  dissolved  in  chloroform  after  24  hrs  of  stirring  in  the  required 
concentration  to  give  10,  40  and  70  weight  %  after  the  evaporation  of  the 
chloroform, while the same amount of PLA was used for each film. These weight 
contents are equivalent to 4.2, 20.9 and 48.0 volume % of HA using 1.250 Mgm
 3 
and 3.156 Mgm
 3 for the densities of PLA and HA respectively and are equivalent 
to 4.3, 21.4 and 48.7 volume % of TCP using 3.07 Mgm
 3 density for TCP. PLA Ca 
P solutions were then stirred for a further 48 hrs. The solution was spread in 
120mm  glass  Petri  dishes  which  were  covered  to  allow  slow  evaporation  of 
chloroform. After evaporation of the chloroform, the films were peeled off the 
dishes and placed in a vacuum oven for one day. The films were then annealed 
by being pressed between the bases of two glass Petri dishes and were placed in 
the oven at 70 
◦C for one hour. The films were then allowed to cool gradually 
overnight. The heat treatment was done to relax any stresses produced in the 
films during the casting process and to prevent curling up of the films during the 
experiments. 
2.3.2 Scanning Electron Microscopy (SEM) 
The morphology and particle size of the Ca P powders and the morphology of the 
films were characterised by SEM (FEI Inspect F, EFI Company, The Netherlands) 
(Figure 2.1). For Ca P powders 20kV and for PLA and PLA Ca P composite films 
5kV were used. All the samples were gold coated.  Chapter 2 
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Figure 2.1: Scanning Electron Microscope. 
 
2.3.3 Transmission Electron Microscopy (TEM) 
High Resolution TEM (JEOL JEM 2010) (Figure 2.2) operated at 200 keV was used 
to analyse the morphology and particle size of the Ca P powders. Powders were 
ultrasonically dispersed in methanol and then collected on copper grids coated 
with carbon (Holey Carbon Film, 300 mesh Cu, Agar Scientific) to be analysed by 
TEM.  
 
 
Figure 2.2: Transmission Electron Microscope. 
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2.3.4 X- ray diffraction (XRD) 
XRD  is  a  non destructive  analytical  technique  which  enables  the  analysis  of 
chemical composition and crystallographic structure of a material. 
Ca  P  powders  were  characterized  using  XRD,  to  find  chemical  composition, 
crystal  state  and  the  crystalline  content.  A  Seimens/Bruker  D5000  X ray 
Diffractometer, with monochromatic Cu Ka radiation (k = 0.15418 nm) was used. 
Scans were obtained in the 2θ range = 20–60 and step size of 0.02° s
 1.  
2.3.5 Fourier Transform Infra red spectroscopy (FTIR) 
FTIR is an analytical technique which measures the infrared radiation absorption 
by  a  material  versus  wavelength,  the  molecular  structure  of  the  material  is 
characterised by the wavelength of the light absorbed which causes vibration of 
the  molecules.  FTIR  is  also  useful  for  the  quantitative  analysis  as  the  band 
intensities  which  appear  in  the  spectrum  due  to  vibration  of  molecules  of  a 
material are directly proportional to the concentration of that molecule [Vlachos 
et al., 2006].  
FTIR spectra of the Ca P powders and PLA and PLA Ca P composite films were 
obtained by a Thermo Electron Nicolet 8700 FTIR spectrometer. Dry helium gas 
was used to purge the sample chambers. The spectra were measured at 8cm
 1 
resolution and a total of 256 scans were obtained. A background spectrum of a 
carbon sample was obtained before obtaining sample spectra.  
2.3.6 Raman Spectroscopy 
Nicolet Almega XR dispersive Raman spectrometer was used to obtain Raman 
spectra of the Ca P powders and films, spectra were collected by taking 256 
scans per sample and an exposure time of 2 sec was used at 8 cm
 1 resolution. 
The spectra were collected between 4000 100cm
 1. A background spectrum was 
obtained before obtaining sample spectra.    
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2.4  RESULTS 
2.4.1 Calcium phosphate powders 
2.4.1.1  SEM and TEM  
nHA powder 
The morphology and size of nHA particles are shown in SEM and TEM images in 
Figure  2.3.  The  images  show  that  the  particles  are  spherical  in  shape  with 
approximate size of 20 200 nm although agglomerated. 
 
 
      
 
 
 
 
Figure 2.3: SEM images (a) lower magnification (scale bar= 5  m) (b) higher magnification 
(scale bar= 1 m) and (c) TEM (scale bar= 100 nm) showing morphology and particle size of 
nHA.    
 
 
(a)  (b) 
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sHA powder 
The morphology and size of sHA particles are shown by SEM and TEM images in 
Figure  2.4.  The  images  show  that  the  particles  have  smooth  surfaces  and 
irregular shape with a mean particle size of approximately 4  m. 
 
      
 
 
 
 
Figure 2.4: SEM images (a) lower magnification (scale bar= 5  m) (b) higher magnification 
(scale bar= 1  m) and (c) TEM (scale bar= 500 nm) showing morphology and particle size of 
sHA. 
 
 
 
 
 
 
 
 
 
 
 
 
(a)  (b) 
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rHA powder 
SEM and TEM images showing the size and morphology of rHA particles are shown 
in Figure 2.5. The images show that the particles have rough surfaces with a 
mean particle size of approximately 4  m and are agglomerates of needle like 
small particles.   
 
      
 
 
 
 
Figure 2.5: SEM images (a) lower magnification (scale bar= 5  m) (b) higher magnification 
(scale bar= 1  m) and (c) TEM (scale bar= 50 nm) showing morphology and particle size of 
rHA. 
 
 
 
 
 
 
 
 
 
 
 
(b)  (a) 
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ßTCP powder 
The morphology and size of ß TCP particles are shown by SEM and TEM images in 
Figure 2.6. The images show that the particles have smooth surfaces, irregular 
shapes and consist of multiple particles which are fused together. The particle 
size ranges from 4 to 20  m.  
 
      
 
 
 
 
Figure 2.6: SEM images (a) lower magnification (scale bar= 5  m) (b) higher magnification 
(scale bar= 1  m) and (c) TEM (scale bar= 500 nm) showing morphology and particle size of 
ßTCP. 
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2.4.1.2  XRD 
Figure 2.7 shows the XRD patterns for (a) nHA, (b) sHA (c) rHA and (d) ßTCP. All 
three HAs show diffraction peaks at 31.8° (211), 32.2° (112) and 32.9° (300) 
which are characteristic of HA XRD pattern and confirm the purity of all three 
HAs,  however  the  crystallinity  of  three  HAs  was  significantly  different.  sHA 
showed narrow and intense peak followed by rHA, whereas XRD of nHA showed 
broad and less intense peaks. The XRD peaks for ßTCP show the characteristic 
pattern with strong diffraction peaks at 27.8°, 31.0° and 34.4°. 
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Figure 2.7: Comparative XRD pattern for (a) nHA (b) sHA (c) rHA and (d) ßTCP.  
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2.4.1.3  FTIR  
Figure 2.8 (a), (b), (c) and (d) show the FTIR spectra of nHA, sHA, rHA and ßTCP 
powders  respectively.  The  spectra  of  all  three  HA  powders  show  the  typical 
peaks associated with HA. The peaks at 3571 and 631 cm
 1 were assigned to the 
hydroxyl group (–OH), while the peaks at 1473 and 875 cm
 1 were attributed to 
stretching mode of carbonate groups (CO3). The peaks at 1040, 946, 603 and 569 
cm
 1 were assigned to phosphate groups (PO4) present in the HAs. Whereas the 
FTIR spectra of ßTCP show the characteristics phosphate peaks at 946, 603 and 
569 cm
 1 and there were no peaks observed associated with OH or CO3.    
 
 
 
 
Figure 2.8: FTIR spectra of Ca P powders (a) nHA (b) sHA (c) rHA and (d) ßTCP.  
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2.4.1.4  Raman spectroscopy  
Figure 2.9 shows the Raman spectra of (a) nHA, (b) sHA, (c) rHA and (d) ßTCP 
powders. For the three HAs the main peak was observed at 960 cm 
 1 which is 
assigned to phosphate (PO4) stretching. The intensity of this peak was highest for 
sHA followed by rHA and nHA respectively and represents the crystallinity of HA.  
In addition a less intense peak, which is assigned to PO4 bending, was observed 
at 590 cm
 1.  
 
 
 
 
Figure 2.9: Raman spectra of Ca P powders (a) nHA (b) sHA (c) rHA and (d) ßTCP 
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2.4.2 PLA and PLA- Ca P composite films 
2.4.2.1  SEM 
PLA film 
Figure 2.10 shows the SEM image of PLA films, the surface of the film appears 
very smooth. 
 
 
 
Figure 2.10: SEM image of PLA film. (Scale bar = 20  m) 
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PLA-nHA composite films 
Figure 2.11 shows the images of PLA nHA composite film containing (a) 10 wt % 
nHA  (PLA nHA10),  (b)  40  wt  %  nHA  (PLA nHA40)  and  (c)  70  wt  %  nHA  (PLA 
nHA70). PLA nHA10 film appears relatively smooth and there was hardly any nHA 
present on the film surface and most of the nHA was covered by a layer of PLA. 
However as the nHA concentrations increased in PLA nHA40 and PLA nHA70 films 
the surfaces became rough and the films also had nHA present on the surfaces 
which was not covered by PLA. 
 
 
 
Figure 2.11: SEM images of (a) PLA nHA10, (b) PLA nHA40 and (c) PLA nHA70 composite 
films. (Scale bar = 20  m) 
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PLA-sHA composite films 
Figure 2.12 shows the images of PLA sHA composite film containing (a) 10 wt % 
sHA (PLA sHA10), (b) 40 wt % sHA (PLA sHA40) and (c) 70 wt % sHA (PLA sHA70).  
The surfaces of all the films appeared rough, however most of the sHA present in 
the films appeared to be covered with PLA, except in PLA sHA70 where some of 
the particles are visible partially out of the PLA layer. 
 
 
    
 
 
 
 
 
Figure 2.12: SEM images of (a) PLA sHA10, (b) PLA sHA40 and (c) PLA sHA70 composite 
films. (Scale bar = 20  m) 
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PLA-rHA composite films 
Figure 2.13 shows the images of PLA rHA composite film containing (a) 10 wt % 
rHA (PLA rHA10), (b) 40 wt % rHA (PLA rHA40) and (c) 70 wt % rHA (PLA rHA70). 
The surface of PLA rHA10 was smoother than the surfaces of the PLA rHA40 and 
PLA rHA70 films. In addition the PLA rHA40 and PLA rHA70 films also  showed 
some micropores.  
 
 
     
 
Figure 2.13: SEM images of (a) PLA rHA10, (b) PLA rHA40 and (c) PLA rHA70 composite 
films. (Scale bar = 20  m) 
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PLA- ßTCP composite films 
Figure 2.14 shows the images of PLA ßTCP composite film containing (a) 10 wt % 
ßTCP (PLA ßTCP10), (b) 40 wt % ßTCP (PLA  ßTCP40) and (c) 70 wt % ßTCP (PLA 
ßTCP70). In PLA ßTCP10 films the ßTCP appeared to be homogenously dispersed, 
whereas PLA ßTCP40 and PLA ßTCP70 films with higher concentrations of ßTCP 
showed some agglomeration of the particles.  
 
 
      
 
Figure  2.14:  SEM  images  of  (a)  PLA ßTCP  10,  (b)  PLA ßTCP40  and  (c)  PLA ßTCP70 
composite films. (Scale bar = 20  m) 
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2.4.2.2  FTIR  
PLA film 
Figure 2.15 shows the characteristic PLA FTIR peaks. The peaks at 2995 and 2945 
cm
 1 are assigned to C H stretching of the methyl group (CH3). The intense peak 
at  1760  cm
 1  was  assigned  to  C=O  (carbonyl)  stretching,  while  the  peaks  at 
1130,1382 and 1453 cm
 1 were assigned to C H bending of CH3.   
 
 
 
 
 
Figure 2.15: FTIR spectrum of PLA. 
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PLA-nHA composite films 
Figure 2.16 shows the comparative FTIR spectra of (a) PLA, (b) nHA, (c) PLA 
nHA10, (d) PLA nHA40 and (e) PLA nHA70. The spectra of PLA nHA10, PLA nHA40 
and PLA nHA70 composites films show the characteristic peaks of both HA and 
PLA. As the concentration of nHA increased the intensities of PO4 peaks at 603 
and 569 cm
 1, which were attributed to phosphate from HA, increased relative to 
the intensities of PLA characteristic peaks at 1760, 870 and 756 cm
 1.  
 
 
 
 
Figure 2.16: Comparative FTIR spectra of (a) PLA, (b) nHA, (c) PLA nHA10, (d) PLA nHA40 
and (e) PLA nHA70. 
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PLA-sHA composite films 
Figure 2.17 shows the comparative FTIR spectra of (a) PLA, (b) sHA, (c) PLA 
sHA10, (d) PLA sHA40 and (e) PLA sHA70. The spectra of PLA sHA10, PLA sHA40 
and PLA sHA70 composites films show the characteristic peaks of both HA and 
PLA. As the concentration of sHA increased the intensities of PO4 peaks at 603 
and 569 cm
 1 which were attributed to phosphate from HA increased relative to 
the intensities of PLA characteristic peaks at 1760, 870 and 756 cm
 1.  
 
 
 
 
 
Figure 2.17: Comparative FTIR spectra of (a) PLA, (b) sHA, (c) PLA sHA10, (d) PLA sHA40 
and (e) PLA sHA70.  
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PLA-rHA composite films 
Figure 2.18 shows the comparative FTIR spectra of (a) PLA, (b) rHA, (c) PLA 
rHA10, (d) PLA rHA40 and (e) PLA rHA70. The spectra of PLA rHA10, PLA rHA40 
and PLA rHA70 composites films show the characteristic peaks of both HA and 
PLA. As the concentration of rHA increased the intensities of PO4 peaks at 603 
and 569 cm
 1, which were attributed to phosphate from HA, increased relative to 
the intensities of PLA characteristic peaks at 1760, 870 and 756 cm
 1. 
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Figure 2.18: Comparative FTIR spectra of (a) PLA, (b) rHA, (c) PLA rHA10, (d) PLA rHA40 
and (e) PLA rHA70. 
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PLA- ßTCP composite films 
Figure 2.19 shows the comparative FTIR spectra of (a) PLA, (b) ßTCP, (c) PLA  
ßTCP10, (d) PLA ßTCP40 and (e) PLA ßTCP70. The spectra of PLA ßTCP10, PLA  
ßTCP40 and PLA ßTCP70 composites films show the characteristic peaks of both 
HA and PLA. As the concentration of ßTCP increased the intensities of PO4 peaks 
at 603 and 569 cm
 1, which were attributed to phosphate from HA, increased 
relative to the intensities of PLA characteristic peaks at 1760, 870 and 756 cm
 1. 
 
 
 
 
 
Figure  2.19:  Comparative  FTIR  spectra  of  (a)  PLA,  (b)  ßTCP,  (c)  PLA ßTCP10,  (d)  PLA 
ßTCP40 and (e) PLA ßTCP70. 
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2.4.2.3  Raman spectroscopy  
PLA film 
Figure  2.20  shows  the  Raman  spectra  of  PLA  film.  The  spectra  show 
characteristic peaks for PLA, the peak at 875 cm
 1 is characteristic of carbon, 
carbonyl bond (C COO) stretching. The peak at 1040 cm
 1 corresponds to C CH3 
stretching while the peak at 1766 cm
 1 corresponds to C=O stretching. The peak 
at 1452 cm
 1 corresponds to methyl group (CH3) symmetric bending and at 1315 
cm
 1 to CH bending. 
 
 
Figure 2.20: Raman spectra of PLA film.  
 
 
 
 
 
C=O  
1766 cm
 1 
C COO 
875 cm
 1 
C CH3 
1040 cm
 1 
 
CH 
1315c
m
 1 
CH3 
1452 cm
 1 Chapter 2 
  108 
PLA-nHA composite films 
Figure 2.21 shows the comparative Raman spectra of (a) PLA, (b) nHA, (c) PLA 
nHA10, (d) PLA nHA40 and (e) PLA nHA70. The spectra of PLA nHA10, PLA nHA40 
and PLA nHA70 composites films show the characteristic peaks of both HA and 
PLA. The PO4 peak corresponding to nHA is low in PLA nHA10, however as the 
concentration of nHA increased in the films from 10 wt % to 70 wt % the PO4 
peak  became  more  intense  and  its  height  relative  to  the  C COO  (PLA)  peak 
increased.  
 
 
 
 
Figure 2.21: Comparative Raman spectra of (a) PLA, (b) nHA, (c) PLA nHA10, (d) PLA nHA40 
and (e) PLA nHA70.  
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PLA-sHA composite films 
Figure 2.22 shows the comparative Raman spectra of (a) PLA, (b) sHA, (c) PLA 
sHA10, (d) PLA sHA40 and (e) PLA sHA70. The spectra of PLA sHA10, PLA sHA40 
and PLA sHA70 composites films show the characteristic peaks of both HA and 
PLA. The PO4 peak corresponding to sHA is low in PLA sHA10, however as the 
concentration of sHA increased in the films from 10 wt % to 70 wt % the PO4 peak 
became more intense and its height relative to the C COO (PLA) peak increased. 
 
 
 
Figure 2.22: Comparative Raman spectra of (a) PLA, (b) sHA, (c) PLA sHA10, (d) PLA sHA40 
and (e) PLA sHA70. 
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PLA-rHA composite films 
Figure 2.23 shows the comparative Raman spectra of (a) PLA, (b) rHA, (c) PLA 
rHA10, (d) PLA rHA40 and (e) PLA rHA70. The spectra of PLA rHA10, PLA rHA40 
and PLA rHA70 composite films show the characteristic peaks of both HA and 
PLA. The PO4 peak corresponding to sHA is low in PLA rHA10, however as the 
concentration of rHA increased in the films from 10 wt % to 70 wt % the PO4 peak 
became more intense and its height relative to the C COO (PLA) peak increased. 
 
 
 
 
Figure 2.23: Comparative Raman spectra of (a) PLA, (b) rHA, (c) PLA rHA10, (d) PLA rHA40 
and (e) PLA rHA70. 
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PLA- ßTCP composite films 
Figure 2.24 shows the comparative Raman spectra of (a) PLA, (b) ßTCP, (c) PLA 
ßTCP10, (d) PLA ßTCP40 and (e) PLA ßTCP70. The spectra of PLA ßTCP10, PLA 
ßTCP40 and PLA ßTCP70 composites films show the characteristic peaks of both 
ßTCP  and  PLA.  The  PO4  peak  corresponding  to  ßTCP  is  low  in  PLA   ßTCP10 
whereas  the  intensity  of  C COO  (PLA)  peaks  is  high,  however  as  the 
concentration of ßTCP increased in the films from 10 wt % to 70 wt % the PO4 
peak  became  more  intense  and  its  height  relative  to  the  C COO  (PLA)  peak 
increased. 
 
 
 
Figure 2.24: Comparative Raman spectra of (a) PLA, (b) ßTCP, (c) PLA ßTCP10, (d) PLA 
ßTCP40 and (e) PLA ßTCP70. 
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2.5 DISCUSSION 
The use of composites in biomedical applications has attracted a huge interest 
over the last few decades as the properties of composites can be tailored to suit 
a specific application. Addition of a Ca P such as HA and TCP to the polymer 
improves  its  bioactivity,  osteoconductivity  and  mechanical  properties. 
Crystalline HA is stable and non soluble, but can be resorbed by osteoclasts, 
whereas TCP is soluble. The rate of dissolution of different Ca P decreases as 
follows [Niemelä, 2005; Velayudhan et al., 2005; Rezwan et al., 2006]: 
Amorphous HA > α – TCP > ß – TCP > crystalline HA. 
In this study PLA Ca P composite films containing nHA, sHA, rHA and TCP at 10, 
40  and  70  wt  %  concentrations  were  produced.  The  concentration,  size  and 
shape of the Ca P particles play an important role in determining the properties 
of the composite. It is reported that composites with higher HA contents have 
higher bioactivity and that nano size HA as compared to micro HA has shown to 
have  better  biological  properties  and  promote  attachment,  proliferation  and 
differentiation of cells [Di Silvio et al., 2002; Murugan and Ramakrishna, 2005; 
Sun et al., 2007].  The solvent casting technique used in this study enabled the 
production  of  films  where  HA  or  TCP  particles  were  present  on  the  surface 
without  or  with  a  thin  coating  of  PLA  with  different  degrees  of  surface 
roughness, this is beneficial as osteogenic cells or body fluid will make contact 
with the bioactive Ca P particles on implantation and it is also suggested that 
the cells adhesion and differentiation is more pronounced on rough surfaces [Ball 
et al., 2008].   
SEM and TEM images of the Ca P powders showed that the HAs and TCP had 
different shapes and sizes. Images showed that nHA was spherical in shape with 
size in the range between 20 to 200nm. sHA has irregular shapes with smooth 
surfaces  and  an  average  particle  size  of  4   m.  Images  of  rHA  showed  that 
although  the  average  particle  size  was  4   m,  each  particle  consisted  of 
agglomerate of small needle like particles and had a rough surface agreeing with 
observation of Zhang and Tanner [2008]. TCP particles were fused together and 
had irregular, but smooth surfaces.   Chapter 2 
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XRD of HA powders showed the purity of these powders as all showed the major 
characteristics  HA  diffraction  peaks  corresponding  to  (211),  (112)  and  (300) 
planes at 31.8°, 32.2° and 32.9° respectively and did not show a peak at 31.0° 
(0210) which confirms that there was no secondary TCP phase present [Huang et 
al.,  2007].  The  XRD  pattern  of  nHA  powder  showed that  its  crystallinity  was 
lower than the other two HAs used in the study as the nHA peaks were broader 
and less intense. Sintered sHA showed very intense and narrow peaks, indicative 
of high crystallinity as would be expected after sintering. The crystallinity of HA 
is  dependent  on  the  temperature  at  which  it  is  synthesised,  HAs  which  are 
synthesised at higher temperature have higher crystallinity. The crystallinity of 
HA in turn affects the solubility of HA, HA with lower crystallinity have higher 
solubility [Matsumoto et al., 2004a; Zhu et al., 2006]. The XRD pattern of ßTCP 
also showed its purity as it showed the characteristics peaks corresponding to 
(214), (0210) and (220) planes at 27.8°, 31.0° and 34.4° respectively and did not 
show any peak at 30.7°(034), which is attributed to α TCP [dos Santos et al., 
2008].     
FTIR of all the three HAs used in the study showed the OH peaks at 3571 and 631 
cm
 1, the peak at 3571 cm
 1 is assigned to stretching mode (vs) while at 631 cm
 1 
is assigned to the librational mode (vL) of OH group. The peak at 1040 cm
 1 is 
assigned  to  P O  bond  vibration  of  the  PO4  while  the  peak  at  960  cm
 1  is 
attributed to symmetric stretching of P O bond of PO4. The peaks at 603 and 569 
cm
 1 are assigned to bending mode of O P O bond of phosphate group [Rey et al., 
1991; Koutsopoulos, 2002]. The absence of OH group in the spectra of TCP can 
be used to establish the difference between HA and TCP [de Aza et al., 1997]. 
Raman spectra of HAs showed a characteristic very strong peak at 960 cm
 1 which 
is assigned to the P O bond symmetric stretching of PO4. Two peaks of medium 
intensities were also found at 590 and 450 cm
 1  which are assigned to O P O 
bending mode of PO4 [de Aza et al., 1997; Koutsopoulos, 2002]. 
SEM images of PLA and PLA/Ca P composite films showed the surface texture of 
these films.  PLA films appeared smooth, whereas the composite films showed 
different  degrees  of  surface  roughness.  Among  the  PLA nHA  films  the  films 
containing 10 wt % nHA appeared smooth as compared to films containing 40 and 
70 wt % nHA. Additionally the films containing 40 and 70 wt % nHA had more nHA 
present on the film surfaces, whereas in films containing 10 wt % nHA most of Chapter 2 
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the nHA was embedded within the PLA matrix. Similarly in PLA sHA composite 
films the surface roughness of films which had 40 and 70 wt% sHA was more than 
films with 10 wt % sHA content. The difference of roughness among the films 
containing 40 and 70 wt% sHA was not very pronounced, this can be due to more 
particle agglomeration in films containing 70 wt % sHA which resulted in less 
spread of particles in the matrix. The same roughness pattern was observed in 
PLA rHA films, however the PLA rHA films surface appear rougher as compared 
to PLA sHA films which can be attributed to rougher rHA particles used in PLA 
rHA films. With the greater specific surface area for the rHA more of the PLA 
will be involved. Among the PLA TCP composite films, the films containing 10 wt 
% TCP had the most homogenous particle spread, while the films containing 40 
and 70 wt % TCP showed some agglomeration of powders on their surfaces.     
FTIR spectra of PLA HA and PLA TCP composite films showed the presence of 
characteristic PLA, TCP and HA peaks. The intensities of the peaks associated 
with PO4 at 1040, 603 and 569 cm
 1 increased with increase in the concentration 
of HA or TCP in the films from 10 to 70 wt %. This finding is in confirmation with 
the SEM images that more HA or TCP particles were present on the surfaces of 
the films containing higher concentrations of HA or TCP. 
Raman spectra for PLA show the characteristic peaks. The peak at 875 cm
 1 is 
characteristic  of  carbon carbonyl  bond (C COO)  stretching,  while  the  peak  at 
1040 cm
 1 corresponds to C CH3 stretching and the peak at 1766 cm
 1 corresponds 
to  C=O  stretching. The  peak  at  1452  cm
 1  corresponds  to methyl  group  (CH3) 
symmetric bending and at 1315 cm
 1 to CH bending. The Raman spectra of PLA 
HA and PLA TCP composite films showed the characteristic strong peak PO4 peak 
at 960 cm
 1 in addition to PLA characteristics peaks. As the concentration of HA 
increased  in  the  films  the  ratio  of  PO4  peak  also  increased  relative  to  PLA 
carbonyl bond (C COO) peak at 875 cm
 1. As the spectra of composite films show 
the presence of both PLA and HA peak, it suggests that no chemical reaction 
took place during the mixing and the mixing was physical.  
The presence of HA or TCP particles in higher quantities on the surface of the 
composite films may affect the biological and physical properties of the films. 
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2.6  CONCLUSIONS 
Ca P powders and PLA Ca P composite films were analysed using SEM, TEM, XRD, 
FTIR and Raman. The powders had different sizes and shapes. XRD, FTIR and 
Raman of Ca P confirmed the purity of these powders. The surface roughness of 
the films were influenced by the concentration and type of the powder used.  
CHAPTER  3:  BIOACTIVITY  OF  POLYLACTIC  ACID 
CALCIUM PHOSPHATE COMPOSITES 
   
3.1 INTRODUCTION 
Biodegradable polymers such as PLA are increasingly used in the treatment and 
fixation of skeletal defects due to their degradability in the body [Rokkanen et 
al.,  2000a].  The  advantages  of  using  biodegradable  polymers  over  non 
resorbable implants are that they do not need a second surgical procedure for 
their  removal  and  stress  shielding  effects  can  also  be  avoided.  However  one 
drawback associated with most of these polymers is  their lack of bioactivity. 
Calcium phosphates such as HA and TCP, because of their osteoconductive and 
osteoinductive properties, are extensively studied and are widely used in various 
dental and orthopaedic application as they can accelerate the healing of bone 
tissue [Xin et al., 2005]. 
By using PLA with HA or TCP in a composite, the biodegradability and bioactivity 
of  these  materials  can  be  combined  to  produce  a  material  with  enhanced 
properties.  The  bioactivity  of  materials  is  usually  analysed  by  the  ability  of 
bone like  apatite  to form  on these  materials  when  soaked in  simulated body 
fluid  (SBF).  Ion  concentrations  in  SBF  closely  match  those  present  in  human 
blood plasma (Table 3.1) [Kokubo et al., 1990].   
Table 3.1: Comparison of ion concentrations in human blood plasma and SBF [adapted from 
Kokubo and Takadama, 2006].   
Ion concentrations (mM) 
                      Na
+         K
+       Mg
2+      Ca
2+      Cl
           HCO
 
3      HPO
2
4
     SO4
2  
Blood plasma 
SBF 
  142.0          5.0          1.5             2.5          103.0          27.0              1.0            0.5   
  142.0          5.0          1.5             2.5          147.8          4.2                1.0            0.5   
 
The aim of this study is to investigate the bioactivity of PLA HA and PLA TCP 
composite  films  by  assessing  the  ability  of  an  apatite  layer  to  form  on  their 
surface when immersed in SBF.  Chapter 3 
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3.2 MATERIALS  
The materials used were PLA (PURAC Biochem, The Netherlands), nHA (Sigma  
Aldrich, UK), sHA and rHA (Plasma Biotal Limited, UK) and TCP (Plasma Biotal 
Limited, UK) as described in detail in section 2.2.  
3.3 METHODS 
3.3.1 Preparation of Simulated Body Fluid 
Simulated body fluid (SBF) was prepared as described by [Kokubo and Takadama, 
2006] by dissolving reagents in deionised water. The reagents, their quantities 
and  the  order  in  which  they  were  dissolved  in  the  deionised  water  for  the 
preparation  of  1000  ml  SBF  are  shown  in  Table  3.2.  All  the  reagents  were 
purchased from Sigma Aldrich, UK.  
Table 3.2:  Order, reagents and their quantities used for the preparation of 1000 ml SBF 
solution [ adapted from Kokubo and Takadama, 2006].   
Order  Reagent  Quantity 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
NaCl 
NaHCO3 
KCl 
K2HPO4.3H2O 
MgCl2.6H2O 
1.0M HCl 
CaCl2 
Na2SO4 
Tris 
1.0M HCl 
8.035g 
0.355g 
0.225g 
0.231g 
0.311g 
39ml 
0.292g 
0.072g 
6.118g 
0 5ml 
 
For the preparation of 1000ml SBF initially 700ml of deionised water was placed 
in a glass beaker with a stirring bar and was heated up to 36.5 + 1.5 °C on a 
magnetic stirrer. The reagents were dissolved in the water one by one at 36.5 + 
1.5 °C in the order of 1 to 8 as listed in Table 1. The next reagent was only 
added after the previous reagent was completely dissolved.  Before the addition 
of 9
th and 10
th reagent, the solution volume was adjusted to 900ml. After volume Chapter 3 
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adjustment Tris was added to the solution little by little to gradually raise the 
pH of the solution to 7.45+0.01. Addition of Tris was stopped once the pH of the 
solution reached 7.45+0.01, as a next step HCl was added to the solution to 
lower the pH to 7.42+0.01 taking care not to lower the pH below 7.40. Again, 
the remaining Tris was added until the pH of the solution reached 7.45+0.01. 
The procedure of alternate addition of Tris and HCl was repeated to maintain 
the  pH  between  7.42  and  7.45  until  all  the  Tris  had  dissolved.  Finally  after 
dissolving the total Tris the pH of the solution was adjusted to 7.40 by adding a 
small amount of HCl at 36.5°C.  After cooling the solution to 20°C, deionised 
water was added to the solution to adjust the solution volume to 1000ml.     
3.3.2 Sample Preparation  
The films were prepared as described in section 2.3.1. The resultant films were 
then  cut  into  12  mm  diameter  discs  and 5  samples  for  each  time  point  and 
composite were used. The samples were sterilised by soaking in 70% ethanol for 
1 minute and then dried at 50°C. The samples were immersed into 20 ml SBF in 
polystyrene bottles for 1, 7, 14, 21 and 28 days at 37 °C.  The SBF in bottles was 
replaced  by  fresh  SBF  after  14  days.  At  given  time  points  the  samples  were 
removed from the solution and rinsed with distilled water and dried at 50°C.  
3.3.3 Sample characterisation 
The  samples  were  characterised  by  scanning  electron  microscopy  (SEM)  with 
energy dispersive spectroscopy (EDS) and Raman Spectroscopy. 
3.3.3.1  SEM  
The samples were carbon coated for SEM.  SEM images and EDS spectra were 
obtained by using FEI Inspect F, EFI Company, The Netherlands.  
3.3.3.2  Raman Spectroscopy 
Nicolet Almega XR dispersive Raman spectrometer was used to obtain Raman 
spectra of the samples, spectra were collected by taking 128 numbers of scans/ Chapter 3 
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sample and an exposure time of 2 sec was used at 8 cm
 1 resolution. The spectra 
were collected between 4000 100cm
 1.  
3.4 RESULTS 
3.4.1 SEM 
3.4.1.1  PLA 
SEM images of PLA samples at 1, 7, 14, 21 and 28 days after immersion in SBF 
are shown in Figure 3.1. There was no apatite formation observed on PLA films 
immersed in SBF, even after 28 days.      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: SEM images of PLA at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF. (Scale bar=10  m) 
 
(a)  (b) 
(c)  (d) 
(e) Chapter 3 
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EDS analysis of PLA samples in SBF are showed in Figure 3.2. The spectra showed 
C and O peaks corresponding to carbon and oxygen present in the polymer and 
there were no Ca or P peaks corresponding to an apatite layer. However, at 28
th 
day of immersion in SBF the spectra of the PLA sample showed small Na and Cl 
peaks which are probably due to deposition of these elements from SBF. 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: EDS spectra of PLA films at (a) 1, (b) 14 and (c) 28 days after immersion in SBF. 
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3.4.1.2  PLA nHA composite films 
Figures 3.3, 3.4 and 3.5 shows the SEM images of PLA nHA10, PLA nHA40 and 
PLA nHA70 samples respectively at (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days 
after immersion in SBF. As the figure shows, there was no apatite formation on 
day  1  on  PLA nHA10  and  PLA nHA40  films,  however  apatite  formation  was 
observed  on  these  films  on  day  7.  Whereas  PLA nHA70  film  showed  apatite 
formation on day 1 and by day 7 the sample was fully covered with the apatite 
layer.  The apatite  layer subsequently  increased  with  time  on PLA nHA10 and 
PLA nHA40 samples and by 21 days, it had started to become dense and packed. 
The apatite layers produced on the films containing 40 and 70 wt% nHA present 
finer  microstructure  as  compared  to  the  layer  on  film  containing  10  wt%  HA 
which has a globular appearance, this difference in morphology of the apatite 
layer is probably due to the presence of more crystallisation nuclei. By 28 days, 
the apatite layer was covering most of the samples surface. Whereas PLA nHA70 
film was fully covered by apatite layer on 7
th day and at 28
th day the apatite 
layer had considerably increased in thickness and had become very dense.  
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Figure 3.3: SEM images of PLA nHA10 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m).  
 
         
 
                                                       
 
                         
 
Figure 3.4: SEM images of PLA nHA40 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m).  
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Figure 3.5: SEM images of PLA nHA70 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m) . 
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Figures 3.6, 3.7 and 3.8 shows the respective EDS spectra for PLA nHA10, PLA 
nHA40 and PLA nHA70 samples at (a) 1, (b) 14 and (c) 28 days after immersion in 
SBF.  Although the spectra for PLA nHA10 and PLA nHA40 shows the presence of 
Ca and P peaks even at day 1, these peaks do not correspond to apatite layer 
formation but to HA present in the films. However, the intensity of Ca and P 
peaks increased with the increase of immersion time in SBF that represent the 
formation of apatite layer. The EDS spectra for PLA nHA70 showed high Ca and P 
peaks even on day 1 and the intensity of these peaks did not change much over 
time especially after day 14
th. 
 
Figure 3.6: EDS spectra of PLA nHA10 at (a) 1, (b) 14 and (c) 28 days after immersion in SBF 
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Figure 3.7: EDS spectra of PLA nHA40 at (a) 1, (b) 14 (c) 28 days after immersion in SBF. 
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Figure 3.8: EDS spectra of PLA nHA70 at (a) 1, (b) 14 (c) 28 days after immersion in SBF. 
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3.4.1.3  PLA rHA composite films 
Figures 3.9, 3.10 and 3.11 show the surface morphologies of PLA rHA10, PLA 
rHA40 and PLA rHA70 samples respectively at (a) 1, (b) 7, (c) 14, (d) 21 and (e) 
28 days after immersion in SBF. There was no apatite formation on any film at 
day  1.  However  all  the  films  have  apatite  crystals  formed  at  day  7.  With 
increases in the soaking time the quantity and size of these crystals increased. 
More nucleation centres were present on films containing higher amounts of HA 
and these films showed increased apatite layer formation. Although by 21 days 
all the films were fully covered with the apatite layer, this layer was dense and 
more tightly packed on the film containing 70 wt% HA.  
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Figure 3.9: SEM images of PLA rHA10 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m). 
 
      
 
      
 
       
Figure 3.10: SEM images of PLA rHA40 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m) . 
(e) 
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Figure 3.11: SEM images of PLA rHA70 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m) . 
 
 
Figures 3.12, 3.13 and 3.14 show the EDS spectra for PLA rHA10, PLA rHA40 and 
PLA rHA70 samples respectively at (a) 1, (b) 14 and (c) 28 days after immersion 
in SBF.  At day 1 the spectra of all the films showed Ca and P peaks which are 
due to the presence of HA in the films and the intensity of these peaks were high 
in film containing higher amounts of HA.  
However, the intensity of these peaks subsequently increased for all the films 
after immersion in the SBF due to the formation of apatite layer. 
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Figure 3.12: EDS spectra for PLA rHA10 at (a) 1, (b) 14 and (c) 28 days after immersion in 
SBF. 
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Figure 3.13: EDS spectra for PLA rHA40 at (a) 1, (b) 14 and (c) 28 days after immersion in 
SBF. 
(c)  
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Figure 3.14: EDS spectra of PLA rHA70 at (a) 1, (b) 14 and (c) 28 days after immersion in 
SBF. 
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3.4.1.4  PLA sHA composite films 
Figures 3.15, 3.16 and 3.17 show the SEM images of PLA sHA10, PLA sHA40 and 
PLA sHA70 samples respectively at (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days 
after immersion in SBF. There was no apatite formation on any film at day 1. At 
day 7 apatite formation has already started on all the films, with the highest 
amount formed on films containing 70 wt% sHA. Apatite formation started at 
individual sites and then grew in size and subsequently united to form a layer. 
The apatite layer subsequently increases with increase in immersion time on all 
films and by 21 days the all the films were fully covered with the apatite layer. 
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Figure 3.15: SEM images of PLA sHA10 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m). 
 
 
       
 
       
 
       
 
Figure 3.16: SEM images of PLA sHA40 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m). 
(e) 
(a) 
(e) 
(d)  (c) 
(b) Chapter 3 
  135 
 
 
 
       
 
       
 
                          
 
Figure 3.17: SEM images of PLA sHA70 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m). 
 
Figures 3.18, 3.19 and 3.20 show the EDS spectra for PLA sHA10, PLA sHA40 and 
PLA sHA70 samples respectively at (a) 1, (b) 14, and (c) 28 days after immersion 
in SBF.  Ca and P peaks present at day 1 correspond to the sHA present in the 
films and the intensity of these peaks is directly proportional to the amount of 
sHA present.   
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The  intensity  of  these  peaks  subsequently  increased  for  all  the  films  after 
immersion in the SBF, which representing formation of an apatite layer on these 
films.  
 
   
         
Figure 3.18: EDS spectra of PLA sHA10 at (a) 1, (b) 14 and (c) 28 days after immersion in 
SBF. 
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Figure 3.19: EDS spectra of PLA sHA40 at (a) 1, (b) 14 and (c) 28 days after immersion in 
SBF. 
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Figure 3.20: EDS spectra of PLA sHA70 at (a) 1, (b) 14 and (c) 28 days after immersion in 
SBF. 
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3.4.1.5  PLA TCP composite films 
Figures 3.21, 3.22 and 3.23 show the SEM images of PLA TCP10, PLA TCP40 and 
PLA TCP 70 samples respectively at (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days 
after immersion in SBF. There was no apatite formation on films containing 10 
and 40% TCP at day 1, however the film containing 70% TCP had apatite particles 
on its surface. All the films have apatite layer formation at day 7.  The number 
of apatite particles increased on the films with increases in soaking time and the 
number of apatite crystals were directly proportional to the amount TCP present 
in the films. The apatite layer subsequently increases with time on all films, 
however, the film containing 70% TCP showed highest apatite formation. 
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Figure 3.21: SEM images of PLA TCP10 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m). 
 
 
       
 
      
 
 
Figure 3.22: SEM images of PLA TCP40 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m). 
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Figure 3.23: SEM images of PLA TCP70 at day (a) 1, (b) 7, (c) 14, (d) 21 and (e) 28 days after 
immersion in SBF (all scale bars =10  m). 
 
 
  
Figures 3.24, 3.25 and 3.26 show the EDS spectra for PLA TCP10, PLA TCP40 and 
PLA TCP70 samples respectively at (a) 1, (b) 14, and (c) 28 days after immersion 
in SBF.  At day 1 the spectra of all the films showed Ca and P peaks which are 
due to the presence of TCP in the films and the intensity of these peaks were 
high in film containing higher amounts of TCP.  
The intensity of these peaks subsequently increased for all the films with the 
formation of apatite layer after immersion in the SBF. 
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Figure 3.24: EDS spectra of PLA TCP10 at (a) 1, (b) 14 and (c) 28 days after immersion in 
SBF 
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Figure 3.25: EDS spectra of PLA TCP40 at (a) 1, (b) 14 and (c) 28 days after immersion in 
SBF. 
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Figure 3.26: EDS spectra of PLA TCP70 at (a) 1, (b) 14 and (c) 28 days after immersion in 
SBF 
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3.4.2 Raman spectroscopy 
3.4.2.1  PLA 
Figure 3.27 shows the Raman spectra of PLA films before immersion in SBF (a) 
and after immersion in SBF at day 1 (b), 14
th (c) and 28
th (d). The spectra show 
characteristic peaks for PLA and no phosphate peaks are visible even at 28 days. 
The peak at 1040 cm
 1 corresponds to C CH3 stretching while the peak at 1766 
cm
 1 corresponds to C=O stretching. The peak at 1452 cm
 1 corresponds to methyl 
group (CH3) symmetric bending and at 1315 cm
 1 to CH bending.  
 
 
 
 
 
 
 
 
Figure 3.27: Comparative Raman spectra of PLA films at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF showing that the peaks do not change with soaking time. 
 
 
 
 
(a) 
(b) 
(c) 
(d) 
1388  1766  875  1040 
1315 
1452 Chapter 3 
  146 
3.4.2.2  PLA HA composite films 
Raman spectra of PLA nHA, PLA rHA and PLA sHA composite films are shown in 
Figures 3.27 3.29, 3.30 3.32 and 3.33 3.35 respectively. The figures show Raman 
spectra of films before immersion in SBF (a) and after immersion in SBF at day 1 
(b)  day  14
th  (c)  and  at  day  28
th  (d).    The  peak  at  960  cm
 1  is  attributed  to 
phosphate (P O stretching). The presence of this peak at 960 cm
 1 in the samples 
before immersion in the SBF can be attributed to phosphate present in the HA 
and  after  immersion  in  the  SBF  to  phosphate  present  in  the  apatite  layer 
formed. The intensity of this peak increased for all the samples with increase in 
immersion time in the SBF which can be ascribed to apatite layer formation. The 
increase was more prominent in PLA HA samples containing 40 and 70 wt % HA 
than samples containing 10 % HA. This is due to greater apatite layer formation 
on samples containing higher quantity of nHA in PLA HA samples. Characteristic 
peaks  of  PLA  are  also  present.  The  peak  at  1766  cm
 1  corresponds  to  C=O 
stretching and the peak at 875 cm
 1 which is characteristic of carbon, carbonyl 
bond (C COO) stretching. The peak at 1040 cm
 1 is assigned to C CH3 stretching.  
The  peaks  at  1388  cm
 1  and  1452  cm
 1  correspond  to  methyl  group  (CH3) 
symmetric bending and at 1315 cm
 1 to CH bending. 
Figure 3.28: Comparative Raman spectra of PLA nHA 10 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF 
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Figure 3.29: Comparative Raman spectra of PLA nHA 40 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF. 
 
 
Figure 3.30: Comparative Raman spectra of PLA nHA 70 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF. 
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Figure 3.31:  Comparative Raman spectra of PLA rHA 10 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF 
 
 
Figure 3.32: Comparative Raman spectra of PLA rHA 10 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF 
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Figure 3.33: Comparative Raman spectra of PLA rHA 70 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF 
 
 
Figure 3.34: Comparative Raman spectra of PLA sHA 10 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF 
 
 
 
 
(a) 
(b) 
(c) 
(d) 
(a) 
(b) 
(c) 
(d) 
960 
960 Chapter 3 
  150 
 
 
Figure 3.35: Comparative Raman spectra of PLA sHA 40 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF 
 
 
 
Figure 3.36: Comparative Raman spectra of PLA sHA 70 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF 
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3.4.2.3  PLA TCP composite films 
Raman  spectra  of  PLA TCP10,  PLA TCP40  and  PLA TCP70  composite  films  are 
shown in Figures 3.36, 3.37 and 3.38 respectively. The peak intensity of peak at 
1388 cm
 1 and 1315 cm
 1 is very high as compared to intensities of the peaks at 
960 cm
 1 which is attributed to phosphate (P O stretching) and at 875 cm
 1 which 
is  characteristic  of  carbon,  carbonyl  bond  (C COO)  stretching.  To  make  the 
changes in the intensities of these two peaks at 960 cm
 1 and 875 cm
 1 more 
appreciable, the selected area for these two peaks in the spectrum is shown in 
the box above the figures. The intensity of PO4
3  peak at 960 cm
 1 for all films 
increased  with  increase  in  the  SBF  immersion  time,  however  the  maximum 
change was observed in film containing 70 wt% TCP. 
 
 
 
 
 
 
Figure 3.37: Comparative Raman spectra of PLA TCP 10 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF 
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Figure 3.38: Comparative Raman spectra of PLA TCP 40 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF 
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Figure 3.39: Comparative Raman spectra of PLA TCP 70 at (a) 0 (b) 1, (c) 14 and (d) 28 days 
after soaking in SBF 
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3.5 DISCUSSION 
When implanted a bioactive material produces a specific biological response and 
a  biologically  active  apatite  layer  is  formed  on  its  surface.  Bone  bioactive 
implant  materials are  proposed to  be categorised  as;  Class  A,  osteoinductive 
materials and class B, osteoconductive materials. Osteoinductive materials elicit 
both extracellular and intracellular responses in the host environment, whereas, 
osteoconductive  materials  only  elicit  an  extracellular  response  [Hench,  1994; 
Cao and Hench, 1996]. The formation of an apatite layer on the implant surface 
also affects the topographic configuration of the material which in turn affects 
the cellular behaviour and tissue response to the implant. Bioactive material 
surfaces  favour  the  proliferation  of  osteoblasts  over  fibroblast  proliferation 
[Seitz,  1982].  The  apatite  which  is  formed  on  the  surface  of  the  bioactive 
material  is  carbonate containing  hydroxyapatite  with  small  crystallites  and 
resembles  the  bone  apatite  in  composition  and  structure.  These  properties 
enable  bone  producing  cells  (osteoblasts)  to  proliferate  and  differentiate 
preferentially on this apatite layer and produce apatite and collagen [Kokubo, 
1998].  
Kokubo et al. [1990] proposed that the “essential requirement for an artificial 
material  to  bond  to  living  bone  is  the  formation  of  bonelike  apatite  on  its 
surface  when  implanted  in  the  living  body,  and  that  this  in  vivo  apatite 
formation  can  be  reproduced  in  a  simulated  body  fluid  (SBF)  with  ion 
concentrations nearly equal to those of human blood plasma”. The process of 
apatite layer deposition on the surface of the material involves formation of 
apatite nuclei which subsequently grow, consuming calcium and phosphate ions 
from the SBF. Various studies have shown that as the apatite layer deposition 
increases  the  concentrations  of  calcium  and  phosphorous  in  SBF  decreases 
[Jaakkola et al., 2004; Me et al., 2006]. SBF is supersaturated with calcium and 
phosphate ions and becomes stable by apatite crystal formation and the rate of 
formation of apatite nuclei is affected by the number of calcium ions released 
from the material. It is also proposed that the rate of formation of apatite on a 
material  surface  when  soaked  in  SBF  is  predictive  of  the  degree  of  in  vivo 
bioactivity of that material [Kokubo, 1998; Kokubo and Takadama, 2006]. Thus Chapter 3 
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the bioactivity of a material can be evaluated by soaking it in SBF and analysing 
the rate of apatite formation.  
Calcium phosphates are well documented bioactive materials and form bonelike 
apatite on their surface in SBF [Gu et al., 2004; Sun et al., 2006]. The formation 
of an apatite layer is thought to involve surface structural changes when soaked 
in SBF. The first structural change involves formation of a Ca rich amorphous 
calcium phosphate (ACP) as a result of specific interaction of HA surface with 
calcium ions in the SBF. The second surface structural change is the formation of 
a Ca poor ACP due the interaction of Ca rich ACP with the phosphate ions in the 
SBF. The third change is the gradual crystallisation of Ca poor ACP into bonelike 
apatite. Subsequently this apatite grows by consuming calcium and phosphate 
ions from SBF. HA has negative surface charge when immersed into SBF due to 
exposure of its hydroxyl and phosphate units. This negative charge HA interacts 
specifically with positive Ca ions in SBF thus forming a Ca rich ACP. Formation of 
Ca rich ACP changes the surface charge to positive which then facilitates the 
interaction of Ca rich ACP specifically with negative phosphate ions in the SBF 
and to form a Ca poor ACP which in turn crystallizes into bonelike apatite. The 
apatite which is formed then acts as nucleation centres for apatite deposition 
[Bell et al., 1972; Neo et al., 1993; Duan et al., 2004; Kim et al., 2005; Me et 
al., 2006].   
In this study the bioactivity of PLA/Ca P composite films containing different 
types of HA and TCP in different concentration was evaluated by assessing the 
ability of an apatite layer to form on their surfaces in SBF. Among the PLA/HA 
and PLA/TCP composite films the formation of an apatite layer was highest and 
most rapid on films containing 70 wt % nHA followed by film containing 70 wt % 
TCP. In contrast there was no apatite layer formation on plain PLA films even 
after 28 days of immersion in SBF. Increased apatite formation on PLA nHA films 
can be attributed to more nucleation centres present on the film in addition to 
its  larger  surface  area.  Previous  studies  have  also  shown  that  materials  with 
large  specific  surface  area produce  earlier  apatite  formation  as  compared to 
materials  with  lower  surface  area  [Jaakkola  et  al.,  2004;  Murugan  and 
Ramakrishna, 2005; Bohner and Lemaitre, 2009]. PLA TCP composite film which 
has  similar  sized  particles  as  PLA sHA  and  PLA rHA  composite  films  showed 
increased and faster formation of the apatite on its surface as compared to PLA Chapter 3 
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sHA  and  PLA rHA  composite  films.  Among  the  PLA TCP  films  the  maximum 
apatite formation was on films containing the highest concentration i.e. 70 wt % 
TCP. This increased apatite formation can be attributed to the fact that the 
dissolution  rate  of  TCP  is  higher  than  HA  [Ducheyne  et  al.,  1993]  and  the 
dissolution  increases  the  Ca
2+  concentration  in  the  SBF  around  the  area  of 
dissolution. This increased Ca
2+ concentration causes more ion attachment to the 
material surface, which then act as nucleation centres and an apatite layer is 
produced [Khor et al., 2003].    
The morphology of the apatite layer formed on PLA nHA films containing 40 and 
70  wt  %  nHA  showed  a  fine  needle  like  structure  as  compared  to  globular 
morphology  of  apatite  formed  on  the  films  containing  10  wt%  nHA.  This 
difference can be attributed to the presence of more nucleation centres which 
are  more  closely  present  on  the  films  with  a  higher  nHA  concentration.  The 
morphology of the apatite layers formed on composite films containing sHA, rHA 
and TCP is globular and the SEM images show individual globules at the site of 
nucleation. The apatite formation increased with the passage of time and the 
globules became tightly packed and gave the apatite layer a cauliflower like 
morphology. 
Raman spectra of all the PLA HA and PLA TCP composite films show a 960cm
 1 
peak which corresponds to symmetric stretching vibration of P O [Zhou et al., 
2007] in apatite crystals, the intensity of this peak increased with increasing SBF 
immersion time which is indicative of apatite formation. In addition the change 
in the intensity of this peak was high in films containing higher amount of HA or 
TCP which is due to formation of more apatite on these films. The strong peak in 
PLA HA  films  at  875  cm
 1  is  characteristic  of  carbon,  carbonyl  bond  (C COO) 
stretching  in  the  polymer  chain  [Patrick,  2001;  Taddei  et  al.,  2002].  Raman 
spectra of plain PLA films did not show emergence of phosphate peak at 960cm
 
1.  
3.6 CONCLUSIONS 
Higher calcium phosphates content in the composite results in a higher rate of 
apatite formation.  Additionally particle sizes of the calcium phosphates used in Chapter 3 
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the composite also play an important role in determining the rate of apatite 
layer formation. Increased apatite formation was observed with nano particles 
used in this study. The formation of an apatite layer on TCP was more compared 
to HA of the same content.  
CHAPTER  4:  DEGRADATION  OF  POLYLACTIC  ACID 
CALCIUM PHOSPHATE COMPOSITES 
   
4.1 INTRODUCTION 
Polylactic  acid  (PLA)  has  been  used  in  many  biomedical  applications  such  as 
tissue engineering, drug delivery, orthopaedics and maxillofacial reconstruction 
due to its biocompatibility and biodegradability.  The ability of PLA to be used in 
many  different  applications  is  due  to  the  possibility  of  tailoring  its  physical, 
chemical and degradation properties to individual needs. The rate at which PLA 
degrades is very important and should match the rate at which the new tissue 
forms at its implantation site. Degradability of PLA depends on various factors 
which  include  its  molecular  weight,  crystallinity,  L  and  D  isomer  ratio, 
configuration, implant size and implant site [Grizzi et al., 1995; Middleton and 
Tipton, 2000; Ural et al., 2000].  
Combining  calcium  phosphates  such  as  hydroxyapatite  (HA)  and  tri calcium 
phosphate  (TCP)  with  PLA  not  only  improves  bioactivity  and  mechanical 
properties of PLA but also affects its degradation rate [Takayama et al., 2009]. 
The aim of this study is to investigate the effect of HA and TCP addition on the 
degradation  of  PLA  and  also  to  examine  the  effect  of  different  HA  and  TCP 
concentrations used.      
4.2 MATERIALS 
The materials used were PLA (PURAC Biochem, The Netherlands), nHA (Sigma  
Aldrich, UK), sHA and rHA (Plasma Biotal Limited, UK) and TCP (Plasma Biotal 
Limited, UK) as described in detail in section 2.2.  Chapter 4 
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4.3 METHODS 
4.3.1 Composite films preparation 
PLA HA and PLA TCP composite films were prepared as described in detail in 
section 2.3.1, namely dissolving the PLA in chloroform and once dissolved adding 
the Ca P powder, continue to stir and finally cast the film.  
4.3.2 Degradation protocol 
Degradation  of  the  composite  films  in  vitro  was  analysed  by  incubating 
composite  film  samples  in  phosphate  buffered  saline  (PBS)  at  37°C.  Circular 
samples 12 mm diameter were cut using a hole puncher and sterilized by soaking 
in 70% ethanol for a 5 minutes and then dried at 50°C. Three samples for each 
composite film and time point were weighted (Wo) before immersion in the PBS 
and were placed in polypropylene bottles for 1 day, 1, 3, 6, 9 and 12 weeks. 
Each  bottle  containing  a  single  sample  was  filled  with  20  ml  PBS  which  was 
replaced with fresh 20 ml PBS after every 3 weeks.  At each time point the 
samples were removed from the bottles and weighted after gently wiping the 
sample surface with a tissue to give wet weight (Ww). The samples were then 
washed with deionised water to remove any soluble salt from their surfaces. 
After washing the samples were dried in an oven at 37 °C for 24 hours and then 
in  a  vacuum  oven  for  2  hours  before  weighing  to  give  dry  weight  (Wd).  The 
difference  between  Wo  and  Ww  was  taken  as  wet  weight  gain  (WG)  and  the 
difference between Wo and Wd was taken as weight loss (WL). These two were 
calculated according to Equations 4.1 and 4.2 respectively. 
WG (%) = 100 (Ww Wo)/ Wo            Equation 4. 1 
WL (%) = 100 (Wo Wd)/ Wo           Equation 4. 2 
4.3.3 Data Analysis 
Statistical analyses were done by 1  way ANOVA with Bonferroni’s post test with 
P < 0.05. Chapter 4 
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4.4 RESULTS 
4.4.1 PLA 
Figure 4.1 shows the percentage wet weight gain by PLA films after immersion in 
PBS  for  up  to  12  weeks.  PLA  films  gained  weight  for  up  to  6  weeks,  which 
increased gradually from day 1 up to the 6
th week and reached a maximum of 
0.59 %. After the 6
th week the weight decreased and dropped until the end of 
testing.  
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Figure 4.1:  Percentage wet weight gain by PLA films versus incubation time in PBS at 37 
°C. The first data point is at day 1 showing weight gain in the 1
st 24 hours. Mean + SD, n=3 
for each time point.  
 
Figure 4.2 shows the percentage dry weight loss by PLA films after immersion in 
PBS  for  up  to  12  weeks.  PLA  films  lost  weight  over  the  entire  duration  of 
immersion in SBF and reached 5 % at the end of the 12
th week.  Chapter 4 
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Figure 4.2:  Percentage dry weight loss of PLA films versus incubation time in PBS at 37 °C. 
The first data point is at day 1 showing weight loss in the 1
st 24 hours. Mean + SD, n=3 at 
each time point. 
 
4.4.2 PLA-nHA composite films 
Figure 4.3 shows the percentage wet weight gain by PLA nHA composite films 
containing 10, 40 and 70 wt % nHA after immersion in PBS for up to 12 weeks in 
comparison with the non filled PLA film (results shown in figure 4.1.). PLA nHA 
composite  film  containing  40  wt  %  nHA  showed  more  weight  gain  than  films 
containing 10 and 70 wt % nHA. At day 1 PLA nHA70 films showed more weight 
gain than PLA nHA10 films, however after the first day the weight gain by PLA 
nHA70  film  decreased  and  remained  less  than  PLA nHA10  throughout  the 
incubation  period.  Weight  gain  by  PLA nHA70  films  was  4  %  on  day  1  which 
decreased to 1.19 % at the 12
th week. PLA nHA40 films showed 4.3 % weight gain 
on day 1 which reached maximum at the 12
th week i.e. 8.33 %. PLA nHA10 films 
showed  minimum  weight  gain  among  all  the  films  on  day  1  i.e.  1.89  %,  the 
weight gain reached its maximum at 1 week and than gradually decreased to 
reach 3.33 % at the 12
th week. All the composite films showed more weight gain 
than the non filled PLA.   
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Figure 4.3: Percentage wet weight gain by PLA nHA composite films versus incubation time 
in PBS at 37 °C. The first data points are at day 1 showing weight gain in the 1
st 24 hours. 
Mean + SD, n=3 at each time point. * Significantly greater than PLA, p<0.05, one way ANOVA 
and Bonferroni post test. 
 
Figure 4.4 shows the percentage dry weight loss by  PLA nHA composite films 
containing 10, 40 and 70 wt % nHA after immersion in PBS for up to 12 weeks in 
comparison with the non filled PLA film (result shown in figure 4.2). For all the 
films  the  weight  loss  increased  with  PBS  immersion  time  and  the  maximum 
weight  loss  was  shown  by  films  containing  maximum  nHA  i.e.  70  wt  %  nHA 
followed by films containing 40 and 10 wt % nHA respectively. Film containing 40 
and 70 wt % nHA showed a sharp weight loss between day 1 and the 1
st week 
which was followed by a plateau until the 3
rd week.  The weight for these two 
types of films then again decreased until the 12
th week reaching 5.6 and 4.5 % 
for films containing 70 and 40 wt % nHA respectively. The films containing 10 wt 
% nHA lost weight gradually and reached 3 % at the end of 12 weeks. Only the 70 
wt % nHA film lost more weight than the non filled PLA film.    
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Figure 4.4: Percentage dry weight loss of PLA nHA composite films versus incubation time 
in PBS at 37 °C. The first data point is at day 1 showing weight loss in the 1
st 24 hours. Mean 
+ SD, n=3 at each time point. * Significantly less than PLA, p<0.05, one way ANOVA and 
Bonferroni post test. 
 
 
4.4.3 PLA-rHA composite films 
Figure 4.5 shows the percentage wet weight gain by PLA rHA composite films 
containing 10, 40 and 70 wt % rHA after immersion in PBS for up to 12 weeks in 
comparison with non filled PLA film (results shown in figure 4.1). On day 1 films 
containing 70 wt % rHA showed slight weight gain i.e. 0.48 %, the remaining two 
types of films containing 40 and 10 wt % did not show any weight gain. However 
after day 1 all PLA rHA composite films showed negative values for weight gain 
up to the 12
th week, except PLA rHA composite film containing 70 wt % rHA 
which showed slight weight gain at the 12
th week i.e. 0.67 %. Unlike PLA all 
composite films showed a reduction in weight. 
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Figure 4.5: Percentage wet weight gain of PLA rHA composite films versus incubation time 
in PBS at 37 °C. The first data points are at day 1 showing weight gain in the 1
st 24 hours. 
Mean + SD, n=3 at each time point. * Significantly greater than PLA, p<0.05, one way ANOVA 
and Bonferroni post test. 
 
 
Figure 4.6  shows  the  percentage  dry  weight  loss  by  PLA rHA  composite  films 
containing 10, 40 and 70 wt % rHA after immersion in PBS for up to the 12 weeks 
in comparison with the non filled PLA film (results shown in figure 4.2). All the 
composite films showed weight loss throughout immersion in the PBS up to 12
th 
week.  The  greatest  weight  lost  was  shown  by  films  containing  10  wt  %  rHA 
followed by films containing 70 and 40 wt % rHA respectively. The final weight 
loss at the end of the 12
th week was 6.3, 3.8 and 5 % for films containing 10, 40 
and 70 wt % rHA. The weight loss of film containing 10 wt % rHA was greater and 
of film containing 40 wt % rHA was less than non filled PLA film.   
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Figure 4.6:  Percentage dry weight loss of PLA rHA composite films versus incubation time 
in PBS at 37 °C. The first data points are at day 1 showing weight loss in the 1
st 24 hours. 
Mean + SD, n=3 at each time point. 
 
4.4.4 PLA-sHA composite films 
Figure 4.7 shows the percentage wet weight gain by PLA sHA composite films 
containing 10, 40 and 70 wt % sHA after immersion in PBS for up to 12 weeks in 
comparison  with  non filled  PLA  film  (results  showed  in  figure  4.1).  At  day  1 
highest weight gain was shown by film containing 70 wt % sHA. After the 1
st day 
the weight gain by film containing 70 wt % sHA decreased sharply and at week 1 
it was less than weight gain by films containing 10 and 40 wt % sHA. However 
after  the  1
st  week  the  weight  gain  by  film  containing  70  wt  %  sHA  again 
increased upto 6
th weeks, before again decreasing up to the 12
th week. After 
increased weight gain at week 1 by both PLA sHA10 and PLA sHA40 films showed 
decrease in weight gain. At the end of the 12
th week the weight gains were  1.3, 
 1.29,  0  %  for  PLA sHA10,  PLA sHA40  and  PLA sHA70  composite  films 
respectively.   Chapter 4 
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Figure 4.7: Percentage wet weight gain by PLA sHA composite films versus incubation time 
in PBS at 37 °C. The first data points are at day 1 showing weight gain in the 1
st 24 hours. 
Mean + SD, n=3 at each time point. * Significantly greater than PLA, p<0.05, one way ANOVA 
and Bonferroni post test. 
 
 
Figure 4.8  shows  the  percentage  dry  weight  loss  by  PLA sHA composite  films 
containing 10, 40 and 70 wt % sHA after immersion in PBS for up to 12 weeks in 
comparison with non filled PLA film (results shown in figure 4.2). All PLA sHA 
composite films showed increasing weight loss with PBS immersion time. Until 
week 1 the maximum weight loss was shown by films containing 10 wt % sHA 
followed by films containing 40 and 70 wt % sHA respectively. However at week 
3 the films containing 70 wt % sHA showed more weight loss compared to films 
containing 40 wt % sHA. At the end of the 12
th week the weight losses were 5.4, 
3.8 and 4.4 % for PLA sHA10, PLA sHA40 and PLA sHA70 films respectively.  
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Figure 4.8: Percentage dry weight loss of PLA sHA composite films versus incubation time 
in PBS at 37 °C. The first data points are at day 1 showing weight loss in the 1
st 24 hours. 
Mean + SD, n=3 at each time point. 
 
4.4.5 PLA-TCP composite films 
Figure 4.9 shows the percentage wet weight gain by PLA TCP composite films 
containing 10, 40 and 70 wt % TCP after immersion in PBS for up to 12 weeks in 
comparison with non filled PLA film (results shown in figure 4.1). On day 1 the 
maximum weight gain was shown by films containing 70 wt % TCP i.e. 1.6 %, 
whereas  the  films  containing  10  and  40  wt  %  did  not  show  any  weight  gain. 
However the weight gain by films containing 70 wt % TCP went negative after 
day 1. The films containing 10 and 40 wt % TCP showed an increase in weight 
gain between day 1 and 1
st week after which the weight gain for these two types 
of films also decreased and went into weight loss.  Chapter 4 
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Figure 4.9: Percentage wet weight gain by PLA TCP composite films versus incubation time 
in PBS at 37 °C. The first data points are at day 1 showing weight gain in the 1
st 24 hours. 
Mean + SD, n=3 at each time point. 
 
Figure 4.10 shows the percentage dry weight loss by PLA TCP composite films 
containing 10, 40 and 70 wt % TCP after immersion in PBS for up to 12 weeks in 
comparison with non filled PLA film (results shown in figure 4.2). All PLA TCP 
composite films showed an increasing weight loss with PBS immersion time. Until 
week 1 the maximum weight loss was shown by films containing 10 wt % TCP 
followed by films containing 40 and 70 wt % TCP respectively. However after 
week 1 the weight loss was more for films containing 70 wt % TCP as compared 
to films containing 40 wt % TCP. At the end of the 12
th week the weight losses 
were 6.9, 5.3 and 6 % for films containing 10, 40 and 70 wt % TCP respectively. 
The weight loss by all composite films was greater than non filled PLA film. Chapter 4 
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Figure 4.10: Percentage dry weight loss of PLA TCP composite films versus incubation time 
in PBS at 37 °C. The first data points are at day 1 showing weight loss in the 1
st 24 hours. 
Mean + SD, n=3 at each time point. * Significantly greater than PLA, p<0.05, one way ANOVA 
and Bonferroni post test. 
 
4.5 DISCUSSION 
The  degradation  rate  of  an  implant  plays  an  important  role  in  defining  the 
success  or  failure  of  a  resorbable  implant.  The  rate  at  which  an  implant 
degrades affects its mechanical properties, cell growth and the body’s response. 
Ideally an implant should maintain its strength until the strength of new bone is 
adequate  and  then  should  degrade  at  the  same  rate  as  the  new  bone 
regenerates [Liao and Cui, 2004].    
Hydrolytic degradation of PLA is heterogeneous and involves surface and bulk 
erosion  mechanisms.  Surface  erosion  occurs  at  the  polymer liquid  interface, 
whereas  bulk  erosion  involves  uniform  degradation  throughout  the  polymer. 
Depending on the manufacturing process the degradation of PLA devices can be 
faster in the centre than on the surface. The first event which takes place on 
immersion of a PLA device in the aqueous solution or when implanted is water 
uptake. These water molecules then produce hydrolytic decomposition of the 
polymer chain. During the degradation, oligomers are produced; the oligomers 
which are present close to the surface escape the matrix into the surrounding 
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medium. However those which are present inside the matrix diffuse out very 
slowly and mainly remain entrapped thus contributing to the autocatalytic effect 
and increasing the degradation rate in the centre of the device [Vasanthan and 
Ly, ; Grizzi et al., 1995].        
The PLA degradation produces lactic acid and burst release of this lactic acid 
can produce tissue inflammation. Addition of TCP or HA can help in lowering the 
acidity thus controlling the degradation rate. However, in PLA Ca P composites 
the  acid  breakdown  is  chemically  buffered  by  the  Ca  P.  Water  absorption 
increases  as  the  degradation  progresses  due  to  accumulation  of  hydrophilic 
degradation products inside the polymer matrix. However on reaching a certain 
level, it reduces due to release of degradation products [Yang et al., 2008]. 
In the present study, the in vitro degradation kinetics of PLA/Ca P composite 
films  containing  HA  or  TCP  in  different  concentrations  was  analysed  by 
incubating samples in PBS at 37 °C. To understand the results obtained in this 
study  it  should  be  considered  that  in  composite  films  two  mechanisms  are 
occurring  simultaneously,  i.e.  degradation  of  PLA  and  dissolution  of  particles 
from the surface and the matrix, while the presence of the interface between 
the PLA and Ca P filler allows liquid to accumulate at this interface. 
Among the non filled PLA and PLA/Ca P films the least weight gain was shown by 
non filled PLA and PLA TCP films containing 40 wt % TCP at the end of 12 weeks. 
However, in the case of PLA TCP40 films the possible reason for this low value is 
the  dissolution  of  TCP  particles  from  the  sample  in  addition  to  polymer 
degradation. Whereas the low liquid absorption by non filled PLA is expected as 
PLA is hydrophobic and the non filled PLA samples also lack any interfaces which 
are present in the composite films and liquid can ingress the matrix through 
these interfaces in the composite films. One thing to note is that at day 1 in all 
the  composite  films,  maximum  liquid  absorption  was  observed  with  samples 
which had the highest filler concentrations i.e. 70 wt %, so it can be seen that 
the water absorption increases with increase in the filler content. Similar results 
of  of  more  liquid  absorption  with  increase  filler  content  were  shown  by 
Suwanprateeb et al. [1997] who investigated 0, 20 and 40 vol % of a spray dried 
HA,  similar  to  the  rHA  used  in  this  study,  in  a  high  density  polyethylene. 
However,  after  the  first  day  the  values  for  liquid  absorption  decreased  for Chapter 4 
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samples which had 70 wt % filler which can be attributed to the dissolution of 
particles from the samples. As the incubation proceeded, the liquid absorption 
by the films did not follow a set pattern which can be due to multiple factors 
that  were  occurring  simultaneously.    These  factors  include  dissolution  of  the 
particles  from  the  films,  degradation  of  PLA  and  exposure  of  the  particle 
surfaces  which  were embedded in  the  matrix  due  to  the  degradation  of  PLA 
matrix and which then caused increase in liquid absorption.  
The degradation of non filled PLA and PLA composite films used in this study was 
slow and the maximum weight loss was 7% in 12 weeks observed with PLA TCP 
films containing 10 wt % TCP. As the thickness of the samples used in the study 
was between 0.04 to 0.07 mm, it is expected that the oligomers produced in the 
matrix were able to escape in the surrounding aqueous medium easily thus their 
effect  of  contributing  to  the  autocatalysis  is  lost  and  did  not  increase  the 
degradation rate.  A study by Grizzi et al. [1995] also showed similar results, in 
that the PLA films lost only 5 7 % weight in 25 weeks. 
Among the composite films which contained rHA, sHA and TCP the maximum 
weight lost was observed in films containing lower filler content i.e. 10 wt % 
filler. This result is in keeping with other studies that HA and TCP incorporation 
into the composite slows the degradation rate by hindering the autocatalytic 
degradation of polymer [Agrawal and Kyriacos, 1997; Imai et al., 1999; Ara et 
al., 2002]. The reason for higher degradation of some composite films than non 
filled PLA films can be due to the dissolution of particles from the composite 
films which also added to the total degradation. Initially films containing 40 wt % 
filler showed more weight loss than from the films containing 70 wt % filler, 
however  after  3
rd  week  of  incubation  more  weight  loss  was  shown  by  films 
containing 70 wt % filler. This is probably due to more filler dissolution from the 
films containing 70 wt % filler which resulted in increased overall weight loss. 
Ural  et  al.  [2000]  has  also  suggested  that  the  addition  of  HA  in  a  polymer 
composite reduces the degradation rate and further that the composites with 
higher filler content degrade at a slower rate compared to those with lower 
filler contents. This may be due to the ability of HA or TCP particles present in 
the composite to absorb water molecules which penetrate the polymer matrix 
and are responsible for the hydrolytic decomposition of polymer chains.   Chapter 4 
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Interestingly  among  PLA nHA  composite  films  the  maximum  weight  loss  was 
observed in films containing 70 wt % nHA followed by films containing 40 and 10 
wt % nHA respectively. The degradation of composite films containing 10 and 40 
%  nHA  was  less  than  neat  PLA  films,  which  is  in  agreement  with  a  study 
conducted by Ural et al. [2000] which showed that adding HA to the polymer 
composite reduces the degradation rate. Higher weight loss in films containing 
70 wt % filler can be attributed to faster dissolution of filler particles from the 
surface of the samples and as the PLA nHA70 had more particles present on the 
surface than PLA nHA40 and PLA nHA10 the weight loss was more pronounced.  
The maximum weight loss at day 1 and at the end of 12 weeks was shown by 
PLA TCP composite films which is also in agreement with other studies, that TCP 
dissolves faster than HA [Paul et al., 1993; Kwon et al., 2003].  
4.6 CONCLUSIONS 
Water absorption increases with the filler content in the composite. Dissolution 
of TCP particles from PLA TCP composite was higher than the dissolution of HA 
particles from PLA HA composite. Incorporation of Ca P in the composite slows 
the degradation rate. Although in this study, the degradation of composite films 
was not always lower than neat PLA films, however in samples where it was 
higher this can be attributed to dissolution of particles from the composite. Thus 
by varying the concentration of Ca P the degradation rate of PLA can be tailored 
to suit individual need of clinical applications.   
CHAPTER  5:  EFFECTS  OF  nHA  AND  PDGF 
CONCENTRATIONS  ON  OSTEOBLAST AND  PDL  CELLS 
GROWTH IN PLA nHA COMPOSITE 
   
5.1 INTRODUCTION 
The use of a ceramic such as HA within a degradable PLA may confer a number 
of  potential  therapeutic  advantages  on  this  material,  including  increased 
mechanical properties, promotion of cell attachment and osteoconduction and 
the potential for use as a vehicle for slow delivery of bioactive proteins such as 
growth factors. PLA HA composite material has been shown to be biocompatible, 
resorbable and have good mechanical properties [Shikinami and Okuno, 1999]. 
The  incorporation  of  a  suitable  growth  factor  into  a  GTR  membrane  could 
enhance significantly the outcome of GTR procedures.   
The  aim  of  the  study  reported  here  was  to  investigate  the  proliferation  and 
differentiation  of  osteoblast  cells  on  PLA nHA  composite  with  different 
concentrations of nHA and assessing the potential of this material to act as a 
carrier system for growth factors delivery. In addition the nHA and the PLA nHA 
composite films produced for the experiments were characterized by Scanning 
Electron Microscopy (SEM), Fourier Transform Infra Red spectroscopy (FTIR) and 
X  Ray Diffraction (XRD).  
5.2 MATERIALS  
5.2.1 Polylactic acid 
PLA (PURAC Biochem, The Netherlands) as described in section 2.2 was used for 
the fabrication of the films. Chapter 5 
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5.2.2 Nano-Hydroxyapatite  
nHA was produced in the lab for this experiment. For nHA production, calcium 
nitrate  tetrahydrate  [Ca(NO3)2.4H2O]  was  used  as  the  calcium  precursor 
dissolved in ethanol, both obtained from Sigma Aldrich (UK). Sodium hydrogen 
phosphate [(NH4)2HPO4] also purchased from Sigma Aldrich (UK) was used as a 
phosphate  precursor  in  the  reactions  dissolved  in  deionised  water.  The 
production method is described in section 5.3.2.  
5.2.3 Cells 
Primary  rat  calvarial  osteoblasts  isolated  by  collagenase  digestion  and  rat 
periodontal ligament (PDL) cells isolated by explant culture were used in the 
experiments. Osteoblasts and PDL cells were donated by Dr C Wellman and Dr M 
Al Masri respectively (Barts & The London School of Medicine & Dentistry). The 
cells were cultured and maintained in Minimal Essential Medium (MEM) Alpha 
medium  (Invitrogen,  UK)  which  was  supplemented  with  10%  fetal  calf  serum 
(FCS)  (Sigma  Aldrich,  UK),  0.3 g/ml  fungizone  (Invitrogen,  UK)  and  50u/ml 
penicillin   50ug/ml  streptomycin  (Invitrogen,  UK).  The  cells  were  grown  in  a 
humidified incubator at 37
◦C with 5% CO2. The medium was replaced twice a 
week. 
5.2.4  Platelet Derived Growth Factor 
Recombinant rat Platelet Derived Growth Factor – BB (PDGF BB) purchased from 
Sigma Aldrich (UK) was used in the experiments. 
5.2.5 CASY cell counter 
Cells cultured on the films were counted using a CASY electronic cell counter 
(Model TTC, Sedna Scientific Ltd). CASY measures the cells suspended in the 
solution by aspirating through a precision measuring pore. On passing through 
the aperture these cells are scanned at a frequency of 1 MHz in a low voltage 
field (Figure 5.1). The signal data is then accumulated to give the total number 
of cells. Chapter 5 
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Figure 5.1: A schematic presentation of CASY cell counter working [adapted from 
sednascientific.com]. 
 
5.2.6 CellTiter 96
® AQueous non-radioactive cell proliferation Assay 
(MTS)  
Cell proliferation on the films was assessed by an MTS assay. A solution of MTS 
(Promega UK Ltd) and phenazine methosulfate (PMS) (Sigma Aldrich, UK) was 
used to determine the number of viable cells on the films.  
5.2.7 Alkaline phosphatase (ALP) 
ALP  assay  was  prepared  by  dissolving  2  ×  15  mg  tablets  of  p nitrophenyl 
phosphate in 8.36ml of distal water in addition to 6 l MgCl2  (2M) and 2.35ml of 
alkaline buffer solution (1.5 M) (Sigma, A9226).  Chapter 5 
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5.3 METHODS 
5.3.1 Film fabrication 
The films were fabricated as described in detail in section 2.3.1. That is the PLA 
was dissolved in chloroform and once fully dissolved the nHA was added to give 
PLA nHA  composite  films  containing  10  wt  %  nHA  (PLA nHA10),  40  wt  %  nHA 
(PLA nHA40) and 70 wt % nHA (PLA nHA70). The suspension was further stirred 
and then the films were cast. The films were cut into 12mm circular samples and 
were sterilized by ultraviolet (UV) irradiation. 
5.3.2 Nano-hydroxyapatite synthesis 
An Ethanol based sol–gel method was used for the synthesis of nHA as reported 
by Feng et al. [2005].   
Calcium nitrate tetrahydrate [Ca (NO3)2.4H2O] (0.083M) in ethanol and amonium 
hydrogen phosphate [(NH4)2HPO4] (0.05M) in water were mixed and the ratio of 
calcium and phosphate precursors was maintained at 1.66. Ca(NO3)2.4H2O was 
mixed in 50ml of ethanol and the solution was stirred and heated upto 85°C. On 
reaching 85°C, (NH4)2HPO4 dissolved in 50 ml of water was added drop by drop 
by means of a glass dropping funnel. Amonium hydroxide (NH4OH) was added 
into the solution to maintain the pH value above pH 10. The solution was stirred 
for 5 6 hrs as gel formation occurred (Equation 5.1). The final gel was then aged 
in an oven for 24 hrs at 40°C.  
The sample was then heat treated in a Carbolite furnance (Sheffield, UK) in air. 
The temperature was increased at the rate of 10°C min
 1 and on reaching 700°C 
the sample was held for 60 minutes and then cooled down to 20°C at the same 
rate. The powder was then ball milled for 12 hrs.  
10Ca (NO3)2 4H2O         +      6(NH4)2HPO4  +  8NH4OH  
       →          Equation: 5.1   
          Ca10 (PO4)6(OH)2            +       20NH4NO3      +  6H2O Chapter 5 
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5.3.3 Films and nHA characterisation 
5.3.3.1  FTIR 
FTIR spectra of the PLA and PLA nHA composite films were collected using a 
Thermo Electron Nicolet 8700 FTIR spectrometer. The spectra were obtained at 
8cm
 1 resolution and a total of 256 scans were collected. 
5.3.3.2  SEM 
The morphology and the size of synthesised n HA particles and the films were 
characterised by SEM (FEI Inspect F, EFI Company, The Netherlands) using the 
field emission technique. For nHA samples 20kV was used and for PLA and nHA 
PLA composite films 5kV was used. 
5.3.3.3  XRD 
The  nHA  powder  produced  was  characterized  using  XRD,  to  find  chemical 
composition, crystal state and the crystalline content. A Simens/Bruker D5000 
Diffractometer, with monochromatic Cu Ka radiation (k = 0.15418 nm) was used 
to obtain the nHA powder XRD. Scans were obtained in the 2θ range = 20–60, 
with a step size of 0.02 s
 1. Commercial nHA (Sigma, UK) was scanned to provide 
a comparative XRD pattern. 
5.3.4 Cell culture 
To evaluate osteoblast proliferation on different films, cells were seeded on PLA 
films and 10, 40, 70 wt % PLA nHA composite films. Osteoblasts of 7 9
th passage 
were used for the tests. 90% confluent cells were trypsinized and cell density 
was adjusted to 3×10
4 cells/ml. UV sterilised films were transferred into 24 well 
plates, a small dot of silicon was used to stick the films to the base of the wells.  
The films were seeded with 3×10
4 cells/ml / well for 1, 2, 4, 7, 10 and 14 days in 
triplicates.  Wells with no films were used as controls. 
For experiments in which platelet derived growth factor was added, the cell 
density  was  decreased  to  1×10
4  cells/ml/well  and  the  medium  was Chapter 5 
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supplemented with 1% fetal calf serum instead of 10% fetal calf serum. The well 
plates  were  placed  in  a  humidified  incubator  at  37
◦C  with  5%  CO2.  Cell 
proliferation was analyzed at day three. 
PDL cell proliferation was analysed on 10 and 70 wt % PLA nHA composite films. 
PDL cells of 11 13
th passage number were used. For cell seeding on films the 
same protocol was used for PDL cells as was used for osteoblasts.   
5.3.5 PDGF addition 
The  effect  of  PDGF  added  to  the  films  on  the  proliferation  of  cells  was 
evaluated.  To  pre adsorb  PDGF  to  films  for  testing,  100ng  recombinant  rat 
platelet derived  growth  factor  –  BB  (PDGF BB)  (Sigma)  in  100   l  phosphate 
buffered saline (PBS) was added to the surface of specimens placed in 24 well 
plates. The films were then incubated for three hrs at 37
◦C. After three hrs the 
PBS solution was carefully removed from the surface of the films and cells at 
density 1×10
4 cell ml
 1 were seeded on to the films.  
In a second set of films, rather than adding PDGF directly on the films, PDGF was 
added to the medium in solution at the same time as adding the cells as above. 
The final concentration of PDGF in the medium was 100ng ml
 1 so that the same 
total amount of PDGF was added to the well as when films were pre adsorbed 
with PDGF. 1ml of PDGF containing medium was then added to each film placed 
in 24 well plates. Cells in medium without PDGF with 1 and 10% FCS supplement 
were used as negative and positive controls respectively. 
5.3.6 CASY cell counting protocol 
In order to measure the cells on the films, films were removed from the medium 
at days 1, 2, and 5 and were placed in new 24 well plates. The films were then 
washed with PBS, after which 500 l trypsin was added to each well and the 
plates  were  placed  in  the incubator  for  10  minutes.  After that  1.5ml  of cell 
medium was added to each well and mixed with trypsin containing cells. From 
this cell containing medium/trypsin solution 500 l was removed and added into 
4.5ml of CASY diluting solution. The cell numbers were then analysed using CASY 
counter. Chapter 5 
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5.3.7 MTS Assay protocol 
MTS  changes  colour  on  reacting  with  cells.  The  amount  of  colour  change  is 
directly  proportional  to  the  number  of  living  cells.  In  order  to  measure  cell 
proliferation films were taken from the medium at day 1, 2, 4, 7, 10 and 14 and 
were  placed  in  new  24  well  plates.  PMS  and  MTS  solution  were  mixed  at  a 
concentration of 50 l/ml just before addition to the medium. MTS/PMS solution 
was then added to the medium at a concentration of 200  l/ ml, then 500  l of 
MTS/PMS solution containing medium was added to the wells containing films. 
The well plates were incubated for 3 hrs, then three samples of 100 l each were 
taken  out  from  each  of  the  wells  and  transferred  to  96  well  plates.  The 
colorimetric  measurement  was  then  performed  using  a  spectrophotometer  at 
490 nm (FLUOstar Optima, BMG Labtech). 
5.3.8 ALP activity 
ALP activity of cells was evaluated by adding 500 l ALP solution to each film in 
24 well plates. ALP solution was added to the same films after taking out MTS 
solution. 
The films were then incubated for at 37°C for one hour. After one hour three 
samples of 100 l each were taken from each film and absorbance was measured 
at 405nm in a photospectrometer.  
5.3.9 Cell morphology 
SEM was used for morphological analysis of cells. At the 14
th day of incubation 
the films containing cells were washed with PBS twice before fixing the cells in 4 
% formaldehyde for 15 minutes. The cells were then dehydrated by suspending in 
successive 50, 70, 80, 90 and 100% ethanol solutions for 5 minutes each.  The 
films containing cells were finally transferred to hexamethyldisilazane and were 
allowed to dry at room temperature. The films samples were then gold coated 
and analyzed under SEM at 5kV. Chapter 5 
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5.3.10  Data Analysis 
Statistical analyses of cell culture data were calculated by 1  way ANOVA with 
Bonferroni’s post test with P < 0.05.  Analysis was carried out using GraphPad 
Prism software. 
5.4 RESULTS 
5.4.1 nHA characterisation  
5.4.1.1  SEM  
Figure 5.2 shows the morphology and size of nHA synthesized. The particles were 
agglomerates of spherical nodules with the nodules being 40 60nm across and 
the agglomerates being 0.5 – 1mm across. High temperature during synthesis, 
low temperature during ageing and then an increase in temperature during heat 
treatment causes variations in the size of the particles. 
 
 
Figure  5.2  SEM  of  nHA  showing  individual  nodule  size  and  morphology  within  the 
agglomerated granules (scale bar= 500nm). 
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5.4.1.2  FTIR 
FTIR spectrum of nHA powder is shown in Figure 5.3. The peaks at 3571 cm
 1 and 
631cm
 1 represent OH group. The peaks at 1040, 603 and 569 cm
 1 represent the 
P O absorption band. CO3 group is represented by the peak at 1473 cm
 1. 
 
Figure 5.3: FTIR spectrum of synthesized nHA powder. 
 
5.4.1.3  X ray Diffraction  
X ray diffraction (XRD) of commercial (Plasma Biotal, UK) and experimental nHA 
are shown in Figure 5.4. A strong diffraction peak at 31.9° with lesser peaks at 
32.2,  32.9  and  25.9  and  39.8,  46.7  and  49.5  confirm  the  presence  of 
hydroxyapatite.  The  diffraction  patterns  correspond  to  hydroxyapatite  and 
confirmed the phase purity and high crystallinity of the materials produced. The 
slight broadening of the peaks shows that the nHA has slightly lower crystallinity 
than the commercial HA.    Chapter 5 
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Figure 5.4 XRD pattern of commercial and experimental nHA 
 
5.4.2 Film characterisation 
5.4.2.1  SEM  
Figures 5.5, 5.6 and 5.7 respectively show the morphology of 10, 40 and 70 wt % 
PLA nHA composite films. The surface of PLA nHA70 film showed more nHA on 
the  surface  as  compared  to  PLA nHA10  and  PLA nHA40  composite  films.  The 
surface of PLA nHA10 film appears smooth, whereas the surface of PLA nHA70 
film is rougher, irregular and shows micropores due to presence of nHA. It is 
interesting to see that at 10 wt %, a few nHA agglomerates can be seen and that 
these  are  all  covered  in  a  visible  PLA  layer.  However  as  the  nHA  content 
increases, the amount of visible nHA increases and at 70 wt % nHA substantial 
areas of the film surface appear nHA exposed from the PLA matrix. It is likely 
that a very thin layer of PLA is covering these particles but that the layer is too 
thin  and  thus  too  electron lucent  to  be  visible  on  the  SEM  image.  All  these 
images are of the “top” surface that is the air contacting surface as the films 
dried.  
Commercial nHA Chapter 5 
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Figure 5.5: SEM image of PLA nHA10 film (scale bar 4  m). 
 
 
 
Figure 5.6 SEM image of PLA nHA40 film (scale bar 4  m). 
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Figure 5.7 SEM image of PLA nHA70 film (scale bar 4  m). 
 
5.4.2.2  FTIR 
FTIR spectra of PLA film and PLA nHA10, PLA nHA40 and PLA nHA70 composite 
films are shown in Figure 5.8. The peak at 1760cm
 1 represents the carbonyl 
group of PLA which is present in all films and showed no drift even in PLA nHA70 
films.    HA  peak  at  3571cm
 1  is  more  pronounced in  PLA nHA  composite  film, 
whereas it decreases as the nHA content decreases in PLA nHA40 and PLA nHA10 
films.  The  peaks  between  538cm
 1  and  638cm
 1  represent  bending  peaks  of 
phosphate from the nHA in PLA nHA composite films.  
 
Figure 5.8 FTIR spectra of (a) PLA nHA70 film (b) PLA nHA40 film (c) PLA nHA10 and (d) 
PLA film.  Chapter 5 
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5.4.3 Cell proliferation assessed by CASY cell counter 
Figure 5.9 shows the number of cells on PLA film, PLA nHA10 and PLA nHA70 
composite films at day 1, 2 and 5 after culture. Although the cell numbers were 
greater at day 5 than at day 1 and 2, the cell number on different films showed 
no specific trend with high variations.  
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Figure 5.9: Osteoblast cell numbers on different films at day 1, 2 and 5 (n=3 per material and 
time). 
 
5.4.4 Cell proliferation assessed by MTS assay  
5.4.4.1  Osteoblast proliferation on PLA and PLA nHA films 
Osteoblasts cell proliferation on different films is shown in Figure 5.10. Among 
the films, cells showed highest proliferation on PLA nHA10 films. The rate of 
proliferation of cells decreased with the increase of nHA content in the films. 
Cells reached confluence at 10 days on PLA and PLA nHA10 films, whereas the 
cells were still proliferating on PLA nHA40 and PLA nHA70 composite films at day 
14. PLA nHA70 films showed less cell growth when compared to the other films. 
The experiment was repeated three times with similar results.  Chapter 5 
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Figure 5.10:  Proliferation of osteoblasts on PLA and PLA nHA films containing different 
amount of nHA (n=3 per material and time) 
5.4.4.2  PDL cells proliferation on PLA nHA films 
PDL cells showed similar responses on films with different nHA content. Cells 
proliferated less on films with higher HA content. Figure 5.11 shows more cell 
proliferation on PLA nHA10 composite film than on PLA nHA70 composite film. 
The experiment was repeated three times with similar results. 
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Figure  5.11:  Proliferation  of  PDL  cells  on  films  containing  different  amount  of  nHA 
compared to tissue culture plastic as the control (n=3 per material and time) 
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5.4.4.3  Osteoblast proliferation with PDGF added on the films and in 
the medium 
Figure 5.12 shows the proliferation of cells at day 3 on different films loaded 
with PDGF and on films in which PDGF was added in the cell medium. The films 
on which PDGF was directly added showed more cell proliferation compared to 
films in which PDGF was added to the cell medium. There was no difference 
between cell proliferation on positive control films with 10% FCS and films with 
PDGF  in  the  medium,  whereas  PDGF  adsorbed  to  films  caused  the  greatest 
proliferation. The lowest cell proliferation was seen on negative control films 
with 1% FCS and no PDGF added. The experiment was repeated three times with 
similar results. 
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Figure  5.12:  Osteoblast  cell  proliferation  in  response  to  PDGF  adsorbed  to  films  or  in 
solution in the medium.  Mean ± SD n=3 per material and serum condition.  *Significantly 
less than other groups.  **Significantly greater than other groups, p<0.05 1–way ANOVA and 
Bonferroni Post test.  
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5.4.4.4  Alkaline phosphatase activity 
Figure 5.13 shows alkaline phosphatase activity of osteoblasts cells at the 14
th 
day after culturing on different films. The data was normalized by cell number. 
The cells on PLA nHA films containing 70 wt % nHA showed the highest alkaline 
activity, whereas the lowest cell activity was observed on control and PLA films.  
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Figure  5.13:  ALP  activity  of  osteoblasts  cells  seeded  on  different  films.  The  data  was 
normalized by cell numbers. (n=3 per material). Mean ± SD.  *Significantly greater than other 
groups, p<0.05 1–way ANOVA and Bonferroni Post test.   
 
5.4.4.5  Cell morphology 
SEM images of cells at day 14 after culturing on PLA, PLA nHA10, PLA nHA40 and 
PLA nHA70 composite films are shown in Figure 5.14. The cells on the films are 
well spread and fully cover the films. The cells on PLA and PLA nHA10 films are 
densely packed and forming layers. On the films containing 40 and 70 wt % nHA 
the cells are bridging over the surface depressions and pores formed by the nHA 
particles. 
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Figure 5.14: SEM images of cells cultures at day 14 on (a) PLA (b) PLA nHA10, (c) PLA 
nHA40 and (d) PLA nHA70 composite films (All scale bars= 2 m). 
 
5.5 DISCUSSION 
Different materials are currently being used as barrier membranes for guided 
tissue  regeneration  (GTR),  however  with  limited  regeneration  potential. 
Consequently  there  is  considerable  interest  in  further  developments  in 
regenerative techniques to improve outcomes and predictability. One possible 
development is to use growth factors incorporated in the membranes for their 
release at the site to enhance tissue growth. 
In this study nHA PLA composite films have been analyzed as potential materials 
for GTR membranes. In order to assess biocompatibility, the effect of these films 
on growth of osteoblasts and PDL cells was tested. The aim was to develop a 
membrane  which  can  enhance  regeneration  by  combining  the  properties  of 
resorbable PLA and bioactive nHA and also has the ability to deliver bioactive 
proteins  such  as  growth  factors  at  the  defect  site,  thus  further  enhancing 
regeneration. 
2  m  2  m 
2  m  2  m  (a)  (b) 
(c)  (d) Chapter 5 
  190 
Hydroxyapatite is a known biocompatible and osteoconductive material and has 
the ability to absorb and release proteins [Matsumoto et al., 2004]. nHA with 
particle size between 40 60 nm was produced and the SEM image (Figure 5.2) of 
nHA shows the nano and spherical structure of the particles. Nano and spherical 
structured HA is advantageous, as it provides more surface area and binding sites 
for both, cell attachment and protein absorption. The crystallinity and purity of 
nHA was confirmed by XRD which only showed the reflection peaks associated 
with HA and no peaks related to tricalcium phosphate or calcium oxide were 
present. Similarly, the nHA FTIR spectra showed the typical characteristics of HA 
[Khan et al., 2008].  
SEM images of films with different nHA content showed that as the nHA content 
increases,  the  surface  of  film  becomes  rougher  which  could  provide  more 
surface area for cell attachment [Teng et al., 2009]. In FTIR spectra of films, 
there was no shift of PLA carbonyl group peak at 1760cm
 1, which shows that the 
mixing of PLA and nHA is physical and no chemical reaction took place. Bending 
peaks  of  phosphate  from  HA  between  538cm
 1  and  638cm
 1  become  more 
pronounced as the nHA content increases from 10 to 70 wt %. The OH group peak 
at 3571cm
 1 is only visible in PLA nHA containing 70 wt % nHA.  
The effect of nHA PLA films on proliferation and differentiation of osteoblasts 
were tested. Both cell proliferation and differentiation were assessed on the 
same sample so that the results can be correlated. It is known that the initial 
cell  adhesion  to  a  material  is  important,  because  it  greatly  influences  the 
succeeding processes of cell proliferation and differentiation [Dalby et al., 2002; 
Verrier et al., 2004].  
CASY cell counter results showed that cell number increased at 5 day compared 
to 1 and 3 days. However, the results did not show any specific pattern of cells 
growth  on  different  films  or  the  effect  of  different  films  on  the  cells 
proliferation.  This  high  variation  can  be  either  due  to  ineffectiveness  of 
trysinisation  to  completely  remove  cells  from  films  or  due  to  CASY  counter 
reading  errors  resulting  from  the  presence  of  nHA  particles  in  the  solution. 
Longer than usual incubation after trysinisation and cleaning of CASY counter 
(cleaning was done with running a cycle of CASY solution) after every reading Chapter 5 
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was  tried  to  overcome  this  problem,  but  with  little  success.  Thus  the  CASY 
technique was rejected in this application. 
The MTS assay showed less variable results and a constant pattern of cell growth 
on different film, so after initial tests all the experiments were carried out using 
the MTS assay. Both osteoblasts and PDL cells showed high proliferation on films 
with lower nHA content and low proliferation on films with high nHA content.  
PDL cells showed more proliferation on films containing 10 wt % nHA than films 
which contained 70 wt % nHA. Similar results were shown by osteoblasts, with 
the highest cell proliferation being shown by cells on films containing 10 wt % 
nHA followed by films containing 40 and 70 wt % nHA respectively. There was 
minimal difference between the number of cells on PLA and PLA nHA10 films at 
day 10 and 14; this may be because the cells had already reached confluence on 
these films at day 10, whereas the cells on PLA nHA40 and PLA nHA70 films were 
still proliferating at days 10 and 14 and showed an increase in number between 
days 10 and 14. 
ALP levels can be attributed to the degree of cell differentiation [Matsuyama et 
al.,  1990].  In  this  study,  high  ALP  expression  showing  differentiation  of 
osteoblasts cells on films containing high concentrations of nHA may explain the 
low number of proliferating cells on PLA nHA40 and PLA nHA70 film, and high 
number of cells on PLA and PLA nHA10 films.  The highest ALP activity was seen 
in the cells on PLA nHA70 films, which is probably due to the differentiation 
promoting effect of nHA on cells. Low levels of ALP in cells on PLA and PLA 
nHA10 films suggest no or low differentiation of these cells. Theses results are in 
support of various studies that nHA encourage bone cells to differentiate [Hott 
et al., 1997; Matsumura et al., 2004; Zhang et al., 2008].  
PDGF  is  a  heparin binding  polypeptide  and  has  mitogenic,  proliferative  and 
chemotactic  effects  on  connective  tissue  cells  [Nevins  et  al.,  2003].  PDGF 
adsorption in the composite films and its subsequent effect on the proliferation 
of osteoblasts was analyzed. The cells which were treated with PDGF, either by 
adding  PDGF  in  the  serum  or  by  absorption  in  the  films,  showed  more 
proliferation  on    day  3  as  compared  to  1%  serum  control  samples.  Cell 
proliferation on samples where soluble PDGF was added to the medium and on 
control samples containing 10% serum in the medium were similar. However the Chapter 5 
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highest cell proliferation was seen on films where PDGF had been pre adsorbed.  
This result shows that the effect of PDGF on cells was highest where a carrier 
was  used  and  also  establishes  that  these  films  can  be  used  as  a  carrier  for 
growth factor delivery. 
5.6 CONCLUSIONS 
The  highest  proliferation  of  PDL  cells  and  osteoblasts  was  achieved  on  PLA 
nHA10  films,  whereas  highest  ALP  activity  was  shown  by  cells  cultured  on 
composite films containing 70 wt % nHA. PDGF enhanced the proliferation of 
osteoblasts. The highest proliferation was shown by cells on films pre adsorbed 
with PDGF which shows the suitability of these composites as a carrier system 
for growth factor delivery. A composite material containing high concentration 
of nHA may be a very useful material for application as a GTR membrane.  
CHAPTER  6:  DETERMINATION  OF  THE  FLEXURAL 
STRENGTH  OF  POLYLACTIC  ACID HYDROXYAPATITE 
COMPOSITE MEMBRANES 
6.1 INTRODUCTION 
Collapse of GTR membranes is one of the major causes of their failure which 
results in compromised clinical outcomes. An ideal  membrane should be stiff 
enough to withstand overlying tissue and masticatory pressure. This requirement 
is more important when the GTR membrane is used without graft to cover a 
large  bone  defect.  Although  a  stiff  membrane  will  be  able  to  withstand  the 
occlusal forces, it may not be easy to adapt a stiff membrane over the bone 
defects and may require substantial chair side preparation. Additionally a stiff 
membrane may also damage the soft tissue.  
The  strength  and  stiffness  of  a  membrane  can  be  improved  by  using  a  fibre 
reinforced composite material, also the limitations of using a stiff membrane 
can  be  avoided  by  using  a  prefabricated  membrane.  This  prefabrication  can 
minimize the chair side preparation and will also improve membrane adaptation. 
As has been investigated in chapter 8, few membranes shapes can fit most of the 
alveolar bone defects it may be possible to use prefabricated membranes with 
adequate strength and stiffness to withstand the occlusal pressures.  
The aim of study reported in this section is to investigate the effect of fibre 
orientation on the flexural strength of the proposed PLA HA PLA fibre composite 
membrane.   
6.2 MATERIALS 
6.2.1 PLA 
The PLA used as the matrix polymer was obtained from PURAC Biochem (The 
Netherlands) and is described in section 2.2.1.  Chapter 6 
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6.2.2 PLA fibres 
Drawn PLLA fibres were obtained from Degradable Solutions Ltd, Switzerland. 
They had mean fibre diameter of 50 – 80  m.  
6.2.3 HA 
Sintered HA (sHA) was used as filler in the composite and is described in section 
2.2.3.  
6.3 METHODS 
6.3.1 Prepregging 
PLA HA PLA fibre composite sheets were prepared using a prepregging machine. 
To prepare the prepreg, PLA fibres were pulled through a PLA HA matrix solution 
and then collected on a rotating drum as shown in Figure 6.1.   
 
 
Figure 6.1: PLA fibre being collected on a drum after passing through PLA HA matrix (image 
from Prof Liz Tanner). 
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The PLA HA matrix solution was prepared by dissolving PLA in acetone, in which 
sHA was added to obtain a final 70 % wt concentration. 10 g PLA was added to 
500 ml acetone in a flask and stirred for 6 hours at room temperature. Once the 
PLA was completely dissolved, 7 g sHA was added to the solution and stirred for 
a further 72 hours to ensure a homogenous mix. The matrix solution was then 
transferred into  the bath  on the  prepregging  machine.  Next  two  fibre  spools 
were mounted at the opposite side of the collection drum and the fibres were 
unwounded and passed through the matrix bath and wounded onto the drum 
which was covered with a wax paper. The machine was started to rotate the 
drum which also moved transversely. After the rotating drum was covered with a 
layer of prepreg the machine was stopped. The prepreg was left on the drum to 
dry overnight. Once completely dried the sheet was cut off from the drum and 
heat  treated.  For  heat  treatment,  the  prepreg  was  cut  into  smaller  pieces 
(Figure 6.2) which were then pressed between two metal plates and placed in 
the oven at 70 °C for 1 hour. After one hour the oven was turned off and the 
specimens  were  allowed  to  cool  gradually  over  night.  An  optical  microscope 
image of the prepreg sheet is shown in Figure 6.3.     
 
 
Figure 6.2: Prepreg containing PLA fibres in a PLA HA matrix. 
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Figure 6.3: An optical microscope image of prepreg sheet showing PLA fibres embedded in 
the PLA HA matrix. (Image from Dr Wojciech Chrzanowski )   
 
  
6.3.2 PLA-HA-PLA fibre composite membrane fabrication 
PLA HA PLA  fibre  composite  membranes  were  fabrication  by  hot  pressing  7 
layers of prepreg in a stainless steel mould with three different lay ups. The 
prepreg  lay  up  used  were  0°/0°/0°/90°/0°/0°/0°,  0°/0°/90°/0°/90°/0°/0° 
and 0°/90°/0°/90°/0°/90°/0° as shown in Figure 6.4 (a) Group 1, (b) Group 2 
and (c) Group 3 respectively.  
 
 
 
 
 
 
 
 
Figure  6.4:  Prepreg  lay  up  used  for  membranes  fabrication  (a)  0°/0°/0°/90°/0°/0°/0°,  (b) 
0°/0°/90°/0°/90°/0°/0° and (c) 0°/90°/0°/90°/0°/90°/0°.  
 
(a)Group 1  (b)Group 2  (c)Group 3 
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The  mould  was  placed  in  the  hot  press  (Mackey  Bowley,  Kent,  UK)  and  the 
pressure was applied. The temperature was gradually increased to a maximum of 
140 °C. The pressure was increased with increase in the temperature, thus final 
pressure at 140 °C was 10 MPa. On reaching 140°C the mould was kept at this 
temperature for 3 minutes before the heating was turned off and the mould was 
allowed  to  cool  under  pressure.  Once  the  temperature  dropped  to  40°C  the 
mould was removed from the hot press and the membrane was taken out (Figure 
6.5). The thickness of all the membranes produced was nominally 0.9mm. The 
samples  were  then  cut  parallel  to  long  axis  of  the  mould  to  get  the  fibre 
orientation shown in Figure 6.4.   
  
   
Figure 6.5: (a) Mould used to hot press the prepreg, and (b) a seven layer PLA HA PLA fibre 
composite membrane produced using the prepreg.  
 
Additionally the membranes of Group 1,2 and 3 were cut across the long axis, 
which gave the samples having fibre orientation 90°/90°/90°/0°/90°/90°/90°, 
0°/90°/0°/90°/0°/90°/90°and 90°/0°/90°/0°/90°/0°/90° respectively and are 
shown in Figure 6.6 (a) Group 4, (b) Group 5 and (c) Group 6. 
(a) 
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Figure 6.6: Membranes of Group 1, 2 and 3  were cut across and resulted in samples with 
fibre orientations (a) Group 4, 90°/90°/90°/0°/90°/90°/90°, (b) Group 5, 90°/90°/0°/90°/0°/90°/90° 
and (c) Group 6, 90°/0°/90°/0°/90°/0°/90° respectively. 
 
6.3.3 Four point bending test 
The tests were carried out using a MTS machine (858 MiniBionix® II). Figure 6.7 
(a) shows sample setup for four point bending test and (b) a sample being tested 
under the applied displacement. 
     
Figure 6.7: (a) Sample setup for four point test and (b) a sample being tested.  
A  force  displacement  curve  was  recorded  for  each  sample.  From  the  curve 
maximum  force  and  displacement  were  extracted  for  calculating  flexural 
strength and flexural modulus using equation 6.1 and 6.2 respectively.  
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where σ is the flexural strength, F is the load (force) at any given point, L is the 
length of the support span, b is the sample width, d is the sample thickness and 
m is the slope.  
The load was applied at the rate of 5 mm.min
 1. The length and width of each 
samples were measured and an average of three readings was obtained. Five 
samples were tested from each group for a maximum displacement of 8 mm.  
6.3.4 Data Analysis 
Statistical analyses were done by 1  way ANOVA with Bonferroni’s post test with 
P < 0.05.   
6.4 RESULTS 
Figure 6.8 show a force displacement curve used to calculate flexural strength 
and flexural modulus.  
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Figure 6.8: A force displacement curve used to calculate maximum force and displacement.  
Equation 6.1 
Equation 6.2 Chapter 6 
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Figure 6.9 show the flexural strength of the membranes with different prepreg 
lay ups. The graph shows the mean value and standard deviation of 5 samples 
from  each  group.  The  highest  flexural  strength  was  shown  by  membranes  of 
groups 2 which had the maximum numbers of prepreg sheets laid at 0°, although 
the difference was not significant from the membranes other groups, except the 
membranes of group 4 and 5. The membranes of group 4 and 5 which had the 
maximum  numbers  of  prepreg  sheets  laid  at  90°  showed  significantly  low 
flexural strength. 
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Figure 6.9: Flexural strength of PLA HA PLA fibre membranes having different prepreg lay 
ups.  Mean +  SD  n=5  per group. *  Significantly  less  than  other  groups,  p<0.05,  one way 
ANOVA and Bonferroni post test.  
 
Figure 6.10 show the flexural moduli of the membranes with different prepreg 
lay ups. The graph shows the mean value and standard deviation of 5 samples 
from each group. The membranes of group 4 which had the maximum numbers 
of prepreg sheets laid at 90° showed significantly lower flexural modulus than 
membranes of all other groups except from the membranes of group 5. Whereas, 
the highest flexural modulus was shown by membranes of groups 2 which had 5 
prepreg  sheets  laid  at  0°,  however  it  was  not  significantly  higher  than 
membranes of group 1 and 3.  
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Figure 6.10: Flexural modulus of PLA HA PLA fibre membranes having different prepreg lay 
ups. Mean + SD n=5 per group. * Significantly different than group 4, 5 and 6, ** significantly 
different  than  group  4  and  5,  ***  significantly  different  than  group  1,  2,  3  and  6,  **** 
significantly different than group 1, 2 and 3, ***** significantly different than group 1,2 and 4, 
p<0.05, one way ANOVA and Bonferroni post test.  
 
6.5 DISCUSSION 
In an attempt to produce a periodontal membrane with improved physical and 
biological  properties  we  have  investigated  PLA HA PLA  fibre  composites  as 
potential  membrane  materials.  The  use  of  fibres  has  been  established  to 
increase the properties of the material. Additionally the use of the fibres of 
same material as matrix results in a chemical bonding between the fibres and 
matrix which eliminate the possibility of a weak interface between the fibre and 
the matrix.  
The mechanical properties of a fibre reinforced composite depends on number 
of factors which includes [Behr et al., 2000]: 
•  orientation of fibres:  
Unidirectional fibres= produce anisotropic mechanical properties 
Multidirectional fibres= produce orthotropic mechanical properties 
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•  adhesion of fibres to the matrix polymer: 
Proper  adhesion  between  fibres  and  the  matrix  is  important  for  the 
transfer of load from matrix to the fibres. Additionally proper adhesion 
between  the  fibre  and  the  matrix  reduces  the  chances  of  voids  and 
cracks.   
In this pilot study flexural strength and flexural modulus of the PLA HA PLA fibre 
membranes were analyzed by a four point bending test.  
As shown in Figure 6.9 and 6.10 the flexural strength and the flexural modulus of 
the  PLA HA PLA  fibre  composite  membranes  were  affected  by  the  fibre 
orientation in the prepreg lay up. The highest flexural strength and modulus was 
shown by membranes of Group 2 which had the maximum number of prepreg 
layers laid at 0° reinforced transversally with two prepreg layers laid at 90°. The 
possible explanation for this pattern of high flexural strength for membranes 
having more prepreg laid up at 0° if the force is applied perpendicular to the 
long axis of the fibres then the fibres contribute to the resistance against the 
force  and  provide  strength  to  the  material.  Whereas  if  the  force  applied  is 
parallel to the fibre long axis, it results in the production of the failure at the 
matrix fibre interface and the fibres do not contribute to the resistance against 
the force applied [Dyer et al., 2004]. The membranes of group 4 which had the 
maximum numbers of prepregs laid at 90° showed the lowest flexural strength 
and modulus. This result can be because the positions of maximum numbers of 
fibre present in these membranes were parallel to the applied force, which can 
result in more chances of a material failure at the fibre matrix interface.   
6.6 CONCLUSIONS 
This study showed that the flexural strength of a PLA HA PLA fibre composite 
membranes  depend  on  the  orientation  of  fibres  in  the  prepreg.  Hence  the 
strength of the membrane can be optimised by laying up most of the prepreg at 
0° reinforced transversally by one or two layers laid at 90°.    
CHAPTER 7: RELEASE OF PROTEIN FROM POLYLACTIC 
ACID HYDROXYAPATITE COMPOSITE MEMBRANES. 
   
7.1 INTRODUCTION 
The  ideal  membrane  for  GTR  is  resorbable  and  has  sufficient  mechanical 
stiffness  to  prevent  intrusion  of  the  soft  tissues  into  the  defect,  yet  be 
sufficiently flexible for the dental surgeon to be able to fit around the defect. 
However, the additional potential benefits of secondary biological activities of 
membranes  including  osteoconduction  and  the  potential  to  release  bioactive 
proteins to accelerate the healing process remain to be investigated. In these 
cases,  release  of  bone  bioactive  proteins  might  ideally  be  directed  in  a 
unidirectional manner, resulting in release to the bone contacting surface, with 
limited release towards the gingival contacting surface. 
In  this  study  the  interaction  of  proteins  with  PLA HA  composite  membrane 
material  has  been  investigated.  Specifically,  the  aims  of  the  study  are  to 
investigate the protein release kinetics of the material, its permeability and the 
effects of alterations in membrane composition on these properties. As this was 
a release study only three layers of pre preg was used in each specimen. 
7.2 MATERIALS 
7.2.1 PLA-HA Composite Membranes 
Composite  sheets  consisting  of  PLA  fibres  in  a  PLA  matrix  with  and  without 
hydroxyapatite were used. The PLA drawn fibres had an L: D ratio of 96:4 (wt %) 
and  a  diameter  between  70  to  90 m  (supplied  by  Tampere  University  of 
Technology Finland). Matrix PLA had an L: D, L ratio of 70:30 (wt %) (Boehringer 
Ingelheim, Germany). Chapter 7 
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For  the  HA  reinforced  sheets  the  PLA  matrix  solution  contained  HA  (Mean 
particle  size=2.99,  Specific  surface  areas  16.3  m
2g
 1)  (Plasma  Biotal  Ltd, 
Tideswell, UK) giving PLA HA PLA fibres composite. Thus in the HA PLA PLA fibre 
composite the PLA fibres were held in an HA PLA matrix while in the PLA PLA 
fibre composite the PLA fibres were in an unfilled PLA matrix. In the HA PLA PLA 
fibre composite the HA content was 20 wt % of the whole specimen. 
7.2.2 PLA-nHA Composite Films 
For  the  production  of  PLA nHA  composite  films,  PLA  and  nHA  were  used  as 
described in detail in sections 5.2.1 and 5.2.2 respectively.  
7.2.3 Other materials 
Bovine serum albumin, minimum 98% (Sigma, batch # 025K0598) was used to 
evaluate the protein release pattern of the membranes.  
Bio Rad protein assay reagents A and B (Catalog # 500113 and 500114) were used 
to determine the quantity of protein released.  
FLUOstar Optima (BMG Labtech) microplate reader was used to read the protein 
concentrations. 
7.3 METHODS 
7.3.1 PLA-HA-PLA fibre composite membrane fabrication 
The  trilayer  membranes  were  produced  using  a  hand  lay up  procedure  in  a 
stainless steel mould using a hot press (Palamine, Haverhill, UK) (Figure 7.1). 
The PLA fibres of the top and bottom layers were parallel, while the fibres of 
the  middle  layer  were  perpendicular  to  the  other  two  layers  (0/90/0).  The 
membranes  were  produced  at  different  pressures  and  temperatures.  The 
temperatures used were 140 °C and 150 °C while the pressures used were 2.72 
MPa  and  3.14  MPa  which  gave  membrane  thickness  of  0.25mm  and  0.2mm 
respectively. Chapter 7 
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Figure 7.1 Hot press [Palamine, Haverhill, UK] 
 
 
7.3.2 Film fabrication 
The PLA and PLA nHA composite films were fabricated as described in detail in 
section 2.3.1. The films were then cut into 6mm circular samples. 
7.3.3 Measurement of Protein Concentrations 
Protein  concentrations  of  solutions  were  measured  using  the  BioRad  protein 
assay based on the method of Bradford [Bradford, 1976].  BioRad reagent was 
added  to  solutions  as  described  below  and  optical  density  measured  by 
spectrophotometery  at  595  nm  wavelength.    Optical  density  readings  were 
converted  to  true  protein  concentrations  from  a  standard  curve  constructed 
using a series of albumin concentrations from 0  g ml
 1 to 500  g ml
 1. Chapter 7 
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7.3.4 Measurement of Protein Release 
For  each  experiment,  PLA HA PLA  fibres  composite  membrane  pieces  of 
nominally equal weight were placed in 24 well plates and 1 mg bovine serum 
albumin (BSA) dissolved in distilled water was added on to the surface of the 
membranes as a drop. Plain PLA PLA fibre membranes were used as controls. 
The membranes were kept at room temperature and allowed to dry overnight. 
Specimens  where  the  drop  did  not  remain  on  them  were  discarded.  Next, 
membranes were placed in new well plates and 1ml of PBS was added to each 
well. A sample solution of 50 l each was taken out at 0.25, 1, 2, 4, 24, 48, 72 
and 96 hours. 50  l Bio Rad with an additional 50 l PBS was added to the sample 
solutions and the readings were obtained as before. The remaining PBS solution 
in  the  wells  was  completely  replaced  by  fresh  1  ml  of  solution  after  each 
sampling time point. Three samples were measured for each material and each 
time point.  
7.3.5 Permeability of films  
Tests  were  conducted  to  check  the  permeability  of  PLA  films  and  PLA nHA 
composite films with different concentrations of nHA.  To conduct these tests, 
films  were  placed  in  a  48  well  micro chemotaxis  chamber  (NeuroProbe  Inc, 
CabinJohn, MD USA) (Figure 7.2). For diffusion control, films were deliberately 
pierced using a small gauge hypodermic needle to allow free diffusion between 
the upper and lower chambers. Chambers in the lower plate were filled with 
26 l of solution and in the upper plate all the chambers were filled with 50 l 
PBS, except the positive control which was filled with 50 l albumin as shown in 
Table 7.1. Thus the negative control had PBS on both sides of the film and the 
positive  control  had  albumin  on  both  sides  of  the  film,  while  the  active 
chambers had PBS in the upper chamber and albumin in the lower chamber. The 
films tested were non filled PLA and PLA nHA composite films containing 25 wt % 
nHA (PLA nHA25) and 75 wt % nHA (PLA nHA75). 25 l of sample solution was 
obtained from the upper chambers at 0.5, 2, 4 and 24 hours.  25 l of PBS and 
50 l  of  Bio Rad  was  added  to  the  25 l  sample  solution  and  readings  were 
obtained using a spectrophotometer at 595nm wavelength as before Chapter 7 
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Figure 7.2: 48 well micro chemotasis chamber used to measure the permeability of PLA and 
PLA nHA composite films. 
 
Table 7.1: Set ups for PLA nHA composite film permeability test (n = 3 for each group) 
showng solutions placed in upper and lower chambers of test kit.  
  Lower Chamber  Upper Chamber 
 ve control 
Test 
Diff control* 
+ve control 
PBS 
BSA 
BSA 
BSA 
PBS 
PBS 
PBS 
BSA 
* Pierced Membrane 
7.3.6 Statistical analysis 
Where appropriate, protein concentrations were calculated from optical density 
readings  using  standard  curves  of  known  concentrations  of  BSA.    Means  and 
standard deviations were calculated, and statistical differences were tested by 
1 way ANOVA with Bonferroni’s post test. Statistical significance was assumed if 
the P value was less than or equal to P < 0.01 
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7.4 RESULTS 
7.4.1 Optical density values for different BSA concentrations 
Figure  7.3  shows  the  optical  density  values  obtained  with  different 
concentrations  of  BSA.  This  standard  curve  was  used  to  convert  the  optical 
density readings obtained in the experiments into protein concentration values. 
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Figure 7.3 Measurement of different proteins concentrations 
 
 
7.4.2 Protein release from the membranes 
During the first hour the PLA PLA fibre composite membrane released more BSA 
than the PLA HA PLA fibre composite membranes (Figure 7.4). The PLA PLA fibre 
membrane released most of the BSA during the first two hours and the release 
reduced  subsequently,  by  the  end  of  24  hours  the  release  was  negligible. 
However release from PLA HA PLA fibres composite membrane was gradual and 
persistent with small amounts released even at 96 hours. Chapter 7 
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Figure 7.4 Amount of BSA released from PLA PLA fibre and HA PLA PLA fibres composite 
membrane in 96 hours showing means and standard deviations. n=3 
 
7.4.3 Protein  release  from  PLA-HA-PLA  fibre  composite 
membranes produced at different temperatures and pressures 
Different  patterns  of  BSA  release  were  observed  from  the  PLA HA PLA  fibres 
composite membranes produced at different temperatures and pressures (Figure 
7.5). During the first hour the membranes produced at higher temperature and 
pressure  i.e.  150  °C  and  3.14  MPa  showed  greater  BSA  release  than  the 
membranes produced at lower temperatures and pressures i.e. 140 °C and 2.72 
MPa.  However,  the  release  of  BSA  from  the  membranes  produced  at  higher 
temperatures and pressures decreased to negligible amounts after four hours. In 
contrast  release  from  the  membranes  produced  at  low  temperatures  and 
pressures were initially lower, and their release was more prolonged and was 
still detectable at 48 hours. Chapter 7 
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Figure  7.5  Release  of  BSA  from  PLA HA PLA  fibres  composite  membranes  produced  at 
150°C and 3.14 MPa or 140°C and 2.72 MPa upto 48 hours showing means and standard 
deviations. n=3 
 
7.4.4 Permeability of membranes with different concentrations of 
HA 
Figure 7.6(a) shows the permeability of PLA films. The diffusion through PLA film 
was negligible even at the end of 24 hours. Figure 7.6 (b) shows the permeability 
of  films  containing  25  and  75  wt  %  nHA.    During  the  initial  four  hours  the 
diffusion of protein from the two membranes was low and did not differ greatly.  
However at the end of 24 hours the diffusion through the PLA nHA75 film was 
substantially higher than through the PLA nHA25 film.  Figure 7.6 (c) shows the 
results of control experiments when albumin was added to both upper and lower 
chambers. Albumin concentration for PLA nHA25 film at half an hour was very 
high when compared to PLA nHA75 film. Albumin concentration for PLA nHA25 
film  decreased  subsequently  with  time,  whereas  for  PLA nHA75  film  the 
concentration  remained  low  throughout.  Figure  7.6  (d)  shows  the  results  of 
“diffusion control” experiments where albumin was placed in the lower chamber 
and the membrane was deliberately pierced to allow  free diffusion. In these 
experiments, the albumin concentration for the PLA nHA75 film was higher than 
PLA nHA25  film  at  0.5,  2  and  4  hours,  whereas  at  24  hours  the  albumin 
concentration for both the films was similar.  Chapter 7 
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Figure 7.6: Permeability tests: 
(a) Amount of protein diffused through PLA film up to 24 hours, (b) Amount of protein diffused 
through PLA nHA25 and PLA nHA75 composite films up to 24 hours, (c) Positive control. Readings 
obtained at different time points for PLA nHA25 and PLA nHA75 composite films when albumin 
was added to both upper and lower chambers of the micro chemotaxis chamber and (d) Diffusion 
(d)  
 
 (c)  
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control. Readings  obtained  at different  time points  for  PLA nHA25 and PLA nHA75  composite 
films when films were deliberately pierced. Mean ± SD  n = 3 replicate samples at each time 
point.  * indicates significantly different between tests at specified time point (P < 0.01) by 1 
way ANOVA and Bonferroni post test. 
 
7.5 DISCUSSION 
As noted previously, although a range of different materials have been used for 
GTR  procedures,  none  of  these  have  ideal  properties.  The  construction  of 
composite membranes using HA filled PLA PLA fibre laminar structures is a novel 
approach to this problem, which may have advantages over current materials.  
The material is expected to have superior mechanical properties compared to 
conventional membranes due to the presence of PLA fibres [Yair, 2006] even in 
thin  sections,  whilst  retaining  its  resorbable  properties.  Whilst  a  full 
characterisation of the mechanical properties of these membranes is planned for 
further investigations, empirically these composite membranes are both stiff and 
strong.     
Protein  release  patterns  from  PLA HA PLA  fibre  composite  membranes  were 
more  sustained  than  protein  release  from  PLA PLA  fibre  membranes.  Both 
membrane types released high levels of BSA during the first hour, which may be 
the result of the release of BSA present on the surface of the membranes and 
which  occurred  quickly.  However  for  PLA PLA  fibre  membranes  there  was 
minimal  sustained  protein  release,  whereas  release  from  PLA HA PLA  fibres 
composite membranes was more sustained with measurable release still being 
detectable after 48 hours.  Mizushima et al. [2006] have reported the sustained 
release of the drug interferon alpha from porous hydroxyapatite particles, which 
would support these observations.  
Similarly,  PLA HA PLA  fibres  composite  membranes  produced  at  lower 
temperatures  and  pressures  had  more  sustained  protein  release  kinetics  than 
membranes  produced  at  comparatively  higher  pressures  and  temperatures. 
Membranes  produced  at  lower  temperature  and  pressure  showed  the  same 
pattern  of  more  sustained  release  for  longer  times,  whereas  for  membranes 
produced at high temperature and pressure most of the total BSA was released Chapter 7 
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during  the  initial  few  hours.  This  difference  is  probably  due  to  greater 
compaction  of  the  membrane  produced  at  higher  temperature  and  pressure, 
allowing less space for the ingress of BSA inside the membrane.  This results in 
the BSA being absorbed or adsorbed only onto the surface of the membrane and 
subsequently released quickly.   
It  appears  that  when  there  is  space  either  between  the  pre peg  sheets  or 
between the HA particles and the PLA matrix within a membrane or film, they 
are  able  to  absorb  more  protein  and  subsequently  release  the  protein  more 
slowly.  
PLA nHA composite films showed much greater permeability for protein when 
compared to PLA films.  The permeability of films increased with the increase of 
nHA content in the films.  These results suggest that permeability is related to 
porosity due to nHA incorporation.  PLA films without nHA were essentially non 
permeable.  
In  these  experiments,  a  “positive  control”  was  used  to  validate  the  assay 
process, whereby equal concentrations of the protein were placed in the upper 
chamber  of  the  diffusion  test  apparatus. This  experiment  was  carried  out  to 
determine  if  there  were  changes  in  protein  concentration  with  time,  due  to 
absorption of protein to the film and the diffusion chamber. Data from these 
controls showed a decrease in albumin for PLA nHA75 film as compared to PLA 
nHA25 film at 30 minutes. This may be due to the fact that albumin is being 
absorbed at a greater rate with the higher concentrations of nHA in PLA nHA75 
film. In addition “diffusion control” was also used where films were deliberately 
pierced to allow free diffusion between chambers of the apparatus. The high 
albumin diffusion through PLA nHA75 composite film seen in these tests during 
the initial four hours may be due to larger holes produced on piercing as that 
material is more highly filled, and therefore has more interfaces through which 
the protein can track. The results demonstrate that the incorporation of the nHA 
into the membrane substantially alters the diffusion of protein through the films 
and suggest the possibility that an unfilled PLA coating on one side of the GTR 
membrane could  be  readily  used  to  direct  protein  release unidirectionally  as 
required clinically.   Chapter 7 
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Overall,  the  data  demonstrates  that  the  protein  release  kinetics  of  these 
composite materials can be controlled by a combination of altering membrane 
composition, and the temperature and pressures used for their production. 
7.6 CONCLUSIONS 
The  protein  release  kinetics  of  PLA HA PLA  fibre  composite  membranes 
demonstrate a  more sustained  release  of protein  when  compared  to  PLA PLA 
fibre  membranes.  Thus  these  composite  membranes  could  be  useful 
therapeutically  as  a  delivery  system  for  bioactive  proteins.  The  diffusion  of 
protein through PLA nHA composite film increases with increased nHA content. 
This property may be beneficial in order to obtain directional release of proteins 
by differential coating of membrane surfaces with unfilled and filled PLA films. 
CHAPTER  8:  ANALYSIS  OF  ALVEOLAR  BONE 
RESORPTION PROFILE 
   
8.1 INTRODUCTION 
Guided tissue regeneration (GTR) membranes are used for the regeneration of 
alveolar bone lost during periodontal diseases or resorbed after the loss of tooth.  
Periodontal diseases affect the periodontium which is the supporting structure 
for the tooth and in severe cases of periodontal disease the supporting structure 
in the jaw gets destroyed which ultimately results in tooth loss. The treatment 
aim in such cases is not only to stop the disease process but to also regenerate 
the lost periodontal tissues. Different methods are being used for the treatment 
and regeneration of periodontal tissues (section 1.4).  
Extraction of teeth which are damaged due to caries or trauma also results in 
the resorption of alveolar bone not only in the buccolingual direction but also in 
the vertical direction (Figure 8.1). In order to restore the alveolar ridge shape to 
be  suitable  for  dental  implants,  different  methods  of  bone  regeneration  are 
employed, including the use of GTR membranes.      
 
Figure 8.1:  The progression of maxilla and  mandible alveolar ridge resorption, from (A) 
shortly after extraction of tooth through to subsequent gross atrophy (E) [modified from 
[Floyd et al., 1999].   
Different  types  of  GTR  membrane  are  currently  used.  Ease  of  use  and 
adaptability are two of the major requirements of GTR membranes for successful 
results. However, additionally the stiffness of the GTR membrane needs to be 
A    B       C       D         E
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high enough to prevent the collapse under the soft tissue or occlusal pressure 
under mastication.  
As  a  part  of  the  study  to  develop  a  composite  membrane  with  enhanced 
regeneration potential, an analysis of the alveolar bone resorption pattern was 
performed to define a membrane shape which is suitable for most of the cases. 
The  PLA/PLA  fibre/HA  composite  material  described  in  previous  chapters 
potentially  has  good  mechanical  properties  for  maintenance  of  space  under 
periodontal  wounds,  compared  to  existing  membranes.  However  existing 
membranes are highly flexible and can be adapted to the required shape over 
the  bone.  In  contrast  our  PLA/  HA  membranes  show  increased  stiffness  and 
therefore are likely to require a degree of pre shaping during the manufacturing 
process.  Thus it is envisaged that a clinician might select one of a number of 
preformed  membrane  shapes  for  each  specific  defect  and  then  trim  it 
accordingly.  In order to test the feasibility of this idea it was decided to carry 
out  a  pilot  study  to  determine  the  cross  sectional  profiles  of  membranes 
required  and  to  determine  the  extent  of  variability  of  membrane  profiles 
required.  
8.2 MATERIALS AND METHODS 
To determine the alveolar bone loss pattern following protocol was devised: 
 
8.2.1 Selection of cases 
To  determine  the  profile  of  alveolar  bone  resorption  seven  partially  and 
completely  edentulous  patients  aged  between  25  and  60  which  were  already 
under clinical assessment for placement of dental implants were selected. 39 
computerised  tomography (CT  scan) slices  from different edentulous areas of 
mandibular  alveolar  ridges  were  obtained,  in  collaboration  with  Dr  Jimmy 
Makdissi, Consultant Radiologist, Barts and the London Dental Hospital. Figures 
8.2 and 8.3 respectively show cross sectional slices of alveolar ridges of anterior 
and posterior mandibles of two different patients. The cross sectional scan slices Chapter 8 
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were obtained parallel to occlusal plane of the mandible. These scans were then 
used to draw possible shapes for GTR membranes.  
Figure 8.2: Cross sectional scan images of an anterior mandible, the distance between each 
scan slice was 2mm. Cortical thickness and trabeculation density can also assessed from 
the scan slices. 
 
Figure 8.3: Cross sectional scan images of posterior mandible, the distance between each 
scan slice was 2mm. Cortical thickness and trabeculation density can also assessed from 
the scan slices.  Chapter 8 
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8.2.2 Determination of GTR membrane shape 
Cross sections of edentulous alveolar ridges obtained from CT scans were printed 
and a suitable GTR membrane shape was hand drawn over the alveolar ridges by 
an  experienced  periodontologist  (Prof  Francis  Hughes).  Figure  8.4  shows  the 
profile  of  GTR  membranes  drawn  over  the  anterior  and  posterior  mandibular 
ridges of 8 different patients.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.4: Membrane shapes, hand drawn over the alveolar ridges of anterior and posterior 
mandible.  Chapter 8 
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8.2.3 Digitizing of membrane shapes 
The  hand  drawn  membrane  contours  were  digitized  using  AccuTab  digitizer 
(GTCO Corporation, USA) (Figure 8.5).  A program was developed to convert the 
drawn membrane contours into mathematical XY contours. The XY contours were 
then exported to an Excel® spread sheet and subsequently graphs were drawn 
using the data obtained.  
 
Figure 8.5: AccuTab digitizer used for digitizing membrane profiles.  
 
8.2.4 Analysis of digitized shapes 
The curves obtained by digitizing the hand drawn membrane contours were then 
arbitrarily aligned by hand to align them as closely as possible. Having done this 
the curves were analysed to describe mathematically the lines of best of fit and 
95% range. This data was analysed by Pengwei Hao (Dept of computer science, 
QMUL) and Yanlin Geng (State Key Lab of Machine Perception, Beijing University, 
China) to define a suitable membrane shape.  
 Chapter 8 
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8.3 RESULTS 
Various curves were obtained from digitizing the membranes shapes which were 
hand drawn over the alveolar ridges scans from mandible of different patients. 
Some of the obtained curves are shown in Figure 8.6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.6:  Curves obtained form digitized contours of membrane profiles hand drawn over 
the alveolar ridges.  
 Chapter 8 
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The curves when superimposed were broadly divided into two main groups (A) 
and (B) depending on their shapes. Figure 8.7 (a) and (b) show Group A and B 
curves respectively and a curve which best fits most of the curves in each group 
was  drawn  and  is shown  by  a  red  line.  The  parabolic best  fit  curves  of  two 
groups  are  represented  by  (a)  y= 0.1204x
2+1.8867x 0.7491  and  (b)  y= 
0.1542x
2+2.0290x+0.9172. 
 
 
Figure 8.7 (a) and (b): Two groups of superimposed curves with respective best fit curves.   
(a) Group A 
(b) Group B Chapter 8 
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As a next step inner and outer boundaries curves for the best fit curves in both 
the groups were drawn as shown in Figure 8.8 (a) and (b). These outer and inner 
boundaries  curve  of  both  best  fit  curves  enclosed  95%  of  the  curves  in  that 
particular group. It can be seen from the equations that the shape of the curves 
has  not  been  altered  it  is  just  the  offset  from  the  zero  axis  that  has  been 
changed. Thus for Group A the offset is  0.7491 with the values of  0.1220 and  
1.4339 for inner and outer boundaries, while for Group B the values for inner 
and outer boundaries are  0.1101 and + 1.9314 about the mean value of 0.9712. 
Thus if the curves   0.1204 x
2 +1.8867x and  0.1542x
2  + 2.0920x are used to 
manufacture the mould profiles they should provide an acceptably good fit to 
the required shape for most patient. 
 
 
 
 
 
(a) Group A Chapter 8 
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Figure 8.8 (a) and (b):  Best fit curves drawn with inner and outer boundaries which include 
most of the digitised curves in the respective group.   
 
In a previous study which was conducted by a group member (Dr Amber Fareed, 
Queen Mary University of London), bone resorption profiles of alveolar ridges 
were analysed using ScanOra of six patients which were under assessment for 
dental  implant  placement.  Figure  8.9  below  shows  (a)  one  of  the  ScanOra 
showing  edentulous  area  of  alveolar  ridge  used  in  the  study  (b)  hand  drawn 
alveolar bone profile on the ScanOra and (c) membrane shape hand drawn by an 
experienced periodontologist (Prof Francis Hughes) on the outline of the alveolar 
bone profile traced on a paper. Similarly membrane shapes were drawn on the 
alveolar bone outline of six different patients (Figure 8.10). 
 
(b) Group B Chapter 8 
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(a)                                     (b)                                    (c) 
Figure 8.9: (a) ScanOra of edentulous alveolar ridges, (b) alveolar bone profile tracing on the 
ScanOra and (c) outline of alveolar bone profile traced on acetate paper with hand drawn 
membrane shape [from Dr Amber Fareed].  
 
 
 
 
 
 
 
Figure 8.10: Membrane shapes hand drawn on alveolar bone outline of six different patients 
[from Dr Amber Fareed]. 
 
The membrane shapes shown in Figure 8.10 were then digitized using the same 
protocol described in section 8.2.3.  
Figure 8.11 (a) shows the digitized shapes of the various hand drawn membrane 
shapes obtained from sketching on the ScanOra of six different patients in the 
previous study. These membrane shapes surprisingly closely fit within the inner 
and outer boundaries of Group B in our study as shown in figure 8.11 (b).   Chapter 8 
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Figure 8.11: (a) Membrane shapes obtained by using ScanOra in a previous study, and (b) 
enclosed by thick black lines representing inner and outer boundaries of group B of the 
present study.     
 
8.4 DISCUSSION 
Periodontal  regeneration  is  based  on  the  concept  of  maintaining  a  space 
between soft tissue and alveolar bone by use of a GTR membrane which creates 
a  protected  environment  and  allows  osteogenic  cells  to  migrate  to  the  area 
[Cortellini and Tonetti, 2000; Park et al., 2000a].  Different types of membranes 
are currently used with varying success. Some of the pre requisites for successful 
periodontal bone regeneration are the ability of the GTR membranes to adapt to 
the bone defect, full coverage of the defected area and ability to maintain a 
space without collapsing under pressure by overlying flaps due to tissue tension, 
mastication or other physiological forces which are transmitted through the flap 
[Tatakis et al., 1999b; Lee et al., 2001a]. The importance of space maintenance 
by the GTR membrane in periodontal regeneration is well documented and had 
been  reported  in  various  studies.  GTR  membrane  collapse  or  failure  of 
maintaining space between the soft tissue and defect area by the membrane due 
(a) 
(b) Chapter 8 
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to  inadequate  or  improper  placement  results  in  compromised  periodontal 
regeneration [Polimeni, 2004].     
The objective of this study was to analyse profiles of mandibular alveolar ridges 
of different patients and define a shape for GTR membranes which can be used 
for  the  vast  majority  of  periodontal  defects.  A  suitable  sized  and  shaped 
membrane  will  not  only  reduce  the  time  needed  to  complete  the  clinical 
procedure but will also enable the clinician to place the membrane properly 
with reduced risk of failure. This can be achieved by defining a shape of the 
membrane which can fit most of the defects. 
CT imaging was used for the evaluation of alveolar ridges. It is one of the most 
commonly  employed  imaging  tools  in  implant  dentistry  for  alveolar  bone 
assessment. Cross sectional and 3 dimensional images can be obtained by using 
CT scans [Garg and Vicari, 1995]. CT scans not only provide information about 
the quantity of the bone available but it is also possible to asses its quality, 
including  thickness  of  cortical  bone  and  cancellous  bone  density.  Three 
dimensional images of the jaw bone can be constructed and stereolithographic 
models can be fabricated using data obtained by CT scans [Floyd et al., 1999; 
BouSerhal et al., 2002].  
CT scans of 7 patients were selected and 39 cross sectional slices from different 
areas of mandibular alveolar ridges were obtained. These cross sectional slices 
of alveolar ridges were then used to draw a suitable shape GTR membrane. The 
digitized  profiles  of  these  membrane  shapes  were  superimposed  to  define  a 
membrane shape which can fit most of the profiles. Interestingly it was found 
that the obtained curves can be broadly divided into two groups. To define a 
shape for the membrane a curve was then drawn which best fit all the curves in 
both the group. Further inner and outer boundaries curves for the best fit curves 
were  drawn  and  it  was  found  that  the  boundary  curves  enclosed  95%  of  the 
curves in a particular group.  
In addition, when comparing the present study with an additional pilot study in 
our group, the total number of patients evaluated for defining the membrane 
shape was 13. It can be seen that most of the alveolar ridge patterns closely 
resemble each other.   Chapter 8 
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Thus  it  can  be  considered  that  the  alveolar  ridge  resorption  patterns  do  not 
differ  a  lot  from  each  other  and  that  most  alveolar  ridge  resorption  defects 
could be treated with few pre formed shapes of GTR membranes. As this study 
shows that the selected curve from each group after minimal chair side trimming 
should be able to fit most of the alveolar ridges in that group.  
Although the CT scans analysed in this study were obtained for potential implant 
cases  rather  than  periodontology  involved  cases,  as  the  radiographic 
examination for implant assessment typically requires tomographic or CT cross 
sections through the jaws, it was felt that this was an appropriate compromise. 
Firstly  because  these  membranes  may  have  application  for  GBR  in  implant 
therapy as well as for periodontal regeneration.  Secondly it is expected that 
buccal lingual profiles obtained from these data are likely to be similar to those 
required for periodontal defects also. Further larger studies would be useful to 
confirm further the universality of this observation.  In addition the study has so 
far restricted itself to analysis of mandibular profiles only, and requires to be 
extended to maxillary profiles in future studies. 
8.5 CONCLUSIONS 
Although a wider study is required to validate fully the findings of this study, it 
can be suggested that relatively few number of pre moulded membranes can be 
employed for the regeneration of maximum number of periodontal defects.  
CHAPTER  9:  GENERAL  DISCUSSION,  FUTURE  WORK 
AND CONCLUSIONS 
9.1 GENERAL DISCUSSION 
Over the last two decades GTR has evolved as a technique to treat periodontal 
defects [Becker and Becker, 1993; Caffesse et al., 1997]. Various studies have 
shown its superiority over flap debridement procedures for its ability to promote 
periodontal  regeneration  [Needleman  et  al.,  2002;  Maurizio  et  al.,  2004]. 
However,  the  fact  remains  that  the  overall  outcomes  for  periodontal 
regeneration using GTR are relatively modest [Michael and Ulf, 2001] and when 
compared to results obtained with other regeneration techniques such as grafts, 
the differences were not substantial.  
Both  resorbable  and  nonresorbable  membranes  are  used  for  GTR  procedures. 
However  all  the  membranes  used  have  limitations  which  affect  the  overall 
outcome of this technique. Resorbable membranes do not require removal with 
a  second  surgical  procedure.  However,  most  of  them  either  lack  adequate 
stiffness  or  collapse under  pressure due  to  too early  loss  of  strength,  so  the 
essential  requirement  of  space  maintenance  is  lost  and  the  results  are 
compromised [McAllister and Haghighat, 2007].  Non resorbable membranes have 
comparatively better strength, but are generally difficult to adapt due to their 
stiffness and can also damage the soft tissues. To overcome the limitations of 
GTR membranes and to obtain better results, GTR membranes are typically used 
in combination with other regenerative techniques such as grafts. However, the 
use of graft materials may have disadvantages according to the type of graft 
used. For example autologus bone causes considerable donor site morbidity, and 
allograft or xenograft materials increase the risk of disease transfer [Sogal and 
Tofe, 1999].  
Thus there is a need to develop a membrane with better physical and biological 
properties.  Ideally it should  have  good clinical  manageability, have  sufficient 
strength to resist pressures from the overlying flap and those exerted during 
mastication, should not only maintain a space and act as a barrier between the 
defect and soft tissue, but also facilitate the regeneration of bone by virtue of Chapter 9 
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having  osteoconductive  properties  and  finally  resorb  without  side  effects. 
Furthermore,  there may  be  additional advantages  for  a  material  to  have  the 
ability to carry growth factors or be seeded by autogenous stem or progenitor 
cells.  
PLA Ca  P  composites  have  been  investigated  as  potential  GTR  membrane 
materials with improved physical and biological properties. The aim of the study 
presented here was to develop a membrane which would fulfil most if not all the 
requirements of an ideal membrane. 
One  of  the  major  problems  associated  with  the  currently  available  materials 
which results in their failure is that they are difficult to adapt to the defect and 
there is a possibility that they will not properly cover the defect or collapse into 
the  defect  space.  To  improve  the  clinical  manageability  and  to  improve  the 
adaption,  it  would  be  ideal  to  have  high  strength  prefabricated  membranes 
which will require minimum chair side preparation and still cover the defect 
appropriately. In a pilot study the profiles of mandibular alveolar bone has been 
investigated  among  different  patients  to  define  shapes  for  GTR  membranes. 
Interestingly, it was found that a low number of different membrane shapes can 
fit most of the mandibular alveolar bone profiles analyzed in this study. The 
limitations  of  this  study  were  that  firstly,  only  the  mandibular  ridges  were 
analysed  and  secondly,  the  CT  images  studied  were  of  the  patients  under 
treatment  for  dental  implants  rather  than  for  periodontal  diseases.  Although 
further investigations are required to validate these findings, it is proposed that 
a few shapes of prefabricated GTR membranes will be suitable to be employed 
for most defects. This development would enable the use of stiffer membranes 
with  high  strength.  Additionally  these  membranes  will  require  minimum 
chairside preparation. Thus the membrane material investigated will have good 
clinical manageability if used as pre fabricated membranes. 
Another  limitation  of  currently  used  membranes  is  the  inability  to  withstand 
occlusal pressures and their collapse into the defect area. This collapse is either 
due to lack of strength or too early loss  of stiffness, before sufficient tissue 
regeneration  has  occurred.  When  collapsed,  a  membrane  loses  its  barrier 
function of preventing migration of the faster growing epithelial and connective 
tissue cells to the bone defect and does not maintain a space for repopulation of Chapter 9 
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the defect area by osteogenic cells. A fibre reinforced PLA HA composite has 
been investigated as a membrane material. Fibre reinforcement in addition to 
HA will increase the strength and stiffness and will enable the fabrication of 
membranes with better mechanical properties [Bleach et al., 2001]. From the 
study  carried  out  to  test  the  flexural  strength  of  the  membranes,  it  can  be 
concluded  that  by  changing  the  orientation  of  fibres  in  a  multiple  layer 
membrane the mechanical properties can be manipulated and further improved 
to optimise the membrane stiffness and strength. Additionally the use of high 
strength fibre reinforced composite materials for the fabrication of pre shaped 
membranes will eliminate the drawbacks associated with the manageability and 
adaptation of the stiffer membrane materials. Although the optimal thickness of 
membranes and hence the number of layers within a membrane, has not been 
determined here, it is recognised that it is probably desirable to keep such a 
membrane as thin as possible and further studies on thinner membranes would 
be useful in future.  
Tissue regeneration may be enhanced and clinical outcomes can be improved if a 
barrier  membrane  also  possesses  bioactive  and  osteoconductive  properties.  
Tests were carried out to analyse the bioactivity and osteoconductivity of the 
proposed composite membrane materials. The results  showed that adding HA 
increased the bioactivity  and  osteoconductivity  of  the  material.  A  membrane 
fabricated using this composite material may thus not only act as a barrier but 
might  also  have  increased  bioactivity  and  osteoconductivity  to  enhance  its 
regenerative potential.  
In  various  studies  growth  factors  have  shown  the  potential  to  induce  and 
enhance the regeneration of periodontal tissues [Cho et al., 1995; Nevins et al., 
2003]. Therefore, there is a considerable interest in the therapeutic application 
of growth factors for periodontal regeneration. An ideal GTR membrane might 
therefore be able to carry and release growth factors in a sustained manner. In a 
preliminary study, albumin and serum proteins were used to analyse the kinetics 
of  protein  interactions  with  fibre  reinforced  PLA HA  composite.  The  results 
showed that the ability of these composites to absorb and release the proteins in 
a sustained manner were dependent on the manufacturing parameters used for 
the membranes. These parameters can be manipulated to optimise the potential 
of these composite materials as growth factor carrier. Furthermore, the ability Chapter 9 
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of PLA HA composite films to absorb and release PDGF and its effect on the 
proliferation of osteoblast cells was tested. The results showed that the PDGF 
added  to  the  composite  materials  retained  its  activity  and  enhanced  the 
proliferation  of  osteoblasts  when  seeded  onto  these  composite  materials. 
Growth factors lost or released into the wrong tissue may limit their clinical 
effectiveness. To address this issue it is proposed to achieve a unidirectional 
release of growth factors by coating the two sides of the membrane with thin 
films of different materials. The permeability of PLA and PLA HA composite films 
was  tested  and  from  the  results  it  was  concluded  that  the  PLA  films  were 
relatively  impermeable  and  the  permeability  increased  with  increase  in  the 
quantity of HA in the films. So the surface of the membrane towards the soft 
tissue could be coated with an impermeable PLA film to prevent the release of 
growth factors on that side, while the bone side could be composite film, thus 
achieving a unidirectional release of growth factor to the appropriate target. As 
basic  protein interaction  kinetics  with  the  fibre  reinforced  PLA HA  composite 
were investigated, further studies involving growth factors (PDGF and BMPs) are 
needed to validate the ability of these composite materials to carry and release 
growth factors.   
One of the issues related with early resorbable materials was their unpredictable 
degradation behaviour and the accumulation of their degradation products due 
to  too  rapid  degradation  [Bostman  and  Pihlajamaki,  2000].  The  degradation 
pattern of PLA Ca P composites was investigated. The results showed that the 
addition of Ca P to the polymer slowed the degradation rate of PLA. Addition of 
Ca P to the polymer may also neutralize the acidic aspect of PLA degradation 
[Niemelä,  2005].  Although  this  study  analyzed  the  effect  of  Ca  P  on  the 
degradation of PLA, it did not take into consideration the effect of fibre matrix 
interfaces  in  the  proposed  multilayer  fibre  reinforced  PLA HA  composite 
membrane on the degradation rate, therefore a study is needed to analyse the 
degradation rate of fibre reinforced membranes. The degradation rate of a fibre 
reinforced PLA HA composite can be tailored to suite the application by altering 
the quantity of L and D isomers in the PLA and concentration of HA.     
From the investigations carried out in this project it can be proposed that a fibre 
reinforced PLA HA composite material will be a suitable material to develop for 
use  as  a  GTR  membrane  and  may  offer  significant  advantages  over  existing Chapter 9 
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materials for this application.  Although the materials investigated in this study 
have shown favourable properties to be used as a GTR membrane material, all 
the tests have been performed in vitro. To be sure about the properties of these 
materials and to ascertain how these materials will perform clinically, in vivo 
tests are required including full clinical evaluation.   
9.2 FUTURE WORK 
Although overall results of the studies described are very encouraging, there are 
a number of studies required to further develop these composite materials for 
possible clinical use. These include various aspects of in vitro testing.  However, 
ultimately  the  potential  application  can  really  only  be  tested  adequately  in 
human clinical trials. Some specific further studies which would be valuable are 
considered below: 
1)  Work is required to improve the reliability of membrane manufacture; in 
particular  to  test  the  parameters  which  can  be  used  to  produce  the 
membranes  without  any  defect.  Studies  are  required  to  optimise  the 
processing  of  prepreg  and  the  fabrication  of  fibre  reinforced  PLA HA 
composite membranes. Use of different prepreg lay ups in the composite 
membrane and their effect on the mechanical properties of the membrane 
need  to  be  investigated  to  optimise  the  stiffness  and  strength  of  the 
membranes. 
2)  Long term  degradation  studies  should  be carried  out.  Additionally,  tests 
should  be  done  to  analyze  the  effects  of  moulding  temperature  and 
pressure on the degradation of the membranes.  
3)  The ability of these membranes to carry and release antibiotics and other 
growth  factors  such  as  BMPs  needs  to  be  investigated.  Fabrication  of 
multilayered membranes consisting of different surface layers be carried 
out to test the directional release of growth factors and proteins.    
4)  Further analysis is required of bone profiles of maxillary and mandibular 
alveolar ridges in both edentulous patients and patients with periodontal Chapter 9 
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diseases  to  broaden  and  validate  the  findings  of  mandibular  ridge 
resorption profiles done in the present study.  
5)  Ultimately, the suitability of these membranes for GTR procedures needs to 
be evaluated in vivo.  This might involve animal studies, although as these 
materials  have  all  been  used  extensively  in  alternative  applications  in 
humans, this might not be necessary or particularly informative. Human 
clinical studies are required firstly to demonstrate safety and basic efficacy 
of the membranes in the first instance.  In the longer term, membranes 
may  have  a  variety  of  different  applications  requiring  slightly  different 
preparations, for example with supplemented growth factors, seeded stem 
cells and for antibiotic delivery. 
9.3 CONCLUSIONS 
1)  PLA Ca  P  composites  containing  three  different  types  HAs  and  one  TCP 
were produced. The production process of the films was optimised and the 
Ca  P  powders  and  PLA Ca  P  films  produced  were  characterised.  Three 
different concentrations of the fillers were used for the manufacturing of 
PLA Ca  P  films  and  their  effect  on  the  film’s  character  was  evaluated. 
Increasing  the  concentration  of  the  filler  increased  its  amount  on  the 
surface, which affected the roughness of the films.  
2)  The bioactivity of the PLA Ca P composite films was dependent on the type 
and  concentration  of  the  HA  and  TCP  used.  The  bioactivity  of  the 
composite films increased with increases in the HA or TCP concentration.  
3)  The degradation of PLA decreased with the addition of Ca P. The highest 
weight  gain  was  shown  by  films  containing  highest  HA  or  TCP 
concentrations. In addition to PLA degradation, Ca P dissolution from the 
composite films also added to the overall weight loss. 
4)  The  proliferation  of  osteoblast  and  PDL  cells  was  highest  on  films 
containing 10 wt % nHA, whereas the highest ALP activity was shown by 
cells on films containing 70 wt % nHA. The addition of PDGF to the films 
increased the proliferation of osteoblasts. Chapter 9 
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5)  The  fibre  reinforced  PLA HA  composite  membranes  produced  at  low 
temperature and pressure showed more sustained protein release than the 
membranes produced at higher temperature and pressure.  Non filled PLA 
films  did  not  show  any  permeability,  whereas  the  permeability  of  the 
composite films increased with increase in the nHA content. 
6)  Analysis of mandibular alveolar bone profiles showed that there was not 
much difference between them and only two specific shapes of membranes 
can fit most patients. 
7)  The flexural strength of the fibre reinforced PLA HA composite membranes 
was dependent on prepreg sheet lay up. The flexural strength was highest 
for  the  membranes  containing  the  maximum  number  of  prepreg  at  0°, 
although transverse fibres are needed for lateral strength.   
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